Index to volume 75

Index to volume Author

--15

index

A Aaberge I, Heier H, Hem E, Giercksky K, Groeng E, 9 (Abst.) Adams GK III, Lichtenstein LM, 20 (Abst.) Adler TR, 3 1 Adolphson CR, 84 Agarwal MK, 84 Ahlstedt S, 37, 594 Alazia M, 338 Alpers MP, 75 Amaud A, 338 Arya SK, Gal10 RC, Hahn BH, Shaw GM, Popovic M, Slaahuddin SZ, Wong-Staal F, 13 (Abst.) Asas SI, Kemeny DA, Youlten LSF, Frankland AW, Lessof MH, 10 (Abst.) Astmc J, 646 Atkins FM, 348, 356 Atkins PC, 239 Auritt WA, 731 Austen KF, 479, 640

C Carroll MP, 290 Chambers M, 304 Chandra R, 12 (Abst.) Charpin J, 338 Chestnut RY, 395 Clauzel A-M, 70 Cogen FC, 728 Committee on drugs, the American Academy of Allergy Immunology, 443 Corey P, 313 Croce CM, Isobe M, Palumbo A, Puck J, Ming J, Tweardy D, Erikson J, 24 (Abst.) Crowley W, 268 Cunningham-Rundles C, Siegal FP, Smithwick EM, Lion-Boule A, CunninghamRundles S, O’Malley J, Barandun S, Good RA, 12 (Abst.) Cushley MJ, 272

B Bahna S, Kaushik S, 22 (Abst.) Ballas ZK, 297 Bardana El Jr. 423 Basran G, Ball A, Hanson .I, Morley J, Turner-Warwick M, 15 (Abst.) Basran GS, Page CP, Paul W, Morley J, 10 (Abst.) Baughman RP, Ploysongsang Y, James W, 5 (Abst.) Beall GN, 31 Bernstein DI, 663 Bernstein IL, 663 Bhagat RG, Chai H, 25 (Abst.) Bjdrksttn B, 594 Blaauw PJ, 556 Bleecker ER, 21 Bock A, 411 Bongrand P, 338 Borgen LA, 698 Borst BC III, 395 Bousquet J, 70, 646 Bousquet J, Fizet D, 3 (Abst.) Brandon ML, 698 Breslin ABX, 364 Bresson K, 720 Broder I, 313 Bmszer GV, 659 Bullough B, 709 Burnett JW, 672 Burroughs HE, 663 Bush RK, 268 Busse WW, 268

D Dal-11 MV, Swanson DL, Jacob HS, 9 (Abst.) Dahlberg MJE, 279 Danish M, 716 David TJ, Wybrew M, Hemressen U, 14 (Abst.) Davies G, 313 Davies RR, 23 (Abst.) Dawkins RL, 373 Day N, Good R, Wahn V, 8 (Abst.) Des Prez L, 334 Dhivert H, 70 Dolovich J, 563, 578 Donohue JI-I, Rosenstein M, Chang AE, Lotze MT, Robb RJ, Rosenberg SA, 17 (Abst.) Dor P, 338 Dowse GK, 75 Drake-Lee AB, Bickerton R, McLanglan P, 26 (Abst.) Durham SR, 290 Dvorin DJ, 735 E Eil C, 395 Eisenbrey AB, 84 Enander I, 37 Engel P, Huguet J, Sanosa J, Sierra P, Cols N, Garcia-Calderon PA. 4 (Abst.) Engler RJM, 395 Erffmeyer JE, 401

F Fabbri LM, 568 Fearon DT, 640 Fink JN, 279 Fletcher MP, 411 Ford A, 676 Freiman P, 297 Friedman SA, Bernstein IL, Emione M, Marcus ZH, 4 (Abst.) Furukawa CT, Shapiro GG, Bierman CW, Kraemer MJ, Ward DJ, Pierson WE, 7 (Abst.) Fusi S, Kupper TS, Green DR, Ariyan S, 24 (Abst.) G Gallagher JS, 663 Galli SJ, Hammel I, 13 (Abst.) Gallo RC, Blattner WA, 17 (Abst.) Gellis S, 304 Georgitis JW, 496, 614, 735 Gershwin ME, 411 Gjesing B, 258 Gleich GJ, 84 Goldstein M, 728 Goldstein MF, 472 Grammer LC, 382, 705 Greene J, 716 Grijnneberg R, 586 Grundbacher FJ, 65 1 Gundersen G, 720 H Hackney JD, Linn WS, Bailey RM, Spier CE, Valencia LM, 15 (Abst.) Haida M, 686 Hall-Craggs M, Light PD, Peters RW, 20 (Abst.) Halmepuro L, Vicontela K, Kalimo K, Bjorksten F, 12 (Abst.) Halverson PC, 297 Halwig JM, 450 Harada S, 320 Hargreave FE, 25, 573, 578 Hartley TF, 501 Hay B, Reade M, 9 (Abst.) Heiner DC, 3 1 Hemady Z, 304 Hendrick DJ, 568 Hewitt B, 70 Hindi-Alexander MC, 709 Hjemdahl P, 586 Hobara T, Kobayashi H, Higashihara E, Kawamoto T, Iwamoto S, Shimazu W, Sakai T, 8 (Abst.) Hoffman DR, 599, 606, 614

(part l), pp. l-102; February, pp. 227-398; March, pp. 329-422; April, pp. 423-530; May, pp. 531-632; June, pp. 633-788. Abstracts: January, pp. 1-2; February, pp. 3-6; March, pp. 7-10; April, pp. 11-14; May, pp. 15-22; June, pp. 23-26.

January

747

748

Author

J. ALLERGY CLIN. IMMUNOL. JUNE 1985

index

Holgate ST, 272 Hollander Dl, 450 Hongo 0,686 Hosoi S, 320 Hudgel DW, Robertson DW, 21 (Abst.) I likura Y, 285 Ind PW, Causon RD, Brown MJ, Barnes PJ, 19 (Abst.) Inouye T, 3 13 Inui H, 285 Ishihara T, 47 Isles AF, 317 Ito K, 686 Jager L, 258 Jenkins C, 364 Johansson SGO, 452 Johnson AJ, Nunn AJ, Somner AR, Stableforth DE, Stewart CJ, 11 (Abst.) Johnson CE, Weiner JS, Wagner DS, McLean JA, 5 (Abst.) Joslyn A, 621 Juniper EF, 25, 578 K Kagey-Sobotka A, 672 Kane JH, 496 Kassis V, Vedel P, Datre E, 24 (Abst.) Katz RM, 698 Kay AB, 290 Kemp JP, 55, 468 Kennedv LK. 578 Kidd J,-279 King TP, 621 Kochoumian L, 621 Komstein MJ, 472 Kroutil LA, 268 L Larsson K, 586 Latimer KM, 25 Lattimore M, 373 Laurent J, Lagme G, Belghiti D, Noirot C, Hlc G, 1 (Abst.) Leboff-Ries E, 44 Lee TH, 285 Lee W, 563 Leiberman PL, 501 Levinson AI, 472 Lewis RA, 479 -Lewis MN. Tattersfield AE, 3 (Abst.) Leznoff A, 3l3 Lichtenstein LM, 672 Lieberman P, 401 London WM, 709 Longbottom JL, 242 uwenstein H, 258, 676 Lowhagen 0, 343, 460 Lutsky I, 279 M McFadden ER Jr, 479 McGeady SJ, 731 McGrath K, 741 McGrath KG, 44 Machado L, 508 McKiiey P, 450 Maestrelli P, 568 Magnusson CGM, 5 13

Mansmann HC Jr, 334, 716, 731 Mapp CE, 568 Markman M, Howell SB, King M, Pfeifle C, Wasserman SI, I1 (Abst.) Marlin GE, 364 March DG, 258 Marshall CP, 563 Mascoli C, 659 Massie FS, 651 Masson PL, 5 13 Matsuo S, 291 May CD, 329,485 Meltzer EO, 468, 501 Mtnardo JL, 646 Merrett J, Bametson RStC, Burr ML, Merrett TG, 25 (Abst.) Meskauskas JA, 334 Messina MS, 252 Metcalfe DD, 348, 356 Metzaer WJ, 297 Michel F-B, 70, 646 Middleton E Jr, 709 Mikawa H, 320 Mintz S, 313 Mitsuya H, Popovic M, Yarchoan R, Matsushita S, Gallo RC, Broder S, 26 (Abst.) Mizushima Y, Shoji Y, Hoshi K, Kiyokawa S, 1 (Abst.) Miyamoto T, 686 Moller DR, 663 Montes N, 709 Morris HG, 1 Morris MM, 573 Mue S, 47 Mule JJ, Shu S, Schwarz SL, Rosenberg SA, 7 (Abst.) Murphy GF, 479 Mygind N, 720 N

Nagakura T, 285 Nagaya H, 388 Nagy SM, 411 Nakajima T, 686 Nakano H, 320 Nelson JC, 659 Nepom GT, Nelson KA, Holbeck SL, Hellstrom 1, Hellstrom KE, 24 (Abst.) Newth CJL, 377 Nickelsen JA, 496 Nordvall SL, 594 Norman PS, 531 Noyes JN, 501 Nygren H, 37 0

O’Connor J, 578 O’Connor RD, Ott H, Leong AB, Cook DA, Street D, Hamburger RN, 19 (Abst.) Gertel T, Loehr MM, 5 (Abst.) Offord KP, 84 Ogita T, 686 Okamura K, Furukawa K, Nakakuki M, Yamada K, Suzuki M, 13 (Abst.) Okudaira H, 686 Grgel HA, 55,468 Ough C, 411

P Patterson R, 44, 67, 382, 450, 705, 741 Pearlman DS, 501 Pearson FC, 563 Petersen LN, 720 Peterson BN, 720 Petry RW, 268 Pichurko BM, McFadden ER Jr, Bowman HF, Solway J, Bums S, Dowling N, 21 (Abst.) Pick R, 44 Pierson W, 334 Piotrowski W, Devoy MAB, Jordan CC, Foreman JC, 14 (Abst.) Platts-Mills TAE, 676 Polato R, 568 R Rachelefsky GS, 698 Ragni MC, 716 Rak S, 343, 460 Ramsdale EH, 573 Randolph CC, 735 Rauls DO, 63 Reiman BEF, 63 Reisman RE, 496, 553, 735 -Littler SJ, Wypych JI, 19 (Abst.) Richard JM, Bedford JM, Witkin SS, 2 (Abst.)

Richerson HB, 297 Roberts RS, 25, 573, 578 Rocci ML Jr, 716 Rocklin RE, 304 Rod&e M, 646 Rosen FS, 640 Rosenberg SA, Grimm EA, McGrogan M, Doyle M, Kawasaki E, Lotlis K, Mark DF, 16 (Abst.) Rosner DH, 709 Russell M, Dark KM, Cummins RW, Ellman G, Callaway G, Peeke HVS, 6 (Abst.) Ryan G, 25 S Sabharwal UK, 31 Saccar CL, 7 16 Saeona MA. 359. 563 SaL M, Eskola ‘J, Nikoskelainen J, 18 (Abst.) Saperstein H, Rapaport M, Rietschel RL, 4 (Abst.) Schmitt LH, 373 Schwartz HJ, 525 Seagroatt V, 676 Senft M, 338 Serkes K, 659 Sharath MD, 297 Sheffer AL, 227, 479, 640 Sher TH, 525 Shinomiya K, 320 Shulan DJ, 297 Siegel SC, 698 Siegle RL, 401 Slavin RG, 334 Smaldone GC, 252 Smith JM. 297 Smithuis LOMJ, 556 Sonin L, 67, 705 Souhrada M, Souhrada JF, 6, 20 (Abst.) Stalenheim G, 508

Author

VOLUME 75 NUMBER 6

Steinberg SS, 348, 356 Stelander M, 594 Stenhammar L, Kilander AF, Nilsson L-A, Stromberg L, Tarkowski A, 18 (Abst.) Stewart GA, 75 Stuckev MS. 373 Suszko-IM, 382 Swanson K, 31 Syty-Golda M, 578

Tuft DS, 411 Turner KJ, 75 V Vervloet D, 338 Voss E Jr, 2 (Abst.) Voss MJ, 268 Vmeburg K, deGroot K, von Blomberg M, Scheper R, 16 (Abst.)

T

w

Takishima T, 47 Talbot S, 472 Tamura G. 47 Tar10 S, 313 Thomas P, 313 Ting S, 63 Tinkelman DG. 55. 501 Togias AG, 672 Tong AKF, 479 Tucker J, Barnetson RStC, Eden OB, 23 (Abst.)

Walls AF, 242 Walsh G, 290 Ward RA. 563 Warlow R, 373 Wathen RL, 563 Webb DR Jr, 55 Weiler JM. 297 Weiss EB,‘692 Weiss SH, Goedert JJ, Sarngadharan MG, Bodner AJ, 17 (Abst.) Welch MJ, 468

index

749

Wiener D, 741 Wihl J-A, 720 Wilcox TG, 663 Wilson RL, 297 Witt CS, 373 Woolcock AJ, 75 Wuthrich B, 452 Wypych JI, 496 Y Yaffe SJ, 716 Yomtovian R, Press C, Engman H, Kline W, Clay M, Hammerschmidt D, McCullough J, 17 (Abst.) Yunginger JW, 84, 279 Z Zciger RS, 633 Zetterstrijm 0, 594 Zielezny MA, 709 Zortea-Caflisch C, 452 Zweiman B, 239, 728

Subject index A Abortions,

repeated spontaneous, immunological analysis of women with, 3 (Abst.) Adenosine-induced bronchoconstriction in asthma: role of mast cell-mediator release (Cushley MJ and Holgate ST), 272 Adrenoceptors, alpha and beta, role of, in airway hyperresponsiveness to histamine (Jenkins C et al), 364 Adverse effects and complications of treatment with beta-adrenergic agonist drugs (Committee on drugs, the American Academy of Allergy and Immunology), 443 (Position statement) Aerosols, bitolterol and albuterol metered-dose: comparison of two long-acting beta,-adrenergic bronchodilators for treatment of asthma (Orgel HA et al), 55 techniques, quantitative, evaluation of, for use in bronchoprovacation studies (Messina MS and Smaldone GC), 252 Agonist, beta-adrenergic, drugs, adverse effects and complications of treatment with (Committee on drugs, the American Academy of Allergy and Immunology), 443 (Position statement) beta,, new long-acting oral, in bronchial asthma: placebo-controlled trial of procaterol (Siegel SC et al), 698 AIDS agent (HTLV-III) antibodies specificity, sensitivity, and applications, screening test for, 17 (Abst.) associated virus, homology of genome of, with genomes of human T cell leukemia viruses, 13 (Abst.) Airway(s) cooling, is it due to: asthma induced by suggestion? 3 (Abst.) reactivity and asthma: significance and treatment (Bleecker ER), 2 1 (Editorial) responsiveness, time course of increase in, associated with late asthmatic reactions to toluene diisocyanate in sensitized subjects (Mapp CE et al), 568 smooth muscle cell membrane, immunologically induced alterations of, 6, 20 (Abst.) temperature in normal subjects, influence of cromolyn sodium on, 21 (Abst.) Albumin, human semm-polymerized soluble venom (Patterson R et al), 382 Albuterol and bitolterol metered-dose aerosols: comparison of two long-acting beta,-adrenergic bronchodilators for treatment of asthma (Orgel HA et al), 55 inhaled, powder for treatment of asthma-dose-response study (Orgel AH et al), 468 Allergen(s)and histamine-induced bronchoconstriction, activation of neutrophils and monocytes after (Carroll MP et al), 290 extracts, comparison of rat fur, urine, saliva, and other rat, by skin testing, RAST, and RAST inhibition (Walls AF and Longbottom JL), 242 histamine sensitivity influences reactivity to (Stuckey MS et al), 373 house dust, is possible causal factor for relapses in lipoid nephrosis, 1 (Abst.) in birch pollen, fruits, and vegetables, cross-reactivity of IgE antibodies with, 12 (Abst.) Hymenoptera venom XIII: isolation and purification of protein components from three species of vespid venoms (Hoffman DR), 599 venom XIV: IgE binding activities of venom proteins from three species of vespids (Hoffman DR), 606 January (part 1). 329-422; April, 788. Abstracts: 7-10; April, pp. 750

pp. l-102; February, pp. 227-328; March, pp. pp. 423-530; May, pp. 531-632; June, pp. 633January, pp. l-2; February, pp. 3-6; March, pp. 11-14; May, pp. 15-22; June, pp. 23-26.

Allergen(s)-cont’d XV: immunologic basis of vespid venom cross-reactivity (Hoffman DR), 611 induced bronchoconstriction by circulating epinephrine in asthmatic subjects, bronchodilatation and inhibition of in (Larsson K et al), 586 irritant, and source of antibodies to Trichophyron rubrum: human nail dust in chiropodial practice, 23 (Abst.) nightly asthma caused by, in silk-filled quilts: clinical and immunologic studies (Johansson SGO et al), 452 of house dust mite Dermafophagoidesfurinue-immunochemical studies of four allergenic fractions (Haida M et al), 686 possible mediator of dual response to? Platelet-activating factor, 10 (Abst.) provocation on complement system, late allergic bronchial reactions and effect of (Stllenheim G and Machado L). 508 relevant, bronchial hyperreactivity after treatment with sodium cromoglycate in atopic asthmatic patients not exposed to (Lowhagen 0 and Rak S), 343 single exposure method for inhalation challenge with (Tamura G et al), 47 -specific IgG in human sera, monoclonal anti-human IgG antibodies for quantitation of (Hosoi S et al), 320 Allergenic, biochemical, and immunologic properties of vespid venoms collected in early and late summer, comparison of, 19 (Abst.) extract, timothy (Phleum prarense) grass pollen, international collaborative study establishing first international standard for (Gjesing B et al), 258 fractions, four, immunochemical studies of-allergens of house dust mite Dermurophagoides farinae (Haida M et al), 686 properties of rat urine and pelt extracts (Lutsky I et al), 279 Allergic and nonallergic black and white individuals, levels of immunoglobulin G, M, A, and E at various ages in (Grundbacher FJ and Massie FS), 651 rhinitis, perennial, effect of nonsedative H,-receptor antagonist astemizole in (Petersen BN et al), 720 respiratory disease using monoclonal antibodies, T cell subsets in, 4 (Abst.) rhinitis (Norman PS), 531 (CME article) Allergy(ies), ancestry of: being account of original experimental induction of hypersensitivity recognizing contribution of Paul Portier (May CD), 485 and immunology, recertification in: historical review with special emphasis on 1983 examination (Slavin RG et al), 334 multiple physical, occurrence of, in same patient: report of three cases (Sonin L et al), 705 physical, serious form of, associated with mast cell degranulation: exercise-induced anaphylaxis (Sheffer AL et al), 479 stinging insect: progress and problems (Reisman RE), 553 (Editorial) to ethylene oxide gas sterilization, reactions during hemodialysis caused by (Marshall CP et al), 563 local dental anesthesia, bisulfite sensitivity manifesting as (Schwartz HJ and Sher TH), 525 (Case report) Alpha and beta adrenoceptors, role of, in airway hyperresponsiveness to histamine (Jenkins C et al), 364 -chain, gene for, of human T cell receptor: location on chromosome 14 region involved in T cell neoplasms, 24 (Abst.) Anaesthetists, T- and B-lymphocyte function in, 18 (Abst.)

Subject

VOLUME 75 NUMBER 6

Analysis,

detailed, of reaction patterns during oral food challenge. II. Evaluation of immediate adverse reactions to foods in adult patients (Atkins FM et al), 356 immunological, of women with repeated spontaneous abortions, 3 (Abst.) Anaphylactic reaction to cytarabine: in vitro evidence that response is immunoglobulin E mediated, 11 (Abst.) to radiocontrast material (Erffmeyer JE et al), 401 (Allergy grand rounds) Anaphylaxis (Sheffer AL), 227 (CME article) after contact with jellyfish (Togias AG et al), 672 bee sting: use of medical antishock trousers, 5 (Abst.) chymopapain, skin testing in (Cogen FC et al), 728 exercise-induced: serious form of physical allergy associated with mast cell degranulation (Sheffer AL et al), 479 human seminal plasma, successful long-term immunotherapy for, 4 (Abst.) idiopathic, metabisulfite challenge in patients with (Sonin L and Patterson R), 67 Anesthesia, local dental, bisulfite sensitivity manifesting as allergy to (Schwartz HJ and Sher TH), 525 (Case report) Antagonist, H,-receptor, astemizole, nonsedative, effect of, in perennial allergic and nonallergic rhinitis (Petersen BN et al), 720 Antibodies, antiidiotypic, in mice, induction of immunity to human tumor marker in vivo administration of, 24 (Abst.) HTLV-III (AIDS agent), specificity, sensitivity, and applications, screening test for, 17 (Abst.) IgE, cross-reactivity of, with allergens in birch pollen, fruits, and vegetables, 12 (Abst.) increased, responses in rats exposed to tobacco smoke (Zetterstrom 0 et al), 594 levels, total and specific IgG4, in atopic eczema, 25 (Abst.) monoclonal anti-human IgG, for quantitation of allergen-specific IgG in human sera (Hosoi S et al), 320 T cell subsets in allergic respiratory disease using, 4 (Abst.) neutrophil-specific, severe pulmonary hypersensitivity associated with passive transfusion of, 17 (Abst.) serum giiadin, for detection and control of childhood coeliac disease, 18 (Abst.) to Trichophyton rubrum. irritant, allergen, and source of: human nail dust in chiropodial practice, 23 (Abst.) Antigen E, ragweed, seasonal variation of in vitro lymphocyte proliferative response to (Eisenbrey AB et al), 84 indometbacin enhances responses of human bronchus to, 20 (Abst.) nasal, challenge in children with allergic thin&is, tympanometric changes following, 19 (Abst.) Antigenic cross-reactivity of venom proteins from hornets, wasps, and yellow jackets (King TP et al), 621 Antiidiotypic antibodies in mice, induction of immunity to human tumor marker in vivo administration of, 24 (Abst.) Antishock trousers, medical, use of: bee sting anaphylaxis, 5 (Abst.) Aphthous ulceration, recurrent, of oral cavity, use of elimination diet in treatment of, 9 (Abst.) Aspirin, crossed tolerance to pyrazolines, mephenamic acid, and glafenine in A. S. A.-triad patients desensitized to (Morales MC et al), 528 (Correspondence) effect of, in aspirin-sensitive patients, 10 (Abst.) -sensitive rhinosinusitislasthma: spectrum of adverse reactions to aspirin (Gtzelewska-Rzymowska I et al), 629 (Correspondence) Astemizole, nonsedative H,-receptor antagonist, in perennial allergic and nonallergic rhinitis (Petersen BN et al), 720 Asthma, acute bronchial, comparative study of aerosolized terbutaline and subcutaneously administered epinephrine in treatment of, 5 (Abst.) circulating catecholamines in, 19 (Abst.) water and electrolyte status in children with, 22 (Abst.)

index

751

Asthma-cont’d adenosine-induced bronchoconstriction in: role of mast cell-mediator release (Cushley MJ and Holgate ST), 272 airways reactivity and: significance and treatment (Bleecker ER), 2 1 (Editorial) association between Dermarophagoides mites and increasing prevalence of, in village communities within the Papua New Guinea highlands (Dowse GK et al), 75 bronchial, new long-acting oral beta,-agonist in: placebo-controlled trial of procaterol (Siegel SC et al), 698 -what are those inflammatory cells doing there anyway? (Atkins PC and Zweiman B), 239 childhood, prodromal itching in, 14 (Abst.) circulating B-adrenoceptor blocking factors in, 15 (Abst.) circumstances of death from, 11 (Abst.) comparison of two long-acting beta,-adrenergic bronchodilators for treatment of: bitolterol and albuterol metered-dose aerosols (Orgel HA et al), 55 controlled nonsteroid-dependent, effect of beclomethasone dipropionate on bronchial responsiveness to histamine in (Ryan G et al), 25 effect of phenobarbital on theophylline disposition in children with (Saccar CL et al), 716 formaldehyde-rare or overlooked (Nordman H et al), 91 in skin test-negative and skin test-positive patients, severity of (Inouye T et al), 313 induced by suggestion: is it due to airway cooling? 3 (Abst.) inhaled albuterol powder for treatment of-dose-response study (Orgel HA et al), 468 mechanisms of action and therapeutic role of corticosteroids in (Morris HG), 1 (CME article) model, toxic oxygen products alter calcium homeostasis in (Weiss EB), 692 monkey dander (Petry RW et al), 268 nightly, caused by allergens in silk-filled bed quilts: clinical and immunologic studies (Johansson SGO et al), 452 pharmacokinetics of sustained-release theophylline preparation in infants and preschool children with (Isles AF and Newth CJL), 377 irhinosinusitis, aspirin-sensitive: spectrum of adverse reactions to aspirin (Grzelewska-Rzymowska I et al), 629 (Correspondence) Asthmatic patients, atopic, not exposed to relevant allergens, bronchial hyperreactivity after treatment with sodium cromoglycate in (L(iwhagen 0 and Rak S), 343 reactions to toluene diisocyanate in sensitized subjects, time course of increase in airway responsiveness associated with (Mapp CE et al), 568 responses, exercise-induced late, factors predisposing to (Iikura Y et al), 285 Asymptomatic bronchial hyperresponsiveness in rhinitis (Ramsdale EH et al), 573 Atopy after bone marrow transplantation, 23 (Abst.) asthmatic patients not exposed to relevant allergens, bronchial hyperreactivity after treatment with sodium cromoglycate in (Lowhagen 0 and Rak S), 343 eczema, total and specific IgG4 levels in, 25 (Abst.) in infancy and early childhood: natural history and role of skin testing (Zeiger RS), 633 (Editorial) B Beclomethasone

dipropionate, effect of, on bronchial responsiveness to histamine in controlled nonsteroid-dependent asthma (Ryan G et al), 25 Bee and yellow jacket venom, evaluation of common diagnostic methods of hypersensitivity for, by means of in-hospital insect sting (Blaauw PJ and Smithuis LOMJ), 556 sting anaphylaxis: use of medical antishock trousers, 5 (Abst.)

752

Subject index

Bermuda grass pollen extracts, immunologic and clinical correlates of bronchial challenge responses to (Adler TR et al), 31 Beta-adrenergic agonist drugs, adverse effects and complications of treatment with (Committee on drugs, the American Academy of Allergy and Immunology), 443 (Position statement) bronchodilators, two long-acting, for treatment of asthma, comparison of: bitolterol and albuterol metered-dose aerosols (Grgel HA et al), 55 adrenoceptor, circulating, blocking factors in asthma, 15 (Abst.) ,-agonist, new long-acting oral, in bronchial asthma: placebocontrolled trial of procaterol (Siegel SC et al), 698 and alpha adrenoceptors, role of, in airway hyperresponsiveness to histamine (Jenkins C et al), 364 Biochemical, immunologic, and allergenic properties of vespid venoms collected in early and late summer, comparison of, 19 (Abst.) Biological activity of recombinant human interleukin-2 produced in Escherichia coli, 16 (Abst.) Birch pollen, fruits, and vegetables, cross-reactivity of IgE antibodies with allergens in, 12 (Abst.) Bisulfite sensitivity manifesting as allergy to local dental anesthesia (Schwartz I-II and Sher TH), 525 (Case report) Bitolterol and albuterol metered-dose aerosols: comparison of two long-acting beta,-adrenergic bronchodilators for treatment of asthma (Orgel HA et al), 55 Black and white individuals, allergic and nonallergic, levels of immunoglobulin G, M, A, and E at various ages in (Grundbacher FJ and Massie FS), 651 “Bleach, dry, industry, failure of enzyme encapsulation to prevent sensitization of workers in,” updating article by Liss et al (Whorton MD and Morgan RW), 630 (Correspondence) Blood, human cord, application to: immunoglobulin E assayedafter pepsin digestion by automated and highly sensitive particle counting immunoassay (Magnusson CGM and Masson PL), 513 lymphocytes, human, effect of dexamethasone on de novo IgE synthesis by (Hemady Z et al), 304 Bone marrow transplantation, atopy after, 23 (Abst.) Breast disease, fibrocystic, and theophylline (Hindi-Alexander MC et al), 709 Bronchial asthma, acute, comparative study of aerosolized terbutaline and subcutaneously administered epinephrine in treatment of, 5 (Abst.) new long-acting oral beta,-agonist in: placebo-controlled trial of procaterol (Siegel SC et al), 698 -what are those inflammatory cells doing there anyway? (Atkins PC and Zweiman B), 239 challenge responses to Bermuda grass pollen extracts, immunologic and clinical correlates of (Adler TR et al), 31 hyperreactivity after treatment with sodium cromoglycate in atopic asthmatic patients not exposed to relevant allergens (L(iwhagen 0 and Rak S), 343 modification of, after treatment with sodium cromoglycate during pollen season (Lowhagen 0 and Rak S), 460 hyperresponsiveness, asymptomatic, in rhinitis (Ramsdale EH et al), 573 reactions, late allergic, and effect of allergen provocation on complement system (Stalenheim G and Machado L), 508 responsiveness to histamine in controlled nonsteroid-dependent asthma, effect of beclomethasone dipropionate on (Ryan G et al), 25 Bronchoconstriction, allergen- and histamine-induced, activation of neutrophils and monocytes after (Carroll MP et al), 290 -induced, by circulating epinephrine in asthmatic subjects, bronchodilatation and inhibition of (Larsson K et al), 586

J. ALLERGY CLIN. IMMUNOL. JUNE 1985

Bronchoconstriction-cont’d exercise-induced, in asthmatics exposed to sulfur dioxide, time course of, 15 (Abst.) in asthma, adenosine-induced: role of mast cell-mediator release (Cushley MJ and Holgate ST), 272 Bronchodilatation and inhibition of allergen-induced bronchoconstriction by circulating epinephrine in asthmatic subjects (Larsson K et al), 586 Bronchodilators, two long-acting beta,-adrenergic, for treatment of asthma, comparison of: bitolterol and albuterol metered-dose aerosols (Orgel HA et al), 55 Bronchoprovacation studies, evaluation of quantitative aerosol techniques for use in (Messina MS and Smaldone GC), 252

Calcium channel-blocking agent nifedipine, development of immune complex nephritis during treatment with, 20 (Abst.) homeostasis, toxic oxygen products alter, in asthma model (Weiss EB), 692 Cataracts, posterior supcapsular, development of, in asthmatic children, 25 (Abst.) Catecholamines, circulating, in acute asthma, 19 (Abst.) Cells, antigen-specific suppressor, induction of, in patients with hay fever receiving immunotherapy (Nagaya H), 388 human T, leukemia viruses, homology of genome of AIDS-associated virus with genomes of, 13 (Abst.) inflammatory, what are those doing there anyway-bronchial asthma (Atkins PC and Zweiman B), 239 LAK, and recombinant interleukm-2, adaptive immunotherapy of established pulmonary me&stases with, 7 (Abst.) mast-deficient and beige mice, unequivocal delayed hypersensitivity in, 13 (Abst.) degranulation, serious form of physical allergy associated with: exercise-induced anaphylaxis (Sheffer AL et al), 479 membrane, airway smooth muscle, immunologically induced alterations of, 6 (Abst.) natural killer, activity during pregnancy, 13 (Abst.) rat mast, substance Preceptor on, and in human skin, 14 (Abst.) smooth muscle, airway, membrane, immunologically induced alterations of, 20 (Abst.) T, subsets in allergic respiratory disease using monoclonal antibodies, 4 (Abst.) Cerebrospinal fluid and plasma theophylline concentrations in children and adolescents taking theophylline, relationship of (Au&t WA et al), 731 Challenge, controlled oral food, correlation of demographic, laboratory, and prick skin test data with response to. I. Evaluation of immediate adverse reactions to foods in adult patients (Atkins FM et al), 348 inhalation, with allergen, single exposure method for (Tamura Getal), metabisulfite, in patients with idiopathic anaphylaxis (Sonin L and Patterson R), 67 nasal antigen, in children with allergic rhinitis, tympanometric changes following, 19 (Abst.) oral food, detailed analysis of reaction pattems.during. II. Evaluation of immediate adverse reactions to foods in adult patients (Atkins FM et al), 356 responses, bronchial, to Bermuda grass pollen extracts, immunologic and clinical correlates of (Adler TR et al), 3 1 Chemonucleolysis, reactivity of IgE and IgG serum levels to chymopapain after (Sagona MA et al), 659 Chiropodial practice, human nail dust in: irritant, allergen, and source of antibodies to Trichophyton rubrum, 23 (Abst.) Chromium and nickel, induction of immunological tolerance by oral administration of, 16 (Abst.)

Subject

VOLUME 75 NUMBER 6

sodium, influence of, on airway temperature in normal subjects, 21 (Abst.) Chromosome 14 region, location of, involved in T cell neoplasms: gene for u-chain of human T cell receptor, 24 (Abst.) Chymopapain anaphylaxis, skin testing in (Cogen FC et al), 728 reactivity of IgE and IgG serum levels to, after chemonucleolysis (Sagona MA et al), 659 Clinical investigator and consultant to industry and Food and Drug Administration (FDA), my role as (Weinberger M), 100 (Correspondence) Coeliac disease, childhood, serum giiadin antibodies for detection and control of, 18 (Abst.) Complement, acquired deficiency of inhibitor of first component of: report of five additional cases with commentary on syndrome (Sheffer AL et al), 640 system, late allergic bronchial reactions and effect of allergen provocation on (Stfilenheim G and Machado L), 508 Cord blood, human, application to: immunoglobulin E assayed after pepsin digestion by automated and highly sensitive particle counting immunoassay (Magnusson CGM and Masson PL) , 5 13 Corticosteroids in asthma, mechanisms of action and therapeutic role of (Morris HG), 1 (CME article) Cromolyn sodium and sustained-release theophylline in childhood asthma, double-blind study comparing effectiveness of, 7 (Abst.) Cross-reactivity, antigenic, of venom proteins from hornets, wasps, and yellow jackets (King TP et al), 621 vespid venom, immunologic basis of: allergens in Hymenoptera venom XV (Hoffman DR), 611 Cutaneous reactions, immediate, effect of H,- and Hz-receptor blockade on inhibition of, 5 (Abst.) Cytarabine, anaphylactic reaction to: in vitro evidence that response is immunoglobulin E mediated, 11 (Abst.) D

753

E

Cromolyn

Dander asthma, monkey (Petry RW et al), 268 Data, demographic, laboratory, and prick skin tests, with response to controlled oral food challenge, correlation of. I. Evaluation of immediate adverse reactions to foods in adult patients (Atkins FM et al), 348 Degranulation, mast cell, serious form of physical allergy associated with: exercise-induced anaphylaxis (Sheffer AL et al), 479 Dental anesthesia, local, bisulfite sensitivity manifesting as allergy to (Schwartz HJ and Sher TH), 525 (Case report) Dermatitis, contact, to methyl methacrylate, 24 (Abst.) -eosinophilia syndrome: treatment with methylprednisolone pulse therapy, 9 (Abst.) Dermatophugoides mites and increasing prevalence of asthma, association between, in village communities within Papua New Guinea highlands (Dowse GK et al), 75 pteronyssinus (house dust mite) extract, collaborative study on first international standard of (Ford A et al), 676 Desensitized, A. S. A.-triad patients, to aspirin, crossed tolerance to pyrazolines, mephenamic acid, and giafenine in (Morales MC et al), 528 (Correspondence) Dexamethasone, effect of, on de novo IgE synthesis by human blood lymphocytes (Hemady Z et al), 304 Dust allergen, house, is possible causal factor for relapses in lipoid nephrosis, 1 (Abst.) human nail, in chiropodial practice: irritant, allergen, and source of antibodies to Trichophyton rubrum, 23 (Abst.) mite, house, Dernuztophagoides farinae, allergens of-immunochemical studies of four allergenic fractions (Haida M et al), 686 extract, (Dermatophagoides pteronyssinus), collaborative study on first international standard of (Ford A et al), 676

index

Eczema, atbpic, total and specific IgG4 levels in, 25 (Abst.) Electrolyte and water status in children with acute asthma, 22 (Abst.) Elephantiasis no&as 1984 (Hollander DI et al), 450 “Enzyme encapsulation, failure of, to prevent sensitization of workers in dry bleach industry,” updating article by Liss et al (Wharton MD and Morgan RW), 630 (Correspondence) Eosinophilia-dermatitis syndrome: treatment with methylprednisolone pulse therapy, 9 (Abst.) Epinephrine, circulating, in asthmatic subjects, bronchodilatation and inhibition of allergen-induced bronchoconstriction by (Larsson K et al), 586 subcutaneously administered, and aerosolized terbutaline in treatment of acute bronchial asthma, comparative study of, 5 (Abst.) Eruption, erythema multiform-like, topical vitamin E as cause of, 4 (Abst.) Erythema multiform-like eruption, topical vitamine E as cause of, 4 (Abst.) Escherichia co/i, biological activity of recombinant human interleukin-2 produced in, 16 (Abst.) Ethylene oxide gas sterilization, reactions during hemodialysis caused by allergy to (Marshall CP et al), 563 Exercise-induced late asthmatic responses, factors predisposing to (Iikura Y et al), 285 Extracts, Bermuda grass pollen, immunologic and clinical correlates of bronchial challenge responses to (Adler TR et al), 31 Dermotophagoides pteronyssinus (house dust mite), collaborative study on first international standard of (Ford A et al), 676 low-dose aqueous ragweed, efficacy of: local nasal immunotherapy (Georgitis JW et al), 496 pelt, and rat urine, allergenic properties of (Lutsky I et al), 279 polyethylene glycol-modified ragweed pollen, in rhinoconjunctivitis (Juniper EF et al), 578 timothy (Phleum prafense) grass pollen allergenic, international collaborative study establishing first international standard for (Gjesing B et al), 258 F Factor,

is house dust allergen possible causal, for relapses in lipoid nephrosis, 1 (Abst.) rheumatoid IgE, detection and clinical significance of, 1 (Abst.) “False positive,” term, use of, in referring to results of food skin tests (Bock SA), 528 (Correspondence) Fibroblasts, cultured skin, effects of triacetyloleandomycin and oleandomycin phosphate on glucocorticoid receptor in (Engler RJM et al), 395 Fibrocystic breast disease and theophylline (Hindi-Alexander MC et al), 709 Fluocortin butyl, efficacy and tolerance of, administered twice daily in adult patients with perennial rhinitis (Hartley TF et al), 501 Food(s) hypersensitivity, are confusion and controversy about, really necessary? (May CD), 329 (Editorial) in adult patients, evaluation of immediate adverse reactions to. I. Correlation of demographic, laboratory, and prick skin test data with response to controlled oral food challenge (Atkins FM et al), 348 in adult patients, evaluation of immediate adverse reactions to. II. Detailed analysis of reaction patterns during oral food challenge (Atkins FM et al), 356 skin tests, use of term “false positive” in referring to results of (Bock SA), 528 (Correspondence) Formaldehyde asthma-rare or overlooked (Nordman H et al), 91 Fruits, birch pollen, and vegetables, cross-reactivity of IgE antibodies with allergens in, 12 (Abst.)

754

Subject

index

Fur, urine, saliva, rat, comparison of, and other rat allergen extracts by skin testing, RAST, and RAST inhibition (Walls AF and Longbottom JL), 242 G Gamma globulin, adverse reactions in selected patients after intravenous infusions of, 8 (Abst.) Gene for a-chain of human T cell receptor: location on chromosome 14 region involved in T cell neoplasms, 24 (Abst.) Genome, homology of, of AIDS-associated virus with genomes of human T cell leukemia viruses, 13 (Abst.) Giiadin, serum, antibodies for detection and control of childhood coeliac disease, 18 (Abst.) Gingivitis, factitious desquamative, simulating possible immunologic disease (McGrath KG et al), 44 Glafenine, pyrazolines, and mephenamic acid, crossed tolerance to, in A.S.A.-triad patients desensitized to aspirin (Morales MC et al), 528 (Correspondence) Glucocorticoid receptor in cultured skin fibroblasts, effects of triacetyloleandomycin and oleandomycin phosphate on (Engler RJM et al), 395 Granuloma, necrotizing, acquired hyper-IgM syndrome with (Goldstein MF et al), 472 Grass pollen allergenic extract, timothy (Phleum prafense) international collaborative study establishing first intemational standard for (Gjesing B et al), 258 extracts, Bermuda, immunologic and clinical correlates of bronchial challenge responses to (Adler TR et al), 31 H H,- and H,-receptor blockade on inhibition of immediate cutaneous reactions, effect of, 5 (Abst.) H,-receptor antagonist astemizole, nonsedative, effect of, in perennial allergic and nonallergic rhinitis (Petersen BN et al), 720 Hay fever, induction of antigen-specific suppressor cells in patients with, receiving immunotherapy (Nagaya H), 388 Hemodialysis, reactions during, caused by allergy to ethylene oxide gas sterilization (Marshall CP et al), 563 Hexahydrophthalic anhydride, detection of IgE-mediated respiratory sensitization in workers exposed to (Moller DR et al), 663 Histamine- and allergen-induced bronchoconstriction, activation of neutrophils and monocytes after (Carroll MP et al), 290 free, in nasal polyp fluid, 26 (Abst.) in controlled nonsteroid-dependent asthma, effect of beclomethasone dipropionate on bronchial responsiveness to (Ryan G et al), 25 release in vivo, antigen-induced, inhibitory effect of hydroxyzine on (Ting S et al), 63 learned, 6 (Abst.) leukocyte, to suxamethonium in patients with adverse reactions to muscle relaxants (Vervloet D et al), 338 role of alpha and beta adrenoceptors in airway hyperresponsiveness to (Jenkins C et al), 364 sensitivity influences reactivity to allergens (Stuckey MS et al), 373 Homeostasis, calcium, toxic oxygen products alter, in asthma model (Weiss EB), 692 Homology of genome of AIDS-associated virus with genomes of human T cell leukemia viruses, 13 (Abst.) Hornets, wasps, and yellow jackets, antigenic cross-reactivity of venom proteins from (King TP et al), 621 House dust allergen, is possible causal factor for relapses in lipoid nephrosis, 1 (Abst.) HTLV-III (AIDS agent) antibodies specificity, sensitivity, and applications, screening test for, 17 (Abst.) suramin protection of T cells in vitro against infectivity and cytopathic effect of, 26 (Abst.)

J. ALLERGY CLIN. IMMLINOL. JUNE 1985

Human, anti-, IgG antibodies, monoclonal, for quantitation of allergen-specific IgG in human sera (Hosoi S et al), 320 blood lymphocytes. effect of dexamethasone on de novo IgE synthesis by (Hemady Z et al), 304 bronchus to antigen, indomethacin enhances response of, 20 (Abst.) nail dust in chiropodial practice: irritant, allergen, and source of antibodies to Trichuphyton rubrum, 23 (Abst.) recombinant, interleukin-2 produced in Escherichia coli, biological activity of, 16 (Abst.) seminal plasma anaphylaxis, successful long-term immunotherapy for, 4 (Abst.) sera, monoclonal anti-human IgG antibodies for quantitation of allergen-specific IgG in (Hosoi S et al), 320 skin, substance P receptor in, and on rat mast cells, 14 (Abst.) T cell leukemia viruses, homology of genome of AIDS-associated virus with genomes of, 13 (Abst.) receptor, gene for o-chain of: location on chromosome 14 region involved in T cell neoplasms, 24 (Abst.) tumor marker, induction of immunity to, in vivo administration of antiidiotypic antibodies in mice, 24 (Abst.) Humoral immunity and prolonged weightlessness, 2 (Abst.) Hymenoptera venom XIII, allergens in: isolation and purification of protein components from three species of vespid venoms (Hoffman DR), 599 XIV, allergens in: IgE binding activities of venom proteins from three species of vespids (Hoffman DR), 606 XV, allergens in: immunologic basis of vespid venom crossreactivity (Hoffman DR), 611 Hyper-IgM syndrome, acquired, with necrotizing granuloma (Goldstein MF et al), 472 Hyperreactivity, bronchial, after treatment with sodium cromoglycate in atopic asthmatic patients not exposed to relevant allergens (Lowhagen 0 and Rak S), 343 modification of, after treatment with sodium cromoglycate during pollen season (L(iwhagen 0 and Rak S), 460 Hyperresponsiveness, airway, to histamine, role of alpha and beta adrenoceptors in (Jenkins C et al), 364 asymptomatic bronchial, in rhinitis (Ramsdale EH et al), 573 Hypersensitivity, food, are confusion and controversy about, really necessary? (May CD), 329 (Editorial) for bee and yellow jacket venom by means of in-hospital insect sting, evaluation of common diagnostic methods of (Blaauw PJ and Smithuis LOMJ), 556 recognizing contribution of Paul Portier, being account of original experimental induction of: ancestry of allergy (May CD),

485

severe pulmonary, associated with passive transfusion of neutrophil-specific antibody, 17 (Abst.) unequivocal delayed hypersensitivity in mast cell-deficient and beige mice, 13 (Abst.) Human cord blood, application to: immunoglobulin E assayed after pepsin digestion by automated and highly sensitive particle counting immunoassay (Magnusson CGM and Masson PL), 513 serum albumin-polymerized soluble venom (Patterson R et al), 382 Hydroxyzine, inhibitory effect of, on antigen-induced histamine release in vivo (Ting S et al), 63

IgE and IgG serum levels, reactivity of, to chymopapain after chemonucleolysis (Sagona MA et al), 659 antibodies, cross-reactivity of, with allergens in birch pollen, fruits and vegetables, 12 (Abst.) binding activities of venom proteins from three species of vespids: allergens in Hymenoptera venom XIV (Hoffman DR), 606 increased, antibody responses in rats exposed to tobacco smoke (Zetterstrom 0 et al), 594

Subject

VOLUME 75 NUMBER 6

IgE-cont’d -mediated

respiratory sensitization, detection of, in workers exposed to hexahydrophthalic anhydride (Moller DR et al), 663 rheumatoid factor, detection and clinical significance of, 1 (Abst.) synthesis, de novo, by human blood lymphocytes, effect of dexamethasone on (Hemady Z et al), 304 IgG and IgE serum levels, reactivity of, to chymopapain after chemonucleolysis (Sagona MA et al), 659 and IgM response to pneumococcal polysaccharide vaccine in normal individuals and individuals splenectomized due to trauma, 9 (Abst.) antibody levels, total and specific, in atopic eczema, 25 (Abst.) antibodies, monoclonal anti-human, for quantitation of allergenspecific IgG in human sera (Hosoi S et al), 320 IgM and IgG response to pneumococcal polysaccharide vaccine in normal individuals and individuals splenectomized due to trauma, 9 (Abst.) hyper-, syndrome, acquired, with necrotizing granuloma (Goldstein MF et al), 472 Immune complex nephritis, development of, during treatment with calcium channel-blocking agent nifedipine, 20 (Abst.) responses, excessive intake of zinc impairs, 12 (Abst.) in rabbits, rectal insemination modified, 2 (Abst.) Immunity, induction of, to human tumor marker in vivo administration of antiidiotypic antibodies in mice, 24 (Abst.) prolonged weightlessness and humoral, 2 (Abst.) Immunoassay, automated and highly sensitive particle counting, immunoglobulin E assayed after pepsin digestion by: application to human cord blood (Magnusson CGM and Masson PL), 5 13 lmmunochemical studies of four allergenic fractions-allergens of house dust mite Dermarophagoidesfan’nae (Haida M et al), 686 Immunodeficiency disease, primary humoral, efficacy of intravenous immunoglobulin in, 12 (Abst.) lmmunoglobulin E assayed after pepsin digestion by automated and highly sensitive particle counting immunoassay: application to human cord blood (Magnusson CGM and Masson PL), 513 mediated, in vitro evidence that response is: anaphylactic reaction to cytarabine, 11 (Abst.) G, M, A, and E, levels of, at various ages in allergic and nonallergic black and white individuals (Grundbacher FJ and Massie FS), 651 intravenous, efficacy of, in primary humoral immunodeficiency disease, 12 (Abst.) Immunologic, biochemical, and allergenic properties of vespid venoms collected in early and late summer, comparison of, 19 (Abst.) disease, factitious desquamative gingivitis simulating possible (McGrath KG et al), 44 Immunological analysis of women with repeated spontaneous abortions, 3 (Abst.) tolerance, induction of, by oral administration of nickel and chromium, 16 (Abst.) lmmunomodulatory therapy, recent developments in (Bardana EJ), 423 (CME article) Immunotherapy, induction of antigen-specific suppressor cells in patients with hay fever receiving (Nagaya H), 388 local nasal: efficacy of low-dose aqueous ragweed extract (Georgitis JW et al), 496 successful long-term, for human seminal plasma anaphylaxis, 4 (Abst.) venom, natural history and modification with: stinging insect allergy (Reisman RE et al), 735 lndomethacin enhances responses of human bronchus to antigen, 20 (Abst.) Inhalation challenge with allergen, single exposure method for (Tamura G et al), 47

index

755

Inhibition

of immediate cutaneous reactions, effect of H,- and Hzreceptor blockade on, 5 (Abst.) RAST, skin testing, and RAST, comparison of rat fur, urine, saliva, and other rat allergen extracts by (Walls AF and Longbottom JL), 242 Inhibitor of first component of complement, acquired deficiency of: report of five additional cases with commentary on syndrome (Sheffer AL et al), 640 Insect sting, in-hospital, evaluation of common diagnostic methods of hypersensitivity for bee and yellow jacket venom bv means of (Blaauw PJ and Smithuis LOMJ). 556 stinging, allergy: natural history and modification with venom immunotherapy (Reisman RE et al), 735 progress and problems (Reisman RE), 553 (Editorial) natural history of large local reactions from (Goldstein GL). 743 (Correspondence) Insemination, rectal, modifies immune responses in rabbits, 2 (Abst.) lnterleukin-2, purified, enhances ability of sensitized murine lymphocytes to cure disseminated syngeneic lymphoma, systemic administration of, 17 (Abst.) recombinant, and LAK cells, adaptive immunotherapy of established pulmonary metastases with, 7 (Abst.) human, produced in Escherichin coli, biological activity of, I6 (Abst.) International collaborative study establishing first international standard for timothy (Phleum prufense) grass pollen allergenic extract (Gjesing B et al), 258 Itching, prodromal, in childhood asthma, 14 (Abst.)

Jellyfish,

anaphylaxis

Kimura’s

disease, boy dence)

after contact

with

(Togias

AG et al), 672

K with

(Cunningham

AS),

629 (Correspon-

L LAK

cells and recombinant interleukin-2, adaptive immunotherapy of established pulmonary metastases with, 7 (Abst.) Leukemia viruses, human T cell, homology of genome of AIDSassociated virus with genomes of, 13 (Abst.) Leukocyte histamine release to suxamethonium in patients with adverse reactions to muscle relaxants (Vervloet D et al), 338 Lipoid nephrosis, is house dust allergen possible causal factor for relapses in, 1 (Abst.) Lymphocytes, human blood, effect of dexamethasone on de novo IgE synthesis by (Hemady Z et al), 304 proliferative response, in vitro, to ragweed antigen E. seasonal variation of (Eisenbrey AB et al), 84 sensitized murine, systemic administration of purified interleukin-2 enhances ability of, to cure disseminated syngeneic lymphoma, 17 (Abst.) T- and B-, function in anaesthetists, 18 (Abst.) Lymphoma, disseminated syngeneic, systemic administration of purified interleukin-2 enhances ability of sensitized murine lymphocytes to cure, 17 (Abst.) M

Marrow, bone, transplantation, atopy after, 23 (Abst.) Mast cell-deficient and beige mice, unequivocal delayed hypersensitivity in, 13 (Abst.) degranulation, serious form of physical allergy associated with: exercise-induced anaphylaxis (Sheffer AL et al), 479 -mediator release, role of: adenosine-induced bronchoconstriction in asthma (Cushley MJ and Holgate ST), 272 rat, substance P receptor on, and in human skin, 14 (Abst.) Mechanisms of action and therapeutic role of corticosteroids in asthma (Morris HG), 1 (CME article)

756

Subject

J. ALLERGY CLIN. IMMUNOL. JUNE 1985

index

airway smooth muscle cell, immunologically induced alterations of, 6, 20 (Abst.) Mephenamic acid, pyrazolines, and glafenine, crossed tolerance to, in A. S. A.-triad patients desensitized to aspirin (Morales MC et al), 528 (Correspondence) Metabisulfite challenge in patients with idiopathic anaphylaxis (Sonin L and Patterson R), 67 Metastases, established pulmonary, with LAK cells and recombinant interleukin-2, adaptive immunotherapy of, 7 (Abst.) Methyl methacrylate, contact dermatitis to, 24 (Abst.) Methylprednisolone pulse therapy, treatment with,: dermatitis-eosinophilia syndrome, 9 (Abst.) Mites, Dermutophugoides, and increasing prevalence of asthma, association between, in village communities within Papua New Guinea highlands (Dowse GK et al), 75 house dust, (Dermarophagoides preronyssinus), collaborative study on first international standard of (Ford A et al), 676 Monoclonal antibodies, T cell subsets in allergic respiratory disease using, 4 (Abst.) anti-human IgG antibodies for quantitation of allergen-specific IgG in human sera (Hosoi S et al), 320 Monocytes and neutrophils, activation of, after allergen- and histamine-induced bronchoconstriction (Carroll MP et al), 290 Murine lymphocytes, sensitized, systemic administration of purified interleukin-2 enhances ability of, to cure disseminated syngeneic lymphoma, 17 (Abst.) Muscle, airway smooth, cell membrane, immunologically induced alterations of, 6, 20 (Abst.) My role as clinical investigator and consultant to industry and Food and Drug Administration (FDA) (Weinberger M), 100 (Correspondence)

P

Membrane,

N Nail

dust,

human, in chiropodial practice: irritant, allergen, and source of antibodies to Trichophyton rubrum, 23 (Abst.) Nasal antigen challenge in children with allergic rhinitis, tympanometric changes following, 19 (Abst.) immunotherapy, local: efficacy of low-dose aqueous ragweed extract (Georgitis JW et al), 496 polyp fluid, free histamine in, 26 (Abst.) resistance during wakefulness and sleep in normal man, 21 (Abst.) Neoplasms, T cell, location on chromosome 14 region involved in: gene for o-chain of human T cell receptor, 24 (Abst.) Nephritis, complex, immune, development of, during treatment with calcium channel-blocking agent nifedipine, 20 (Abst.) Nephrosis, lipoid, is house dust allergen possible causal factor for relapses in, 1 (Abst.) Neutrophils and monocytes, activation of, after allergen- and histamine-induced bronchoconstriction (Carroll MP et al), 290 Nickel and chromium, induction of immunological tolerance by oral administration of, 16 (Abst.) Nifedipine, calcium channel-blocking agent, development of immune complex nephritis during treatment with, 20 (Abst.) Nonatopic children, applicability of rhinomanometry in: comparison of three techniques (Georgitis JW), 614 Nostras, elephantiasis, 1984 (Hollander DI et al), 450 0 Oleandomycin

Oxygen

phosphate and triacetyloleandomycin on glucocorticoid receptor in cultured skin fibroblasts, effects of (Engler RJM et al), 395 products, toxic, alter calcium homeostasis in asthma model (Weiss EB), 692

P, substance,

receptor on rat mast cells and in human skin, 14 (Abst.) Pelt extracts and rat urine, allergenic properties of (Lutsky I et al), 279 Pepsin digestion, immunoglobulin E assayed after, by automated and highly sensitive particle counting immunoassay: application to human cord blood (Magnusson CGM and Masson PL), 5 13 Pharmacokinetics of sustained-release theophylline preparation in infants and preschool children with asthma (Isles AF and Newth CJL), 377 Phenobarbital, effect of, on theophylline disposition in children with asthma (Saccar CL et al), 716 Phleum prufense (timothy) grass pollen allergenic extract, international collaborative study establishing first intemational standard for (Gjesing B et al), 258 Placebo-controlled trial of procaterol: new long-acting oral beta,agonist in bronchial asthma (Siegel SC et al), 698 Plasma, anaphylaxis, human seminal, successful long-term immunotherapy for, 4 (Abst.) theophylline concentrations and cerebrospinal fluid in children and adolescents taking theophylline, relationship of (Auritt WA et al), 731 Platelet-activating factor: possible mediator of dual response to allergen? 10 (Abst.) Pneumococcal polysaccharide vaccine in normal individuals and individuals splenectomized due to trauma, IgM and IgG response to, 9 (Abst.) Pollen allergenic extract, timothy (Phleum prarense) grass, international collaborative study establishing first intemational standard for (Gjesing B et al), 258 birch, fruits, and vegetables, cross-reactivity of IgE antibodies with allergens in, 12 (Abst.) extracts, Bermuda grass, immunologic and clinical correlates of bronchial challenge responses to (Adler TR et al), 31 polythylene glycol-modified ragweed, extract in rhinoconjunctivitis (Juniper EF et al), 578 season, modification of bronchial hyperreactivity after treatment with sodium cromoglycate during (Lowhagen 0 and Rak S), 460 sunflower, occupational allergy to (Bousquet 1 et al), 70 Polyethylene glycol-modified ragweed pollen extract in rhinoconjunctivitis (Juniper EF et al), 578 Polyp fluid, nasal, free histamine in, 26 (Abst.) Portier, Paul, recognizing contribution of, being account of original experimental induction of hypersensitivity: ancestry of allergy (May CD), 485 Pregnancy, natural killer cell activity during, 13 (Abst.) Procaterol, placebo-controlled trial of: new long-acting oral beta,agonist in bronchial asthma (Siegel SC et al), 698 Prodromal itching in childhood asthma, 14 (Abst.) Protamine sulfate, serious adverse reactions to: are alternatives needed (Weiler JM et al), 297 Protein(s) components from three species of vespid venoms, isolation and purification of: allergens in Hymenoptera venom XIII (Hoffman DR), 599 venom, from hornets, wasps, and yellow jackets, antigenic crossreactivity of (King TP et al), 621 three species of vespids, IgE binding activities of: allergens in Hymenoptera venom XIV (Hoffman DR), 606 Provocation, allergen, on complement system, late allergic bronchial reactions and effect of (Stalenheim G and Machado L), 508 Pulmonary hypersensitivity, severe, associated with passive transfusion of neutrophil-specific antibody, 17 (Abst.) metastases, established, with LAK cells and recombinant interleukin-2, adaptive immunotherapy of, 7 (Abst.)

Subject

VOLUME 75 NUMBER 6

Pyrazolines,

mephenamic acid, and glafenine, crossed tolerance to, in A. S. A.-triad patients desensitized to aspirin (Morales MC et al), 528 (Correspondence) R

Radiocontrast

material, anaphylactoid reactions to (Erffmeyer JE et al), 401 (Allergy grand rounds) Ragweed antigen E, in vitro lymphocyte proliferative response to, seasonal variation of (Eisenbrey AB et al), 84 extract, low-dose aqueous, efficacy of: local nasal immunotherapy (Georgitis JW et al), 496 polyethylene glycol-modified, pollen extract in rhinoconjunctivitis (Juniper EF et al), 578 RAST, RAST inhibition, and skin testing, comparison of rat fur, urine, saliva, and other rat allergen extracts by (Walls AF and Longbottom JL), 242 Reactions, anaphylactoid, to radiocontrast material (Erffmeyer JE et al), 401 (Allergy grand rounds) immediate adverse, to foods in adult patients, evaluation of. I. Correlation of demographic, laboratory, and prick skin test data with response to controlled oral food challenge (Atkins FM et al), 348 to foods, immediate adverse, in adult patients, evaluation of. II. Detailed analysis of reaction patterns during oral food challenge (Atkins FM et al), 356 wine, adverse: grand rounds (Gershwin ME et al), 411 (Allergy grand rounds) Reactivity to allergens, histamine sensitivity influences (Stuckey MS et al), 373 Receptor blockade, H, and H,, on inhibition of immediate cutaneous reactions, effect of, 5 (Abst.) glucocorticoid, in cultured skin fibroblasts, effects of triacetyloleandomycin and oleandomycin phosphate on (Engler RJM et al), 395 H,, antagonist, astemizole, nonsedative, effect of, in perennial allergic and nonallergic rhinitis (Petersen BN et al), 720 human T cell, gene for a-chain of: location on chromosome 14 region involved in T cell neoplasms, 24 (Abst.) substance P, on rat mast cells and in human skin, 14 (Abst.) Recertification in allergy and immunology: historical review with special emphasis on 1983 examination (Slavin RG et al), 334 Relaxants, muscle, leukocyte histamine release to suxamethonium in patients with adverse reactions to (Vervloet et al), 338 Respiratoty disease, allergic, using monoclonal antibodies, T cell subsets in, 4 (Abst.) Responses bronchial challenge, to Bermuda grass pollen extracts, immunologic and clinical correlates of (Adler TR et al), 31 exercise-induced late asthmatic, factors predisposing to (Iikura Y et al), 285 immune, in rabbits, rectal insemination modifies, 2 (Abst.) in vitro, lymphocyte proliferative, to ragweed antigen E, seasonal variation of (Eisenbrey AB et al), 84 regional and systemic immune, to trinitrophenyl derivatives after intranasal and subcutaneous sensitization of mice (Enander I et al), 37 Responsiveness, airway, time course of increase in, associated with late asthmatic reactions to toluene diisocyanate in sensitized subjects (Mapp CE et al), 568 bronchial, to histamine in controlled nonsteroid-dependent asthma, effect of beclomethasone dipropionate on (Ryan G et al), 25 Rheumatoid factor, IgE, detection and clinical significance of, 1 (Abst.) Rhinitis, allergic (Norman PS), 531 (CME article) tympanomehic changes following nasal antigen challenge in children with, 19 (Abst.)

index

757

Rhinitis-cont’d asymptomatic

bronchial hyperresponsiveness in (Ramsdale EH et al), 573 perennial allergic and nonallergic, effect of nonsedative H,-receptor antagonist astemizole in (Petersen BN et al), 720 perennial, efficacy and tolerance of fluocortin butyl administered twice daily in adult patients with (Hartley TF et al), 501 Rhinoconjunctivitis, polyethylene glycol-modified ragweed pollen extract in (Juniper EF et al), 578 Rhinomanometry, applicability of, in nonatopic children: comparison of three techniques (Georgitis JW), 614 Rhinosinusitis/asthma, aspirin-sensitive: spectrum of adverse reactions to aspirin (Grzelewska-Rzymowska I et al). 629 (Correspondence) S Saliva,

fur, urine, rat, comparison of, and other rat allergen extracts by skin testing, RAST, and RAST inhibition (Walls AF and Longbottom JL), 242 Seafood allergy (Preuss L), 743 (Correspondence) Seminal plasma, anaphylaxis, human, successful long-term immunotherapy for, 4 (Abst.) Sensitivity, histamine, influences reactivity to allergens (Stuckey MS et al), 373 Sensitization, IgE-mediated respiratory, detection of, in workers exposed to hexahydrophthalic anhydride (Moller DR et al), 663 intranasal and subcutaneous, of mice, regional and systemic immune responses to trinitrophenyl derivatives after (Enander I et al), 37 “of workers in dry bleach industry, failure of enzyme encapsulation to prevent,” updating article by Liss et al (Whorton MD and Morgan RW), 630 (Correspondence) Serum(a) albumin, human-polymerized soluble venom (Patterson R et al), 382 giiadin antibodies for detection and control of childhood coeliac disease, 18 (Abst.) human, monoclonal anti-human IgG antibodies for quantitation of allergen-specific IgG in (Hosoi S et al), 320 levels, IgE and IgG, reactivity of, to chymopapain after chemonucleolysis (Sagona MA et al). 659 Silk-filled bed quilts, nightly asthma caused by allergens in: clinical and immunologic studies (Johansson SGO et al), 452 Skin fibroblasts, cultured, effects of triacetyloleandomycin and oleandomycin phosphate on glucocorticoid receptor in (Engler RJM et al), 395 human, substance P receptor in, and on rat mast cells, 14 (Abst.) tests, food, use of term “false positive” in referring to results of (Bock SA), 528 (Correspondence) -negative and skin test-positive patients, severity of asthma in (Inouye T et al), 313 prick, demographic, and laboratory data with response to controlled oral food challenge, correlation of. I. Evaluation of immediate adverse reactions to foods in adult patients (Atkins FM et al), 348 reactivity in infancy (MCnardo JL et al), 646 testing in chymopapain anaphylaxis (Cogen FC et al), 728 natural history and role of: atopy in infancy and early childhood (Zeiger RS), 633 (Editorial) RAST, and RAST inhibition, comparison of rat fur, urine, saliva, and other rat allergen extracts by (Walls AF and Longbottom JL), 242 Smoke, tobacco, increased IgE antibody responses in rats exposed to (Zetterstriim 0 et al), 594 Smooth muscle cell membrane, airway, immunologically reduced alterations of, 6 (Abst.) Sneezing, factitious (Wiener D et al), 741 (Brief communication)

758

Subject

index

J. ALLERGY CLIN. IMMUNOL. JUNE 1985

Sodium

cromoglycate during pollen season, modification of bronchial hyperreactivity after treatment with (Lowhagen 0 and Rak S), 460 in atopic asthmatic patients not exposed to relevant allergens, bronchial hyperreactivity after treatment with (Liiwhagen 0 and Rak S), 343 Sterilization, ethylene oxide gas, reactions during hemodialysis caused by allergy to (Marshall CP et al), 563 Sting anaphylaxis, bee: use of medical antishock trousers, 5 (Abst.) insect, in-hospital, evaluation of common diagnostic methods of hypersensitivity for bee and yellow jacket venom by means of (Blaauw PJ and Smithuis LOMJ), 556 Stinging insect allergy: progress and problems (Reisman RE), 553 (Editorial) Sulfur dioxide, time course of exercise-induced bronchoconstriction in asthmatics exposed to, 15 (Abst.) Sunflower pollen, occupational allergy to (Bousquet J et al), 70 Suppressor cells, antigen-specific, induction of, in patients with hay fever receiving immunotherapy (Nagaya H), 388 Suramin protection of T cells in vitro against infectivity and cytopathic effect of HTLV-III, 26 (Abst.) Suxamethonium in patients with adverse reactions to muscle relaxants, leukocyte histamine release to (Vervloet D et al), 338 Syndrome, acquired hyper-IgM, with necrotizing granuloma (Goldstein MF et al), 472 dermatitis-eosinophiha: treatment with methylprednisolone pulse therapy, 9 (Abst.) Synthesis, de novo IgE, by human blood lymphocytes, effect of dexamethasone on (Hemady 2 et al), 304 T T cells,

human, leukemia viruses, homology of genome of AIDSassociated virus with genomes of, 13 (Abst.) in vitro, suramin protection of, against infectivity and cytopathic effect of HTLV-III, 26 (Abst.) receptor, human, gene for a-chain of: location on chromosome 14 region involved in T cell neoplasms, 24 (Abst.) subsets in allergic respiratory disease using monoclonal antibodies, 4 (Abst.) Temperature, airway, in normal subjects, influence of cromolyn sodium on, 21 (Abst.) Terbutaline, aerosolized, and subcutaneously administered epinephrine in treatment of acute bronchial asthma, comparative study of, 5 (Abst.) Test(s), prick skin, demographic, and laboratory data with response to controlled oral food challenge, correlation of. I. Evaluation of immediate adverse reactions to foods in adult patients (Atkins FM et al), 348 skin, food, use of term “false positive” in referring to results of (Bock SA), 528 (Correspondence) reactivity in infancy (Menardo JL et al), 646 Testing, skin, in chymopapain anaphylaxis (Cogen FC et al), 728 skin, natural history and role of: atopy in infancy and early childhood (Zeiger RS et al), 633 (Editorial) RAST, and RAST inhibition, comparison of rat fur, urine, saliva, and other rat allergen extracts by (Walls AF and Longbottom JL), 242 Theophylline and fibrccystic breast disease (Hindi-Alexander MC et al), 709 disposition in children with asthma, effect of phenobarbital on (Saccar CL et al), 716 pharmacology and therapeutic use of (Katz RM et al), 743 (Correspondence) plasma, concentrations and cerebrospinal fluid in children and adolescents taking theophylline, relationship of (Au&t WA et al), 731 preparation, sustained-release, in infants and preschool children with asthma, pharmacokinetics of (Isles AF and Newth CJL), 377

Theophylline-cont’d sustained-release, and cromolyn sodium in childhood asthma, double-blind study comparing effectiveness of, 7 (Abst.) Therapy, immunomodulatory, recent developments in (Bardana EJ), 423 (CME article) Time course of increase in airway responsiveness associated with late asthmatic reactions to toluene diisocyanate in sensitized subjects (Mapp CE et al), 568 Timothy (Phleum pratense) grass pollen allergenic extract, international collaborative study establishing first intemational standard for (Gjesing B et al), 258 Tobacco smoke, increased IgE antibody responses in rats exposed to (Zetterstriim 0 et al), 594 Tolerance, immunological, induction of, by oral administration of nickel and chromium, 16 (Abst.) Toluene diisocyanate in sensitized subjects, time course of increase in airway responsiveness associated with late asthmatic reactions to (Mapp CE et al), 568 in shipyard, health hazard by exposure to, 8 (Abst.) Transfusion, passive, of neutrophil-specific antibody, severe pulmonary hypersensitivity associated with, 17 (Abst.) Transplantation, bone marrow, atopy after, 23 (Abst.) Triacetyloleandomycin and oleandomycin phosphate on glucocorticoid receptor in cultured skin fibroblasts, effects of (Engler RJM et al), 395 Trichophyton rubrum, irritant, allergen, and source of antibodies to: human nail dust in chiropodial practice, 23 (Abst.) Trinitrophenyl derivatives after intranasal and subcutaneous sensitization of mice, regional and systemic immune responses to (Enander I et al), 37 Tumor, human, marker, induction of immunity to, in vivo administration of antiidiotypic antibodies in mice, 24 (Abst.) Tympanometric changes following nasal antigen challenge in children with allergic rhinitis, 19 (Abst.) r,

”

Ulceration,

recurrent aphthous, of oral cavity, use of elimination diet in treatment of, 9 (Abst.) Updating article by Liss et al. “Failure of enzyme encapsulation to prevent sensitization of workers in dry bleach industry” (Whorton MD and Morgan RW), 630 (Correspondence) Urine, fur, saliva, rat, comparison of, and other rat allergen extracts by skin testing, RAST, and RAST inhibition (Walls AF and Longbottom JL), 242 rat, and pelt extracts, allergenic properties of (Lutsky I et al). 279 Urticaria, localized cold-reflex (Ting S and Mansfield LE), 421 (Correspondence) V Vaccine,

pneumococcal polysaccharide, in normal individuals and individuals splenectomized due to trauma, IgM and IgG response to, 9 (Abst.) Vegetables, birch pollen, and fruits, cross-reactivity of IgE antibodies with allergens in, 12 (Abst.) Venom(s), bee and yellow jacket, evaluation of common diagnostic methods of hypersensitivity for, by means of in-hospital insect sting (Blaauw PJ and Smithuis LOMJ), 556 XIII, Hymenoptera, allergens in: isolation and purification of protein components from three species of vespid venoms (Hoffman DR), 599 XIV, Hymenoptera, allergens in: IgE binding activities of venom proteins from three species of vespids (Hoffman DR), 606 XV, Hymenoptera, allergens in,: immunologic basis of vespid venom cross-reactivity (Hoffman DR), 611 immunotherapy, natural history and modification with: stinging insect allergy (Reisman RE et al), 735

Subject

VOLUME 75 NUMBER 6

polymerized soluble-human serum albumin (Patterson R et al), 382 proteins from hornets, wasps, and yellow jackets, antigenic cross-reactivity of (King TP et al), 621 vespid, comparison of biochemical, immunologic, and allergenic properties of, collected in early and late summer, 19 (Abst.) Vespids, IgE binding activities of venom proteins from three species of: allergens in Hymenoptera venom XIV (Hoffman DR), 606 venoms, comparison of biochemical, immunologic, and allergenic properties of, collected in early and late summer, 19 (Abst.) cross-reactivity, immunologic basis of: allergens in Hymenoptera venom XV (Hoffman DR), 611 isolation and purification of protein components from three species of: allergens in Hymenoptera venom XIII (Hoffman DR), 599 Virus, AIDS-associated, homology of genome of, with genomes of human T cell leukemia viruses, 13 (Abst.) Vitamin E, topical, as cause of erythema multiform-like eruption, 4 (Abst.)

index

759

w Wasps, hornets, and yellow jackets, antigenic cross-reactivity of venom proteins from (King TP et al), 621 Water and electrolyte status in children with acute asthma, 22 (Abst.) Weightlessness, prolonged, and humoral immunity, 2 (Abst.) White and black individuals, allergic and nonallergic, levels of immunoglobulin G, M, A, and E at various ages in (Grundbacher FJ and Massie FS), 65 1 Wine, adverse reactions to: grand rounds (Gershwin ME et al), 411 (Allergy grand rounds) Y Yellow jacket(s) and bee venom, evaluation of common diagnostic methods of hypersensitivity for, by means of in-hospital insect sting (Blaauw PJ and Smithuis LOMJ), 556 hornets, and wasps, antigenic cross-reactivity of venom proteins from (King TP et al), 621 2 Zinc, excessive intake of, impairs immune responses, 12 (Abst.)

Index to meeting Author

abstracts

index A

Ackerman SJ, 116 Adams GK III, 142 Adelman S, 131 Adelsberg BR, 132 Adkinson NF, 125, 143 Adkinson NF Jr, 108, 138 Agarwal MK, 134 Ahlstedt S, 156 Ahrens R, 113 Ahrens RC, 161 Akiyama K, 134 Alazia M, 150 Allard A, 135 Allansmith MR. 186 Allen D, 145 Allen R, 114 Alper C, 155 Alper CA, 131 Altenburger KM, 128 Altman LC, 144 Alving K, 156 Ambrosino D, 188 Amdall L, 127 Ameisen JC, 123 Anderson MC, 137, 174 Anderson SD, 143 Andes WA, 191 Anfosso FJ, 124 Annis L, 161 Anorve-Lopez E, 150 Applin W, 161 Arkins J, 203 Amaud A, 150, 159 Armed J, 122 Arreaza E, 190 Asser S, 188 Atkins FM, 144 Atkins P, 148, 167, 183 Austen KF, 114, 126, 140 Auty RM, 199 Awdeh 2, 155 Ayars GH, 144 B Bacon JS, 107 Baer H, 137, 174 Baer MD, 163 Bahna SL, 204, 205 Bain RP, 189 Baker JR Jr, 106, 158 Balazs T, 136 Ballachey ML, 143

Ballow M, 187 Banks D, 115 Banks DE, 152 Bar-Sela S, 203 Bar-Yishay E, 172 Barker S, 125 Barr RJ, 130 Barrett KE, 193 Baskerville J, 158 Bass G, 181, 182 Batenhorst RL, 168 Baumgarten CR, 112 Bayol A, 123 Baysa J, 125 Bean MA, 127 Becker AB, 149 Becker N, 161 Btdard PM, 126 Befus D, 153 Bell T, 161 Benedict LM, 166 Bengtsson A, 121 Benincori N, 206 Benveniste J, 123 Benyounes A, 180 Berger MM, 199 Berger W, 187 Bergeron M, 201, 202 Berkowitz R, 128 Bernard K, 137 Bernard KW, 108 Bemheim HA, 182 Bernstein DI, 130, 136, 170, 206 Bernstein IL, 117, 130, 136,163, 170,206 Bernstein J, 111 Berscheid BA, 142 Bewtra A, 125, 140, 142, 149, 166 Bhola R, 106 Biagini RE, 136 Bias WB, 155, 156 Bielory L, 130 Bienenstock J, 153 Bierman CW, 127, 129, 145, 160, 161, 173, 177, 187 Billesbolle K, 119 Birx DL, 181 Bischof M, 208 Bisgaard H, 140 Bjorkander J, 137 Bjijrksten B, 156 Blainey AD, 135 Blaiss MS, 206 Bleecker ER, 173

Abstracts of papers presented at the meeting of The American IMMLJNOL 75(No. 1, part 2):103-226, 1985. 760

Academy

of Allergy

Blessing-Moore J, 106 Bleys W, 196 Bliwise N, 167 Block KJ, 186, 203 Bloch M, 203 Blockx P, 196 Bloom NR, 185 Bluestone C, 111 Blumenthal M, 155 Blythe S, 148 Bobila R, 192 Bock SA, 178 Bohl B, 177 Bongrand P, 150 Borish LC, 109 Bose R, 190 Bousquet J, 159, 164, 180, 195, 209 Bozelka BE, 157, 191 Bradford TR, 183 Brandon M, 161 Braquemond P, 164 Brenner M, 128 Bres J, 180 Bridts CH, 202 Brighton WD, 107 Brink C, 123 Britt EJ, 173 Bronsky EE, 163 Brooks CD, 185 Brown C, 150 Brown TE, 182 Brummond W, 132, 203 Brunet C, 126 Buchbinder EM, 132 Bucholtz G. 119 Buckley CE III, 144 Buckley RH, 120, 137, 138, 188, 189 Bukantz SC, 167 Burdash NM, 189. Burge H, 117, 118, 146 Burks AW, 188 Burman KD, 158 Burroughs HE, 170 Bush R, 113, 117, 118, 160, 174 Bush RK, 163 Businco L, 206 Busse W, 113, 116, 124, 160 Butcher B, 175 Butcher BT, 147

Cabradilla C, 192 Cador D, 1.50

and Immunology,

March

16-20,

1985; J ALLERGY CLIN

Meeting abstracts author

VOLUME 75 NUMBER 6

Cahalan MD, 181 Calvanico NJ, 115 Calvayrac P, 164, 180 Cameron W, 110 Cantani A, 206 Capron A, 123, 132 Carpenter GB, 121 Carrico J, 128 Carrington DM, 147 Carroll MP, 194 Cattier A, 134, 135, 170, 172 Caruso FS, 161, 187 Casale TB, 180 Casimir G, 206 Castells C, 207 Castracane J, 138 Cats A, 202 Cerrina J, 123 Ceuppens JL, 182 Chamovitz A, 107, 111 Chan TB, 141 Chart-Yeung M, 156 Chand N, 194 Chandy KG, 181 Chang B, 159 Chang KC, 131 Chapman J, 117 Chapman MD, 146, 147 Charpin J, 108, 150 Chase M, 177 Chen M, 185 Cheng J, 140 Cheng JB, 125 Chervinsky P, 160, 161, 163 Chi EY, 127 Chiaramonte LT, 106, 110 Chilingar L, 133 Christiansen SC, 177 Chryssanthopnulos C, 17 1, 200 Chun Y, 140 Chung KF, 149 Church MK, 195 Ciappi G, 149 Cissel DS, 120 Clark RAF, 132 Clark RH, 169 Clarke AJ, 199 Clauzel AM, 159, 180 Cocchiara R, 119 Cochrane CG, 177 Cockcroft DW, 142 Cogswell JJ, 178 Cohen M, 206 Coleman R, 142 Coleman RM, 167 Collins JV, 193 Collins RP, 118 Conboy C, 128 Condemi JJ, 163, 198 Conder GA, 143 Copeland DF, 117 Corey FJ, 140 Cornell-Be11 AH, 186 Corrado OJ, 153 Cort D, 181, 182 Cota KA, 141 Coulter KM, 155 Crawford LV, 109, 194 Crescioli S, 129 Creticos PS, 164 Crispin BF, 136 Cromwell 0, 112, 183, 193

Cummins L, 106 Cundell DR, 109 Cunningham-Rundles C, 137 Curd JG, 131 Czemiawska-Mysik G, 158 D Dal Vecchio L, 129 Daugirdas JT, 150 Daul C, 115 Daul CB, 191, 205 D’Amore J, 110 Davies RJ, 109, 135, 153 Davies S, 170 Davis V, 186 Day JH, 169, 209 De Clerck LS. 196. 202 De Cleyn K, l87 DeCoursey TE, 18 1 de la Sota A, 172 Delaage MA, 124 Del Carpio J, 143 DelCarpio J, 155 Delespesse G, 139, 190 Delohery J, 145 Demaille .I, 164 Dement W, 167 Denapoli T, 106 Denburg J, 153 Denny TN, 192 Desai H, 113 De Schepper A, 187 deShazo R, 107, 115 deShazo RD, 147, 152, 157, 191 Dessaint JP, 210 Deutsch AJ, 108 de Week AL, 108, 139 Dhivert H, 164 Diamantis W, 194 Dick E, 116 Di Marzo A, 149 Dinarello CA, 182 Djuh Y, 158 Dobozin BS, 132 Dockhom RJ, 163 Dolan J, 202 Dolovich J, 153, 160 Dor P, 108, 150 Dorval G, 155 Doshan HD, 161 Doyle K, 110 Doyle W, 111, 154 Drake-Lee A, 112 Drayton G, 130 Drazen JM, 140 Dreesen DW, 108 Drewniak J, ‘158 Dreyfuss EM, 177 Drouin MA, 155 Druce H, 111 Druce HM, 112 DuBuske L, 126 Duchateau J, 203, 206 Duff MJ, 126 Duke KR, 169 Dunnette SL, 116 Dupont LA, 166 DurhamSR, 140,148, 170,174,176,194, 195 Dvorin D, 167 Dvorin DJ, 165 Dyer J, 184

E Easton J, 180 Eboriadou M, 171, 200 Eby D, 159 Edward Smith CI, 137 Edwards AM, 199 Eggleston P, 176 Eggleston PA, 125 Ehrreich SJ, 136 Einarsson R, 121 Eiser N, 141 Ekramoddoullah AKM, 120 Ekwo E, 197 Elias J, 114 Ellis E, 128 Ellis J, 138 Elvey SM, 185 Engler RJM, 158, 210 Epstein E, 191 Errinaton GW. 193 Esser-B, 148 Esteban MM, 207 Evans R III, 169, 197 F Fabbri LM, 129 Fairshter R, 106 Famam J, 114 Farr R, 114 Farr RS, 184 Fawcett WA, 137 Ferguson AC, 141 F&rig S, 192 Filion L, 201 Finch M, 171 Fineberg SE, 107 Finegold I, 137 Fink JN, 132, 203 Finkle S, 165 Fireman P, 107, 111, 154 Firestone JE Jr, 204 Fischer T, 151 Fish JE, 143 Fishman M, 144 Fitzharris P, 112, 193 Flaherty M, 198 Fleisher TA, 18 1 Floyd R, 202 Fonferko EB, 114 Fonlupt P, 160 Ford L, 149 Forest F, 135 Forsythe A, 133 Foster A, 126 Foster TS, 168 Fourneron JD, 150 Foumier E, 123, 132 Fox RW, 167 Francis D, 192 Frank M, 130 Freidhoff LR, 155, 156 Freisheim J, 201 Frentz J, 107 Frick OL, 125, 149 Friedli HP, 208 Friedman MM. 153 Frosolono M, l67 Fujikura T, 200 Fukuda T, 116 Furstos R, 150

index

761

762

Meeting

abstracts

Furukawa CT, 127. 177, 187 Furumizo RT, 121

129.

G Gadde J, 108, 208 Caddy J, 124 Gallagher J, 206 Gallagher JS, 136, 170 Galli SJ, 152 Gal10 R, 192 Galloway J, 107 Galloway JA, 131 Gandhi MD, 204, 205 Gansbacher B , 182 Garippa R, 142 Garvin PJ, 135 Geha R, 188 Geha RS, 109, 138, 139 Geissler W, 119 Gelfand E, 187 Gendreau-Reid LF. 168 Georgitis JW, 111; 186 Geraci D. 119 German D, 157 Gerrard JW, 177, 178, 204 Gewurz A, 133, 208 Ghezzo H, 172 Ghory PK. 189 Gibbons J, 190 Gilbertson E, 187 Gillespie CA, 113 Gilmore N, 143 Gin W, 157 Girard JP, 107 Gleich GJ, 116, 138, 148 Glezen L, 148 Godfrey S, 172 Goetzl E, 183 Gold B, 118 Gold S, 111 Gold WM, 149 Goldsobel A, 130 Goldstein IM, 162 Gomez E, 153 Gonzalez G, 106 Gonzalez GE, 165 Goodfriend L, 155 Gordon DJ, 122 Gore BP, 142 Gorevic PD, 202 Gossart B, 206 Gosset P, 132 Gosset Ph, 210 Grabenstein J, 106 Gracey V, 105 Gracey VL, 130 Graff&tnevig V, 163 Graft DF. 151 Graham LM, 127 Crammer L, 208 Crammer LC, 150, 165 Grandel K, 114 Grandel KE, 184 Granerus G, 154 Grant JA, 114 Grant W, 107 Grauman JS, 197 Graves J, 148 Greenberg MA, 165 Greenberg MR, 205 Greenberger P, 133

author

145,

160,

index

173,

J. ALLERGY CLIN. IMMUNOL. JUNE 1985

Greenberger PA, 133 Greene D. 107 Grieco MH, 183 Gross CL, 127 Groth S, 140 Gruber BL, 202 Gruber RA, 189 Gutrin B, 107, 164 Guerra IC, 137, 189 Guill MF, 159 Gupta CS, 181 Gupta S, 187 Cuss C, 110

Horike M, 145 Howald W, 129 Howarth PH, 140, 166, 174, 195 Howatt J, 196 Howie G, 188 Howland WC, 145 Hoyt RS, 136 Hsieh KH, 110 Hsu SH, 155, 156 Hsu Y-P, 175 Humphries T, 197 Hutchinson V, 197 Hyatt J, 106

H Halpem GM, 196 Haltom JR, 105 Hamblin AE, 176 Hamburger R, 178 Hammarstrom L, 137 Han VL, 200 Hann LE, 186 Hannah J, 184 Hansen JA, 156 Hanson B, 155 Hanson LA, 137 Harden K, 133 Hardt H VD, 126 Hardwig JA, 151 Hargreave FE, 173 Harman E, 173 Harris JB, 161 Harris R, 157 Hatoum NS, 135 Haverlv RW. 205 Hawryiko E, 110 Hayakawa T, 134 Hayden ML, 146 Hayward A, 201 Heagarty M, 197 Hdbert J, 126 Hedlin G, 163 Heilbom H, 163 Hein E, 185 Hejjaoui A, 164 Heller S, 178 Helm RM, 138 Hendeles L, 173 Henderson WR, 127 Hensel A III, 119 Henson PM, 152 Herckert A, 159 Herman JJ, 130, 204 Herrod HG, 109, 194 Hess A, 200 Hesselmar B, 156 Heymann P, 172 Heymann PW, 146 Hill M, 173 Hindi R, 106 Hitch D, 153 Hoemke JA, 179 Hoey J, 143 Hoffman C, 133 Hoffman DR, 121 Hoffman M, 128 Holford-Strevens V, 198 Holgate ST, 140, 166, 174, 195 Holsen BB, 204 Hong R, 187 Hood D, 194 Hopp R, 142, 149

Iikura Y, 149 Incorvaia C, 207 Indianer L, 130 Indrisano J, 129 Ing TS, 150 Ingemann L, 122 Ingestad R, 122 Ingold CH, 120 Ingraham A, 154 Inui H, 149 Ipsen H, 119 Isersky C, 184 Ishibe T, 202 Ivanovich PT. 150

Jabara HH, 138 Jaber L, 199 Jaber M, 106 Jackson LJ, 181 Jacobitz J, 204 Jacobson RS, 121 Jaeger JJ, 194 James 0, 138 Jamieson DM, 210 Jean F, 164 Jenne J, 128 Jewett DL, 205 Joad J, 113 Johansson S-A, 158 Johansson SGO, 122, 208 John PA, 190 Johnson B, 155 Johnson CL, 136 Johnson HG, 143 Johnson LE, 144 Jones L, 204 Jones LA, 196 Jones RM, 196 Jorizzo JL, 114 Joseph M, 123 Joseph X, 136 Juniper EF, 173 Junk P, 148 K Kagey-Sobotka A, 125,143,151,154,208 Kaliner M, 111, 153, 180, 184 Kaliner MA, 112, 129, 144, 175, 176, 199 Kang AH, 202 Kaplan A, 148 Kaplan AP, 114, 202 Kaulan JE. 192 Kaplan M; 172 Karlsson A, 121 Karpink P, 167 Kaslow RA, 197

Meeting

VOLUME 75 NUMBER 6

Katz R, 105 Katz RM, 105, 130 Katzen DR, 129 Kaufman CR, 165 Kautzky EE, 156 Kay AB, 112, 116, 125, 140, 148, 149, 157. 174. 176. 183. 193. 194. 195 Kazaniwsky N, 201 Kazim F, 160 Keahey TM, 129 Keller RH, 115 Kelly L, 172 Kemp J, 167 Kemp JP, 161, 162, 163, 179 Kennedy L, 160 Kepron W, 169 Kerr JW, 167 Kersschot E, 187 Kesarwala H, 151 Khoury MJ, 169 Kiechel F, 128 Kilduff JE, 127 King SJ, 125 Kisil FT, 120 Knicker T, 202 Knoller J, 126 Knutti-Mbller J, 139 Koenig J, 144 Koenig JQ, 145 Koepke JW, 195 Kohi F, 125 Kohler PF, 132 Keller M, 126 Kiinig W, 120, 126 Koontz F, 195 Koponen M, 108 Kordash T, 117 Koup J, 129 Kray KT, 179 Kronenberg R, 155 Kroutil L, 117, 118, 174 Krzanowski J, 123, 141 Krzanowski K, 123 Kubicka M, 177 Kullman MH, 122 Kurtz EM, 189 Kurup VP, 132 Kus J, 156 Kwiterovich KA, 151 L L’Archeveque J, 170 L’Archeveque L, 172 Labat C, 123 Lad P, 180 LaForce C, 186 Lang D, 166, 168 LappP, 153 Larocque P, 201 Larsen GL, 148 Ladle Ph, 210 Lasser EC, 176 Latimer KM. 173 Lauhe B, 16i, 194 Laube BL, 142 Lawley T, 130 Lawrence EC, 137 Lazarus SC, 149 Laze11 MI, 207 Lazzara BM, 136 Leach CL, 135 Ledford D, 119. 123, 208

Ledford DK, 122 Lee TH, 140, 174, 176, 195 Lee TP, 201 Lees REM, 169 Lefkowitz M, 105 Lehrer S, 135, 175 Lehrer SB, 147, 174, 205, 206 Lemanske R, 148 Leong R, 106 Lemer CJ, 133 Lemer CL, 204 Lemer MR, 154 Leslie CC, 152 Lett-Brown MA, 114 Leune DYM. 109. 129. 138. 139 LeviGon AI,’ 182,’ 191 Levitz D, 135 Levy DA, 200 Lew DB, 152 Lewis C; 172 Lewis M, 172 Lewis R, 126 Lewiston N, 106 Lichtenstein L, 176 Lichtenstein LM, 112, 125, 151, 154, 208 Lieberman PL, 109, 194 Lile C, 196 Lilja G, 163 Lind P, 121 Lindgren S, 113 Liotta J, 133 Lippes H, 201 Litwin A, 151, 201 Lackey R, 119, 123, 141, 166, 208 Lackey RF, 122, 167 Loegering DA, 148 Lmez M. 175 Lord RA; 114 Lorusso JR, 147 Lotner GZ, 127 Lowenstein H, 119, 121, 163 Lubitz A, 110 Lund M, 124 Luraghi MT, 207 Lutsky I, 171 Lyon D, 200 Lyon SG, 176 M Maasch HJ, 119, 164 Maayan C, 172 McCall MK, 168 McCallum Deighton J, 146 McCants M, 135, 175 McCants ML, 147, 174, 206 Macchi M, 200 MacDonald AJ, 116, 125, 193, 194 McDonald DM, 149 McDowell LJ. 185 McGeady SJ, ‘188 McGettigan MC, 110 Machtinger S, 106 Mackav JA. 194 McNek ML; 143 McNeil D, 139 Madsen F, 140 Maestrelli P, 134 Mahan LK, 177 Malley A, I19 Malo J-L. 134. 135. 170. 172 Maloney MJ, 159, 210 Mansfield LE. 205

abstracts

author

index

Mansmann HC Jr, 105, 185, 188 Mapp C, 129 Marcer G, 134 Markham PB, 192 Marley T, 142 Marom ZM, 199 Marauardt DL. 192 M&ML, 162 Marsh D, 190 Marsh DG, 118, 143, 155, 156, 164 Marsh WR, 148 Marshal N, 147 Marshall S, 144 Marshall SG, 173 Massey DG, 121 Mathews KP, 107 Martin LB, 198 Martin P, 188 Martin RR, 172 Martynec DM, 185 Massanari M, 128 Mattoli S, 149 Maurice F, 209 Meadows CD, 128 Meggs WJ, 144 Meier HL, 127 Mekori YA, 132, 152, 193 Melamed J, 131 Mele CA, 110 Mellon M, 178 Mellon MH, 139 Meltzer EO, 162, 163, 179 Menardo JL, 159, 195 Merrick J, 171 Merton H, 167 Metcalfe DD, 144, 193 Metzler CM, 185 Meyers DA, 155, 156 Meyers S, 118 Michael JG, 151, 201 Michel FB, 159, 164, 180, 195, 209 Middleton E, 167, 201 Middleton E Jr, 184 Middleton HB, 159 Milavetz G, 128, 161 Miles-Lawrence R, 13 1 Miller DS , 120 Miller HRP, 125 Milsap R, 186 Mingo T, 163 Mingo TS, 161 Minnefor AB , 192 Mitchell EB, 146, 178 Miyamoto T, 134 Moessner H, 106 Moller DR, 170 Monafo V, 139 Mookerjee BK, 201 Moore P, 173 Moorman D, 136 Moqbel R, 116, 125, 193, 194 Morales P, 125 Morel AM, 124 Morgan J, 115 Moriarty ML, 183 Morn& F, 149 Morris EC, 189 Morris MM, 173 Morris T, 208 Morrison BJ, 141, 171 Moss R, 106, 175 Muilenberg M, 118, 146

763

764

Meeting

abstracts

author

index

Mullally DI, 197 Mullarkey MF, 127, 156 Miiller U, 208 Miiller W, 126 Murdock KY, 142 Murphy GF, I14 Murphy KR, 148 Murray AB, 141, 171 N Naclerio R, 176 Naclerio RM, 112, 154 Nagakura T, 140, 149, 174 Nagaya H, 191 Nair N, 166, 168, 142, 149 Nakajima T, 139 Nail TM, 207 Nathan RA, 163 Nathan RD, 161 Nauman J, 203 Neiss S, 161 Nelson AL, 185 Nelson BL, 166 Nelson DL, 190 Nelson HS, 179 Neyrinck JL, 210 Newman Taylor AJ, 122 Newill CA, 169 Newton J, 167 Nicholls AJ, 150 Nicklas RA, 136 Nisperos B, 156 Nizankowska E, 158 Nordlee JA, 198 Nordvall S, 208 Nordvall SL, 122 Norman P, 176 Norman PS, 112, 121, 142, 143, 154, 164, 194 Norrlind K, 163 Nuntirooj K, 157 Nygren H, 156 0 Ohata T, 149 O’Conner C, 123 O’Connor R, 178 O’Connor RD, 133, 188 O’Donnell M, 142 Ogasawara H, 184 Ohman JL Jr, 147 O’Hollaren MT, 179 Ohta K, 134 Ojeda A, 207 Olaisson E, 156 Oleske J, 187 Oleske JM, 192 Ollier S, 135 Olson G, 202 Olson J, 175 O’NeiJ CE, 147, 174 Oppenheimer P, 113 Orchik D, 202 O’Reillv D. 109 Orgel HA, ‘162, 163, 179 Orr TSC, 199 Chtiz AA, 121 Chtolani C, 207 Osborne E, 196 Osterland CK, 143 Ostrom NK, 134

J. ALLERGY CLIN. IMMUNOL. JUNE 1985

Qtsuka H, 153 Otto W, 180 P Pacheco H, 160 Pacheco Y, 160 Pahwa R, 192 Pahwa S, 187, 192 Paleari D, 129 Panush RS, 203 Papanagiotou J, 200 Papastavrou T, 171 Papirmeister B, 127 Parada N, 180 Pascual C, 207 Pastorello E, 207 Patalano F, 149 Pate1 KR, 168, 184 Paterson BF, 150 Patterson R, 150, 165, 208 Paul1 BR, 147 Pauwels R, 190 Pegelow K-O, 163 Pelikan M, 112, 186 Pelikan Z, 112, 186 Pelletier G, 126 Pence H, 209 Perelmutter L, 177, 178, 201, 202, 204 Peretz A, 203 Perhach JL, 167 Perrin-Fayolle M, 160 Perry RP, 203 Pesce AJ, 151, 201 Peter JB, 130 Peters MS, 116 Philip-Joet F, 159 Phillips P, 117 Phillips Y, 194 Picarella D, 147 Pichler WJ, 108 Pieper J, 173 Pierson W, 129 Pierson WE, 127, 144, 145, 160, 173, 177, 187

Pillar J, 194 Pin I, 108 Pineau L, 170 Pinnas JL, 163 Pipkom U, 154 Pirofsky B, 187, 200 Plancey RM, 185 Platts-Mills TA, 146 Platts-Mills TAE, 146, 172, 178 Poiesz B, 190 Polson J, 141 Portnoy J, 117 Post TJ, 110 Pozzan M, 129 Prenner BM, 162 Prigent A-F, 160 Proud D, 112, 154, 176, 177 Purchase ECR, 198

Q Quinnan

G, 137 R

Rachelefsky G, 105 Rachelefsky GS, 105, 130, 172 Radden EB, 143 Raffestin B, 123 Rajan R, 153

Ramos D, 111 Randolph CC, 151, 165 Rao YAK, 106 Raphael G, 111 Raphael GD, 112, 153 Rams DO, 123, 124, 196, 205 Recht M, 117, 118 Rector E, 139 Reddy MM, 183 Redmon AH, 137 ReedCE, 116, 150, 161, 179, 181 Reed M, 175 Reed MA, 147 Reid MJ, 166 Reinprecht C, 152 Reisman RE, 151, 165, 207 Reller LLB, 195 Renard R, 106 Repsher L, 161, 180 Repsher LH, 163 Resnick A, 132 Richards IM, 143 Richerson HB, 195 Riches DWH, 152 Richman PG, 120 Rineau L, 170 Rivington RN, 198 Rivory J-P, 209 Roberts JR, 113 Roberts M, 133 Roberts RS, 173 Robertson L, 185 Rocci ML Jr, 105 Rock HS, 196 Rocklin R, 109, 110, 138 Rockwell WJ, 118 Roger J-C, 135 Rogers M. 192 Rohr A, 105 Rohr AS, 105, 130 Rolfsen W, 121 Rosati G, 149 Rosen FS, 131 Rosenberg GL, 143 Rosenblatt CD, 165 Rosenblan HM, 137 Rosenthal RR, 161, 194 Rosenwasser LJ, 147, 182, 191 Rowntree S, 178 Roxe D, 150 Rubiner K, 204 Rubinstein S, 106 S Saad S, 192 Saccar CL, 105,

185 Sadja R, 184 Sakamoto Y, 123, 141 Sakatani T, 200 Saltzman HA, 144 Salvaggio J, 175 Salvaggio JE, 157, 174 Sampson HA, 179, 188 Sanders G, 146 Santilli J Jr, 118 Sarngadharan MG, 192 Sasagawa S, 200 Saxon A, 147 Squillace DL, 151 Schatz M, 133 Schellenberg RR, 126 Schiff SE, 120, 189

Meeting

VOLUME 75 NUMBER 6

Schmidt J, 209 Schmitt D, 115 Schneider AT, 106 Schneiderman R, 204 Schocket AL, 132, 193 Schoenwetter WF, 209 Schiinfeld W, 126 Schriider H, 122 Schubcrth KC, 151 Schuller D, 113 Schuller DE, 196 Schulman ES, 110 Schumacher MJ, 141 Schuster B, 106 Schuyler M, 115 Schuyler MR, 115 Schwartz LB, 183 Schwartz RH, 177 Schwartz S, 187 Scott AL, 200 Scovem H, 152 Sedmak GV, 171 Stguin P, 135 Sehon AH, 120, 139, 169, 190, 198 Seidehamel RJ, 181 Seidel W, 167 Selner JC, 195 Senft M, 108, 150 Serbousek D, 119 Shababian MA, 202 Shapiro Cl, 129, 187 Shapiro GG, 127, 145, 160, 161, 173, 177 Sharma B, 181 Sharpe G, 116 Shaughnessy JJ, 165 Shaughnessy M, 208 Shaughnessy MA, 165 Shaughnessy T, 128 Shaw RJ, 112, 183, 194 Shea JJ, 202 Shearer WT, 137, 189 Sheffer AL, 114 Shelhamer JH, 199 Shelton D, 141 Shen DD, 186 Shenassa MM, 177 Shirley LR, 189 Shore S, 140 Shulan DJ, 195 Siber G, 188 Siegel S, 105 Siegel SC, 105, 130, 161 Sieker HO, 144 Silber G, 176 Sillano V, 207 Silvers WS, 193 Simon R, 177 Simon RA, 145, 176 Simonet M, 159 Simons FER, 113, 168 Simons KJ, 168 Siskind G, 190 Sjolander AJ, 122 Skassa-Brociek W, 195 Skoner D, 107, 111, 154 Skvaril F, 208 Slater J, 184 Slater JE, 176 Sliski A. 192 Sly RM, 159 Smiley P, 180 Smith A, 113, 160

Smith BR, 139 Smith CM, 143 Smith E, 118 Smith L, 133 Smith TF, 172, 189 Snapp S, 106 Sneddon RC, 162 Sofia RD, 194 Solomon W, 117, 118, 146 Sorenson L, 127 Soter NA, 132 Soubasi B, 171 Soubasi V, 200 Souliou E, 200 Spector S, 105, 128, 167 Spector SL, 105, 130 Sperling W, 133 Spiegelberg HL, 139 Splansky GL, 206 Sprenger JD, 144 Squillace DL, 138 Stadler BM, 139 Stafford CT, 210 Stalcup J, 197 Stankus RP, 157 Stark BJ, 210 Steele R, 187 Stein R, 176 Stempel DA, 199 Stevens R, 126 Stevens W, 197 Stevens WJ. 187. 196. 202 Stillwagon P, 154 Stormont JM, 198 Storms W, 161, 167 Stout BK, 143 Strecker RA, 154 Snicker WE, 150 Stroud RM, 203 Strunk RC, 128 Stuart JM. 202 Sudo N, 202 Suez D, 201 Sugimoto S, 131 Sullivan TJ, 210 Summers R, 106 Summers RJ, 165, 181 Sundin B, 163 Suzuki K, 200 Swanson MC, 134 Sweeney M, 117, 118 Swift DL, 142 Szczeklik A, 158 Szefler S, 128 Szefler SJ, 105 Szentivanyi A, 141 Szucs E, 193 T Tacconi ML, 206 Takeda T, 202 Takevama H. 140 Talbot SF, 148, 183 Tamir R, 138 Tannenbaum AS, 187 Tar L, 191 Tasaka K, 124 Taussig LM, 141 Taylor AJN, 170, 176 Taylor SL, 198 Tee RD, 122 Telizyn S, 153

abstracts

author

index

Terr AI, 169 Tessier P, 172 Theobald K, 120 Thomas PS, 156 Thomas R, 106 Thompson LF, 139 Tillson S, 128 Ting S, 123, 124, 196, 205 Tinkelman DG, 127 Togias A, 176 Togias AG, 112 Tomar RH, 190 TonnelAB, 123, 132, 210 Toogood JH, 158 Townley R, 140, 142 Townley RG, 125, 149, 166, 168 Tronolone MJ, 165 Tsai JJ, 185 Tsang P, 117 Tsay YG, 136 Tse KS, 156 Turkeltaub P, 166 Turkeltaub PC, 163 Turner KJ, 119

Ulmer WT, 120 Umetsu D, 188 Umetsu DT, 138 Underdown BJ, 138 Upshur JK, 189 Urata C, 134 V Valentine MD, 15 1, 208 Van Bever H, 187, 197 Vandewalker ML, 179 VanMetre TE, 143 Varsano I, 199 Vaughan L, 128, 197 Vauehan TR. 205 Vecchio LD, 134 Venables K, 170 Venov D, 122 Verhelst JA, 196 Vermeer BJ, 202 Vervloet D, 108, 150, 159 Vickerson F, 160 Vigdennan RJ, 110 Vijay HM, 117 Vis HL, 206 Voisin C, 132 Volovitz B, 199 W Wagner HN Jr, 142 Wahl R, 119 Walden SM. 173 Walker AW,’ 203 Walker LL, 192 Walker S, 129 Walker SB, 173 Wallaert B, 123, 132, 210 Walsh GM, 183, 193, 194 Wanderer A, 114 Wang SR, 185 Wara D, 187 Wardlaw AJ, 112, 193 Wardlow ML, 184 Waring NP, 205 Wasserman S, 114, 133 Wasserman SI, 192

765

766

Meeting

abstracts

author

Webb DR, 156 Weber RW, 179 Webster EM, 203 Wedner HJ, 175, 181, 182 Wei B-Y, 198 Weiler JM, 195 Weinherger G, 128 Weinberger M, 113, 171, 197 Weiss J, 187 Weiss S. 149 Weiss SJ, 166, 168 Weissman D, 115 Weissman DN, 152 Weksler M, 190 Welch MJ, 162, 163. 179 Weliky I, 167 Weller PF, 129 Wells JH, 154 Welsh PW, 181 Weltevreden EF, 202 Welton AF, 142 Wescott S, 180 Westedt ML, 202 Wheeler B, 108 White AF, 209 White MV, 175 Whitehurst VE, 136

index

J. ALLERGY CLIN. IMMUNOL. JUNE 1985

Wiener M, 128 Wilcox TG, 170 Wilkins S, 146 Wilkins SR, 146, 172 Wilkins SW. 146 Williamson S, 117 Wilson T, 209 Win GH, 121 Windt MR, 191 Wintroub B, 183 Wo J, 105 wolfs, 171 Wolfe J, 128 Wong S, 149, 166, 168 Wright R, 111, 112 Wrieht RH. 144 wu-c, 107’ Wu J-P, 190 Wyatt R, 128 Wypych JI, 165 Wyrick R, 203 Y Yacono M, 159 Yancey K, 130 Yang WH, 155, 198 Yeung-Laiwah AC, 184

Yitzhaki T, 172 Yoo TJ, 202 Yoshimoto Y, 200 Younaszai K, 171 Young MC, 109 Young N, 130 Young NM, 117 Young SH, 132 Younger RE, 109, 194 Yunginger J, 203 Yunginger JW, 134, 138, 151 Yunis E, 155 Z Zabala M, 192 Zaloga G, 210 Zeiger R, 178 Zeiger RS, 133, 139 Zeiss CR, 135 Zenger VE, 175 Zimmerman B, 138 Zocca E, 129 Zora JA, 151 Zuraw BL, 131 Zweiman B, 148, 167, 183

Subject index A A-bomb survivors, evaluation of defense function in: age-related decline of functions of lymphocytes and polymorphonuclear leukocytes (Suzuki K et al), 200 ABPA and aspergilloma, antibody detection in patients with (Kurup VP et al), 132 Acaracide, use of: house dust mite reduction in home (Mitchell EB et al), 146 Adrenergic, beta, ligand binding antibodies (BLA) in adult, steroid dependent asthmatics (Baker JR et al), 158 specificity, bronchoprovocation studies as way to measure (Doshan HD et al), 161 versus anticholinergic: treatment of acute asthma (Amoud A et al), 159 Aerosol, albuterol, delivery of, by Inhal-Aid to young children (Chang B et al), 159 dose, single, of anticholinergic compound glycopyrrolate (GA), twelve-hour bronchodilation in asthma with (Busse W et al), 160 procaterol, MDI, versus placebo, multicenter trial of, in patients with asthma (Chervinsky P et al), 161 saline, in patients with asthma, effect of bronchial obstruction on bronchopulmonary distribution of (Laube BL et al), 142 SO,-saline, versus SO,, pulmonary effects of (Koenig JQ et al), 145 Agammaglobulinemia, common variable, (CVA), anaphylactic reactions in: detection of IgE and IgG antibodies in ELISA assay (Burks AW et al), 188 Agonists, beta, and anti-cholinergics, comparison of bronchodilatation due to, in asthmatic children (Menardo JL et al), 159 AIDS, oral desensitization to trimethoprim-sulfamethoxazole in patient with (Finegold I), 137 pediatric acquired immune deficiency syndrome, HTLV IIULAV antibodies in (Oleske JM et al), 192 immune deficiency syndrome, pathology of thymus in (Joshi VV et al), 192 B lymphocyte dysfunction in (Pahwa S et al), 192 TAC antigen and lymphocyte transformation in, effect of interleukin-2 and thymosin fraction V on expression of (Reddy MM et al), 183 Air conditioning and house dust mite (Carpenter GB et al), 121 Airflow and hydrocortisone impairment in aspirin-induced asthma (Nizankowska E et al), 158 Airway(s) disease, obstructive (OAD), and gastroesophageal reflux (GER), relationship between (Wolf S et al), 171 human, in vitro, anaphylatoxin C3a enhances mucous glycoprotein release from (Marom ZM et al), 199 hyperreactivity and mediator release in clinical models of asthma (Holgate ST et al), 140 hyperresponsiveness to histamine, leukotriene E4 (LTE,)-induced (Lee TH et al), 140 isolated guinea pig, and vascular smooth muscle, relaxant activity of atriopeptins in (O’Donnell M et al), 142 responses, bronchospastic, to aerosolized ascaris antigen in normal primates after oral administration of Ascaris suum ova (Stout BK et al), 143 responsiveness, changes in, to histamine preceding fluctuations of bronchomotor tone in occupational asthma (L’Archeveque J et al), 170 Abstract of papers presented at the meeting of The American Academy of Allergy and Immunology, March 16-20,1985; J ALLERGY CLIN IMMUNOL75(No. 1, part 2):103-226, 1985.

Airway(s) disease-cont’d non-specific, (NR), effect of metaproterenol (M) and albuterol (AL) administered by metered dose inhaler (MDI) on (Ahrens RC et al), 161 Albumin, ethylene oxide-human serum, antibody against, in patients with anaphylactic reactions to dialysis (Patterson BF et al), 150 human serum, beta propiolactone treated (BPL-HSA): allergen for humans receiving rabies vaccine (Baer H et al), 137 soluble copolymer of wasp (Polistes) venom with, for immunotherapy (Gewutz A et al), 208 Albuterol aerosol by Inhal-Aid, delivery of, to young children (Chang B et al), 159 (ALB) and terbutaline (TER), subcutaneous: single-dose, crossover comparison in acute asthma (Hoemke JA et al), 179 metaproterenol (M), effect of, administered by metered dose inhaler (MDI) on non-specific airway responsiveness (NR) (Ahrens RC et al), 161 terbutaline (TER), and epinephrine (EPI), subcutaneous, comparison of, in acute asthma (Kemp JP et al), 162 inhaled, and theophylline (T) used separately and in combination (C), physiological and psychological variables during maintenance therapy with (Joad J et al), 113 parenteral, single dose double-blind placebo-controlled cross over study of cardiopulmonary effects of (Prenner BM et al), 161 subcutaneous (SC), intramuscular (IM), and intravenous (IV) injectable, single-dose comparison of, in acute asthma (Grgel HA et al), 162 versus cromolyn therapy in prevention of exercise-induced bronchospasm (Marshall SG et al), 173 Allergens, Alrernaria (ALT), detection of, by western blotting (Kroutil L and Bush R), 174 /antigens, Fusarium solanae, analysis of (O’Neil CE et al), 174 1, cat, (CAT-l), dose of, which induces asthma (VanMetre TE et al), 143 characteristics and effect of: nasal mast cells (Corrado OJ et al), 153 cross-reacting and partially identical, analysis of, by inhalation of crossed radioimmunoelectrophoresis (CRIE-inh.) (Maasch HJ et al), 119 D. farinae, measurement of, in mite and house dust extracts and in houses of asthmatic patients (Platts-Mills TAE et al), 146 extracts, dog, reproduction of skin test potency of, by means of immunochemical standardization procedure (lngemann L et al), 122 for humans receiving rabies vaccine: beta propiolactone treated human serum albumin (BPL-HSA) (Baer H et al), 137 grass pollen, and allergoid, double-blind placebo controlled rush immunotherapy trial with (Jean F et al), 164 in mould and mite allergen preparations, detection of, by using protein blotting (Bengtsson A et al), 121 -induced increase in ultrasonic mist responsiveness (Rosati G et al), 149 inhalant, and food, development of antibody response to, in infants and young children (Rowntree S et al), 178 inhalation, treadmill exercise, isocapnic hyperventilation and methacholine challenge, mediator release in asthma after (Nagakura T et al), 174 isolation of, from Cladosporium cladosporioides (Vijay HM et al), 117 767

768

Meeting

Allergens-cont’d Kentucky

abstracts

subject

index

blue grass pollen, isolation of, using murine monoelonal antibody immunosorbent (Ekramoddoullah AKM et al), 120 major, from D. pzeronyssinus and D. farinae defined with monoclonal antibodies, cross-reacting and species specific epitopes on (Heymann PW et al), 146 mouse urinary (MAl), immunologic properties of (Lorusso JR et al), 147 of imported fire ant (IFA), Solenopsis invicta (Nordvall SL et al), 122 pollen, lymphocyte responses to: effect of polymerized allergen immunotherapy (Buckley RH et al), 120 release from Ahmaria (ALT), kinetics of (Sweeney M et al), 118 shrimp, identification of, by immunoelectrophoretic methods (Lehrer SB and McCants ML), 147 species specific, from Triazonzaprotracra identification and characterization of (Chapman MD et al), 147 Allergenic extracts, simple procedure for total protein determination of (Richman PG and Cissel DS), 120 profile of patients, efficacy of grass pollen immunotherapy according to (Hejjaoui A et al), 164 Allergenicity of airborne ascospores (Burge H et al), 118 Australian pine pollen (Casuarina equisetifolia) (Bucholtz G et al), 119 Allergic and idiopathic rhinitis, histamine hyperreactivity in (Druce H et al), 111 arthritis, food-induced. I. Rheumatoid arthritis exacerbated by milk (Panush RS et al), 203 conjunctivitis, role of nasal mucosa in some cases of, and effects of disodium cromoglycate (DSCG) (Pelikan M and Pelikan Z), 186 or non-allergic asthma, type 1, and rhinitis, patients with, radiographic sinus abnormalities in (Stevens WJ et al), 187 patients, house dust mite (HDM), presence of auto-anti-idiotypic antibodies in (Wu J-P et al), 190 reactions, atopic, due to potato (Castells C et al), 207 systemic, to inhalant immunotherapy (Greenberg MA et al), 16.5 respiratory disease among grain workers (Blainey AD et al), 135 rhinitis, evaluation of HEPP in (McDowell LJ et al), 185 -major study of habits and attitudes of consumers (Hess A and Lyon D), 200 seasonal, ragweed (RW) induced, placebo controlled trial of 4% cromolyn sodium nasal solution in controlling symptoms of (Plancey RM and Hein E), 185 skin reactions, human, patterns of LTC, release in (Talbot SF et al), 183 Allergoid and grass pollen allergen, double-blind placebo controlled rush immunotherapy trial with (Jean F et al), 164 booster, mixed, immunotherapy (IT) in patients (PTS) allergic to ragweed, grass, oak, and plantain (Creticos PS et al), 164 Allergy, cow’s milk, and betalactoglobulin (IgG), antibody against (Casimir G et al), 206 chronic diarrhea due to. 4-10 year follow-up (Businco L et al), 206 honey bee sting, combined active and passive immunotherapy in (Muller U et al), 208 Hymenoptera: diagnostic evaluation (Pastorello E et al), 207 IgE mediated, RAST-positive, to peanut (PN), cow’s milk (M) and egg (E): relationship to feeding and maternal diet (Gerrard JW and Perelmutter L), 178 inhalant, comparative evaluation of multiple RAST and discrete RAST for (Verhelst JA et al), 196 insect: sting outcome in history-positive, skin-test negative children (Schuberth KC et al), 151 insulin, management of (Fireman P e: al), 107

J. ALLERGY CLIN. IMMUNOL. JUNE 1985

Allergy-cont’d occupational,

to honeybee whole body dust in honey processing plant (Ostrom NK et al), 134 laboratory animals, management practices in (Lutsky I), 171 peach pollens (Ohta K et al), 134 prevention program for high risk infants, prospective, double blind food challenges (FC) in (Mellon M et al), 178 spore, Coprinus micaceus, Fuligo septica. and Alternaria alternata, in highly ragweed-sensitive subjects (Santilli J et al), 118 sugar, and children’s behavior (Mahan LK et al), 177 sweat bee, evaluation of, with sweat bee venom (Pence H et al), 209 to dyes (Guerin B et al), 107 locusts (Schistocerca gregaria and Locusta migratoriu,) (Tee RD et al), 122 Alternaria (ALT) allergens, detection of, by western blotting (Kroutil L and Bush R), 174 grown on synthetic versus organic medium, comparison of extracts obtained from (Bush R et al), 117 kinetics of allergen release from (Sweeney M et al), 118 Fuligo septica, and Coprinus micaceus spore allergy in highly ragweed-sensitive subjects (Santilli J et al), 118 lectin-specific antigens in (Meyers S et al), 118 Alveolar macrophage activation does not suppress lung immunologic reactivity (Schuyler MR), 115 human, modulation of natural killer cell function by (Weissman DN et al), 152 Alveohtis, neutrophil, after inhalation challenge in pigeon breeder disease with appearance of seric neutrophil chemotactic activity (Foumier E et al), 132 Ames Seralyzer (AS) versus high pressure liquid chromatography (HPLC) for serum theophylline determinations (Amda11 L et al), 127 Ammonium ions, quatemary, role of, in mechanisms of anaphylactic reactions to succinylcholine (Sch) (Cador D et al), 150 Anaphylactic reactions in common variable agammaglobulinemia (CVA): detection of IgE and IgG antibodies in ELISA assay (Burks AW et al), 188 to dialysis, antibody against ethylene oxide-human serum albumin in patients with (Patterson BF et al), 150 succinylcholine. Prevention of mediators release by choline (Vervolet D et al), 150 role of quatemary ammonium ions in mechanisms of (Cador D et al), 150 reactivity to trypsin (Tonne1 AB et al), 210 shock with formaldehyde (Maurice F et al), 209 Anaphylaxis (ANA) to tetanus toxoid (‘IT): IgE-mediated disease (Engler RJM and Zaloga G), 210 biphasic (Stark BJ and Sullivan TJ), 210 exercise-induced, altered mast cell threshold in (Errington GW et al), 193 idiopathic, food skin testing in patients with (Stricker WE et al), 150 in nurses caused by inhaled psyllium seed (Schoenwetter WE), 209 systemic, in Nippostrongylus brusiliensis-primed rats, parenteral and enteral release of leukotrienes and RMCPl 1 after (Moqbel R et al), 125 inhibition of, by combined Hl and H2 histamine receptor blockade in canine model of ragweed hypersensitivity (Kepron W et al), 169 unexplained (UEA) or systemic mastocytosis (SM), sulfite challenges in patients with (Meggs WJ et al), 144 Angioedema, hereditary (HAE), and acquired C 1 inhibitor (C 1 inh) deficiency (ACID), protease-inhibitor complexes in (Zuraw BL and Curd JG), 131 (HAE), and acquired ClNH deficiency, rocket immunoelectrophoresis for C4d and C4 in (Curd JG et al), 131

VOLUME 75 NUMBER 6

Angioedema-cont’d recurrent, and hyper eosinophilia, in 2% year old girl (Katzen DR et al), 129 Ant, imported fire, hypersensitivity: antigenic analysis of whole body extracts and venom (Butcher BT et al), 147 Solenopsis invicta, allergens of (Nordvall SL et al), 122 whole body extract (IFA-WBE), specific IgE and IgG responses to immunotherapy (IT) with, in IFA hypersensitivity (H) (Johnasson SGO et al), 208 Antagonists, calcium, in vitro effect of, on basophil degranulation (Yeung-Laiwah AC et al), 184 two beta, bucindolol and metoprolol, effect of, on pulmonary function in subjects with asthma (Welsh PW et al), 181 Antibody(ies) (ab) response to pneumococcal polysacchtides (PPS) in immunodeficient children, serum IgG, concentration does not correlate with (Smith TF et al), 189 against betalactoglobulin (IgCi) and cow’s milk allergy (Casimir G et al), 206 ethylene oxide-human serum albumin in patients with anaphylactic reactions to dialysis (Patterson BF et al), 150 anti HTLV l-MA, patients with selective IgA deficiency/at have (Tomar RH et al), 190 -tetanus toxoid (‘IT), and auto-anti-idiotype (Id) antibody responses of young and old human subjects following boosting with tetanus toxoid (Arreaza EE et al), 190 antigen specific hybridoma IgE, bronchoalveolar lavage analysis of rat pulmonary late phase reactions mediated by (Lemanske R et al), 148 auto-anti-idiotypic, presence of, in house dust mite (MDM) allergic patients (Wu J-P et al), 190 beta-adrenergic ligand binding, (BLA) in adult, steroid dependent asthmatics (Baker JR et al), 158 deficiency syndromes with anti-IgA antibodies and successful immunoglobulin prophylaxis (Bjorkander J et al), 137 detection in patients with ABPA and aspergilloma (Kurup VP et al), 132 giant and short ragweed-specific, comparison of: response to local nasal immunotherapy (LNIT) with polymerized ragweed extract (PRW) (Tronolone MJ et al), 165 grass pollen-specific IgG, quantitative immunoenzymatic assay for (Moss R and Hsu Y-P), 175 HTLV IIULAV, in pediatrics acquired immune deficiency syndrome (AIDS) (Oleske JM et al), 192 IgE, monoclonal helper T cells induce normal B cells to synthesize (Umetsu DT et al), 138 response, antigen enhancement of IgE, from peripheral blood lymphocytes (PBL) of ragweed atopics (Kazaniwsky N et al), 201 to foods, comparison between RIA-MAST and RIA-RAST in detecting (Firestone JE Jr and Bahna SL), 204 IgG, response to timothy grass pollen antigen B, characterization of (Turner KJ and Malley A), 119 levels, auto-anti-idiotypic, in hay fever patients treated by immunotherapy (Bose R et al), 190 monoclonal, cross-reacting and species specific epitopes on major allergens from D. pteronyssinus and D. furinae defined with (Heymann PW et al), 146 specific to FC.R, identification of membrane molecules from RPM1 8866 cells reacting with (Nakajima T et al), 139 murine IgE, responses to trimellitic anhydride, suppression of (Wei B-Y et al), 198 monoclonal, immunosorbent, isolation of Kentucky blue grass pollen allergen using (Ekramoddoullah AKM et al), 120 response, mite exposure and, of asthmatic children in Atlanta (Kelly L et al), 172 to food and inhalant allergens, development of, in infants and young children (Rowntree S et al), 178

Meeting

abstracts

subject

index

769

Antibody(ies)-cont’d serum factor, non-, in asthmatic patients inhibits binding to beta adrenergic receptors (Lad P et al), 180 skin-sensitizing, following booster dose of rabies human deploid cell vaccine, serum sickness-like reaction associated with (Deutsch AJ et al), 108 specific IgE and IgG, from peripheral blood lymphocytes (PBL) of Mt. Cedar atopics, antigen suppression of, study on (Bergeron M et al), 202 Anticholinergic versus beta,-adrenergic: treatment of acute asthma (Amaud A et al), 159 Antigen, aerosolized ascaris, in normal primates after oral administration of Ascaris suum ova, bronchospastic airway responses to (Stout BK et al), 143 /allergens, Fusarium solunae, analysis of (O’Neil CE et al), 174 B, timothy grass pollen, characterization of IgG antibody response to (Turner KJ and Malley A), 119 challenge, endogenous heparin-like material (EHM) elevations following (Lasser EC et al), 176 cockroach, detection of, in commercial house dust (HD) extracts by ELISA inhibition (Sanders G et al), 146 distinctive, of epicoccum: intra- and interstrain variations (Portnoy J et al), 117 enhancement of IgE antibody response from peripheral blood lymphocytes (PBL) of ragweed atopics (Kazaniwsky N), 201 food, hypersensitivity, altered specific IgG to specific IgE ratio (SGE) in children with (Holsen BB et al), 205 used in skin and RAST testing, variability of (Brummund W et al), 203 HLA, RA5 immune responses, and complotypcs (Blumenthal M et al), 155 in Basidiomyceres spores and mycelia, comparison of (Lopez M et al), 175 induced histamine release in vivo, effects of propanolol on terbutaline suppression of (Rauls DO and Ting S), 123 lectin-specific, in Alternaria (Meyers S et al), 118 Purieruria judaica, immunochemical characterization of (Geraci D et al), I19 specific hybridoma IgE antibody, bronchoalveolar lavage analysis of rat pulmonary late phase reactions mediated by (Lemanske R et al), 148 suppression of specific IgE and IgG antibodies from peripheral blood lymphocytes (PBL) of Mt. Cedar atopics, study on (Bergeron M et al), 202 TAC, and lymphocyte transformation in AIDS, effect of interleukin-2 and thymosin fraction V on expression of (Reddy MM et al), 183 Antigenicity, drug metabolite, generation of, in intestinal mucosa (Wu C et al), 107 Antihistamine, oral, effects of, on antigen-induced asthma (Chan TB et al), 141 sedation in man, direct measurement of (Coleman RM et al), 167 Arachidonic acid metabolites but not histamine, osmotically activated human lung mast cells (MC) and basophils release (Eggleston PA et al), 125 possible role of: induction of macrophage lysosomal hydrolase synthesis and secretion by p-1,3-glucan (Lew DB et al), 152 Arthritis, (allergic), food-induced. 1. Rheumatoid arthritis exacerbated by milk (Panush RS et al), 203 rheumatoid, C3D as marker of extraarticular manifestations of (Peretz A and Duchateau J), 203 exacerbated by milk. I. Food-induced (allergic) arthritis (Panush RS et al), 203 patients (pts), IgE, IgE-containing circulating immune complexes (InE-CIC), IaE-rheumatoid factor (RFI and skin IgE-deposition 1’ (De Clerck LS et al): 202 type 11 collagen autoimmune, and ear disease in monkey, induction of (Yoo TJ et al), 202

770

Ascuris

Meeting

abstracts

subject

index

suum ova, bronchospastic airway responses to aerosolized ascaris antigen in normal primates after oral administration of (Stout BK et al), 143 Ascospores, airborne, allergenicity of (Burge H et al), 118 Aspergilloma and ABPA, antibody detection in patients with (Kurup VP et al), 132 Aspergillosis, allergic bronchopulmonary, (ABPA), bronchoalveolar lavage in (Greenberger PA et al), 133 in children (Lemer CJ et al), 133 Aspirin-sensitive asthma, genetic markers in (Thomas PS et al), 156 specific abnormal platelet activation in: basis for in vitro diagnostic test (Ameisen JC et al), 123 Astemizole (A) terfenadine (T), and hydroxyzine (H), comparison of efficacy and adverse effects of (Gendreau-Reid LF et al), 168 (AST), efficacy of, for treatment of chronic idiopathic m&aria (CIU) (Bernstein IL and Bernstein DI), 130 double-blind randomized evaluation of, in comparison with placebo in treatment of seasonal allergic rhinitis (Nair N et al), 166 H,-antagonist, in allergic asthma (Howarth PH and Holgate ST), 166 treatment of chronic idiopathic m&aria (CIU) with (Fox RW et al), 167 Asthma, acute, comparison of subcutaneous albuterol (ALB), terbutaline (TER), and epinephrine (EPI) in (Kemp JP et al), 162 in children, comparison of inhaled metaproterenol, inhaled atropine, or combination of both in treatment of (Guill MF and Maloney MJ), 159 dose response study of nebulized metaproterenol for (Furukawa CT et al), 160 single-dose comparison of subcutaneous (SC), intramuscular (IM), and intravenous (IV) injectable albuterol in (Orgel HA et al), 162 crossover comparison in: subcutaneous altuberol (ALB) and terbutaline (TER) (Hoer&e JA et al), 179 treatment of: anticholinergic versus beta,-adrenergic (Amaud A et al), 159 airway hyperreactivity and mediator release in clinical modela of (Holgate ST et al), 140 allergic, astemizole, H,-antagonist, in (Howarth PH and Holgate ST), 166 and COPD, platelet activating factor in sputum of patients with (Grandel KE et al), 184 cystic fibrosis (CF), once day theophylline (UNIPHYLY) for treatment of patients with (Blessing-Moore Jet al), 106 antigen-induced, effects of oral antihistamine on (Ghan TB et al), 141 aspirin-induced, hydrocortisone and airflow impairment in (Nizankowska E et al), 158 -sensitive, effect of diflunisal on pulmonary function in (Szczeklik A and Nizankowska E), 158 genetic markers in (Thomas PS et al), 156 specific abnormal platelet activation in: basis for in vitro diagnostic test (Ameisen JC et al), 123 azelastine (AZEL) in treatment of (Storms W et al), 167 bitolterol mesylate (BMS) and isoproterenol (ISO) solutions by open, continuous flow nebulization in (Ming0 T et al), 163 bronchial, corticosteroids and monocyte activation in (Gin W and Kay AB), 157 low density eosinophils in (Dunnette SL et al), 116 case training (ACT) for kids (Lewis C et al), 172 childhood, demographic and clinical characteristic of (Humphries T et al), 197 comparison of once and twice daily sustained release theophylline in (Thomas R et al), 106 sustained-release (SR) terbutaline vs. SR theophylline in young patients with (Roberts JR et al), 113

J. ALLERGY CLIN. IMMUNOL. JUNE 1985

Asthma-cont’d course, effect of stage of pregnancy on (Forsythe A et al), 133 development, subsequent, bronchiolitis and (Schuller DE), 196 dose of cat allergen 1 (CAT-l) which induces (VanMetre TE et al), 143 dose-response characteristics of bitolterol mesylate in children with (Biennan CW et al), 161 during pregnancy, distinguishing clinical and biochemical characteristics associated with improvement or deterioration of (Schatz M et al), 133 effect of bronchial obstruction on bronchopulmonary distribution of saline aerosol in patients with (Laube BL et al), 142 terfenadine on methacholine-induced bronchoconstriction in (Pate1 KR et al), 168 enhanced basophil histamine release (HR) to concanavalin A (CON A) in (Gaddy J and Busse W), 124 exercise induced, effect of nedocromil on (Bleecker ER et al), 173 enhanced leucocyte cytotoxicity after (Kay AB et al), 194 role of mediator in (Rosenthal RR et al), 194 exogenous, bronchial hyperreactivity to LTD, and histamine in patients with (Bisgaard H et al), 140 guinea pig (GP) experimental, leukotriene D, receptors in (Takeyama H et al), 140 hospitalizations of children for, in U.S.A. 1965-1982 (Mullally DI et al), 197 hyperventilation, hyperosmolarity as stimulus to (Smith CM and Anderson SD), 143 infantile bronchial, (BA) diagnostic criteria in early diagnosis of (Eboriadou M et al), 171 kininogenase activity in bronchoalveolar lavage (BAL) fluids in (Christiansen SC et al), 177 laboratory animal-induced, neutrophil chemotactic activity in (Newman Taylor AJ et al), 176 mediator release in, after allergen inhalation, treadmill exercise, isocapnic hyperventilation and methacholine challenge (Nagakura T et al), 174 metabisulfite induced (Allen D and Delohery J), 145 multicenter trial of procaterol aerosol MD1 versus placebo in patients with (Chervinsky P et al), 161 new modulator of inflammation for treatment of-nedocromil sodium (Edwards AM et al), 199 occupational, changes in airway responsiveness to histamine preceding fluctuations of bronchomotor tone in (L’Archeveque J et al), 170 due to azobisformamide (Pineau L et al), 170 Indian ebony wood dust (Maestrelli P et al), 134 IgE sensitization in snow-crab processing workers with (McCants M et al), 135 in sawmills of Eastern Canada (Malo JL and Cartier A), 134 new cause of: pentamethylene diethylene triamine (Venables K et al), 170 prevalence of, in paint shop (Cartier A et al), 135 pulmonary function in subjects with, effect of two beta antagonists, bucindolol and metoprolol, on (Welsh PW et al), 181 restaurant-provoked: sulfite sensitivity (Howland WC and Simon RA), 145 severity, bronchial reactivity and, cigarette smoke from mothers increases, in their children (Murray AB and Morrison BJ), 171 study of naso-bronchial reflex in allergic rhinitis with (Schumacher MJ et al), 141 treatment, single daily dose theophylline (THEO) and aerosol salbutamol (SAL) in (Smith A et al), 113 type 1 allergic or non-allergic, and rhinitis, patients with, radiographic sinus abnormalities in (St&ens WJ et al), 187 UFFI related, formaldehvde. formaldehvde free UFFI off-gas. and particles in, respiratory responses to (Lees REM et al), 169

Meeting

VOLUME 75 NUMBER 6

Asthma-cont’d with single aerosol dose of anticholinergic compound glycopyrrelate (GA), twelve-hour bronchodilation in (Busse W et al), 160 Asthmatic responses, exercise-induced dual, effect of drugs on (Iikura Y et al), 149 Atopic allergic reactions due to potato (Castells C et al), 207 and normal subjects, histamine type 1 (H,) receptor radioligand binding studies in T cells from (Cameron W et al), 110 dermatitis (AD), persistence of food hypersensitivity (FH) in children with (Sampson HA), 179 increased in vivo skin histamine releasability in (Ting S and Rauls DO), 196 spontaneous IgE formation in vitro by isolated B cells from patients with (McNeil D et al), 139 dogs, histamine response in, relationship of cutaneous late phase response (LPR) to (Becker AB et al), 149 Mt. Cedar, study on antigen suppression of specific IgE and IgG antibodies from peripheral blood lymphocytes (PBL) of (Bergeron M et al), 202 patients during immunotherapy, generation of suppressor cells that modulate IgE synthesis in (Tamir R et al), 138 Atopy as screening criterion for employment: epidemiologic evaluation (Evans R et al), 169 Atriopeptins, relaxant activity of, in isolated guinea pig airway and vascular smooth muscle (O’Donnell M et al), 142 Atropine, inhaled, inhaled metaproterenol, or combination of both, comparison of, in treatment of acute asthma in children (Guill MF and Maloney MJ), 159 Atrovent, ipratropium bromide nasal spray in vasomotor rhinitis (Dolovich J et al), 160 Azelastine (AZ) and lipoxygenase inhibitors (LI), allergic and nonallergic histamine release (HR) by, inhibition of (Chand N et al), 194 treatment of asthma (Storms W et al), 167 inhibition of skin test reactivity in humans (Merton H et al), 167 Azobisformamide, occupational asthma due to (Pineau L et al), 170 B Bosidiomyceres

spores and mycelia, antigens in, comparison of (Lopez M et al), 175 Basophils and human lung mast cells (MC), osmotically activated, release histamine but not arachidonic acid metabolites (Eggleston PA et al), 125 degranulation, in vitro effect of calcium antagonists on (YeungLaiwah AC et al), 184 histamine release (BHR), characteristics of, after exposure to radiocontrast agent diatrizoate (DT) (Herrod HG et al), 194 effect of sex steroids on (Slater JE and Kaliner MA), 176 enhanced, to concanavalin A (CON A) in asthma (Gaddy J and Busse W), 124 human blood, bulk culture of, from patients with chronic myelogenous leukemia (CML) (Mullarkey MF et al), 127 role of esterases in mechanism of histamine release from (Meier HL et al), 127 peripheral blood, basophil precursors, and nasal metachromatic cells (NMC) in patients with allergic rhinitis (Denburg J et al), 153 precursors, peripheral blood basophils and nasal metacbromatic cells (NMC) in patients with allergic rhinitis (Denburg J et al), 153 B cell(s) deficiency, permanent intrinsic, due to phenytoin hypersensitivity (Guerra IC et al), 137 isolated, from patients with atopic dermatitis, spontaneous IgE formation in vitro by (McNeil D et al), 139 normal, monoclonal helper T cells induce, to synthesize IgE antibody (Umetsu DT et al), 138 polyclonal, activation and rheumatoid factor production, tetanus toxoid induces (Tar L and Levinson AI), 191

Beclomethasone

abstracts

subject

index

771

dipropionate (BDP), intranasal, nasal septal perforation in patients using (LaForce C and David V), 186 relation to clinical status and response to: human nasal metachromatic cell (NMC) heterogeneity (Otsuka H et al), 153 Bee, sweat, allergy, evaluation of, with sweat bee venom (Pence H et al), 209 venom, honey, (HBV) sensitive patients, treatment of, with fragment of phospholipase A, (PLA,) (Litwin A et al), 151 Beta-adrenergic ligand binding antibodies (BLA) in adult, steroid dependent asthmatics (Baker JR et al), 158 receptors, non-antibody serum factor in asthmatic patients inhibits binding to (Lad P et al), 180 specificity, bronchoprovocation studies as way to measure (Doshan HD et al), 161 tachyphylaxis, attempt of predicting (Clauzel AM et al), 180 versus anticholinergic: treatment of acute asthma (Amaud A et al), 159 Beta-agonists and anti-cholinergics, comparison of bronchodilatation due to, in asthmatic children (Menardo JL et al), 159 Betalactoglobulin (IgG) and cow’s milk allergy, antibody against (Casimir G et al), 206 Beta-receptors, guinea pig (GP) lung, localization of, by immunoperoxidase histochemistry (Casale TB et al), 180 Bitolterol and isopreterenol nebulizer solutions, safety and efficacy study of (Pinnas JL et al), 163 mesylate (BMS) and isoproterenol (ISO) solutions by open, continuous flow nebulization in asthma (Ming0 T et al), 163 dose-response characteristics of, in children with asthma (Bierman CW et al), 161 B lymphocyte dysfunction in pediatric AIDS (Pahwa S et al), 192 Blood basophils, human, bulk culture of, from patients with chronic myelogenous leukemia (CML) (Mullarkey MF et al), 127 peripheral, basophil precursors, and nasal metachromatic cells (NMC) in patients with allergic rhinitis (Denburg J et al), 153 leucocytes, human, are incubated with anti-IgE (reversed-type __ anaphylaxis), alterations in granuloc$e function when (Walsh GM et al), 193 lymphocytes, human, NCA release from: effects of salbutamol and sodium cromolyn (SC) on this release (Cundell DR and Davies RJ), 109 peripheral (PBL), of Mt. Cedar atopics, antigen suppression of specific IgE and IgG antibodies from, study on (Bergeron M et al), 202 ragweed atopics, antigen enhancement of IgE antibody response from (Kazaniwsky N et al), 201 /plasma, whole, ratio determined by new theophylline test without instrumentation (Hoffman M et al), 128 whole, theophylline test, evaluation of, requiring no instrument (Comboy C et al), 128 BR, decreased, prevention of, inhibition of phospholipid methylation, and cyclic AMP phosphodiesterase stimulation by ketotifen in leukocytes from asthmatic subjects (Per&-Fayolle M et al), 160 Brompheniramine and pseudoephedrine, pharmacodynamics of, in treatment of perennial rhinitis (Shen DD et al), 186 Bronchial asthma (BA), infantile, diagnostic criteria in the early diagnosis of (Eboriadou M et al), 171 corticosteroids and monocyte activation in (Gin W and Kay AB), 157 low density eosinophils in (Dunnette SL et al), 116 asthmatic attacks, potential of ergonovine to precipitate, via serotonin receptors (Sakamoto Y et al), 141 fluids and plasma, leukotrienes and their metabolism in (Schonfeld W et al), 126

772

Meeting

abstracts

subject

index

Bronchial asthma-cont’d hyperreactivity to LTD, and histamine in patients with exogenous asthma (Bisgaard H et al), 140 hypersensitivity or bronchospasm, failure of aqueous urea-formaldehyde foam insulation (UFFI) extract to elicit (Del Carpio J et al), 143 naso reflex, study of, in allergic rhinitis with asthma (Schumacher MJ et al), 141 obstruction, effect of, on bronchopulmonary distribution of saline aerosol in patients with asthma (La&e BL et al), 142 preparations from human lung (HBP), thiazinamium chloride (TC) is potent muscle relaxant in (Raffestin B et al), 123 provocation test and total and individual antigen-specific IgG tests in double blind cross-over study, results of. Immunotherapy with animal dander extracts. (Sundin B et al), 163 reactivity and asthma severity, cigarette smoke from mothers increases, in their children (Murray AB and Morrison BJ). 171 non-allergic, in asthmatic children, mite immunotherapy increases (Ferguson AC et al), 141 responses versus nasal to pharmacologic challenges in guinea pigs (Wells JH et al), 154 responsiveness, non-specific, eosinophils, and allergen-induced late-phase asthmatic reactions (Durham SR et al), 148 Bronchiolitis and subsequent asthma development (Schuller DE), 196 infants with, response of lung function to treatment in (Maayan C et al), 172 Bronchoalveolar lavage analysis of rat pulmonary late phase reactions mediated by antigen specific hybridoma IgE antibody (Lemanske R et al), 148 cells on B-lymphocyte function, effect of (Morgan J et al), 115 fluids in asthma, kininogenase activity in (Christiansen SC et al), 177 in allergic bronchopulmonary aspergillosis (ABPA) (Greenberger PA et al), 133 Bronchoconstriction, exercise-induced (EIB), blocking of, by inhaled verapamil (V) (Hendeles L et al), 173 methacholine-iuduced, in asthma, effect of terfenadine on (Pate1 KR et al), 168 stimulated by hyperventilation of cold dry air: magnitude and duration of inhibitory effect of three doses of sodium cromoglycate (Juniper EF et al), 173 Bronchodilatation due to beta-agonists and anti-cholinergics, comparison of, in asthmatic children (Menardo JL et al), 159 Bronchodilation, twelve-hour, in asthma with single aerosol dose of anticholinergic compound glycopyrrolate (GA) (Busse W et al), 160 Bronchodilator efficacy, aerosol, do spacer devices improve (O’Hollaren MT and Reed CE), 179 Bronchomotor tone in occupational asthma, changes in airway responsiveness to histamine preceding fluctuations of (L’Archeveque J et al), 170 Bronchoprovocation studies as way to measure beta adrenergic specificity (Doshan HD et al), 161 Bronchopulmonary aspergillosis, allergic, (ABPA), bronchoalveolar lavage in (Greenberger PA et al), 133 in children (Lemer CJ et al), 133 distribution of saline aerosol in patients with asthma, effect of bronchial obstruction on (Laube BL et al), 142 Bronchospasm, exercise-induced, albuterol versus cromolyn therapy in the prevention of (Marshall SC et al), 173 or bronchial hypersensitivity, failure of aqueous urea-formaldehyde foam insulation (UFFI) extract to elicit (Del Carpio J et al), 143 Bronchus, human, in vitro, anti-IgE induced contraction of (Schellenberg RR et al), 126

J. ALLERGY CLIN. IMMUNOL. JUNE 1985

Bronkosol, Bucindolol

inhaled, reactivity to, in sulfite sensitive asthmatics (SSA) (Simon RA), 145 and metoprolol, two beta antagonists, effect of, on pulmonary function in subjects with asthma (Welsh PW et al), 181 C

Calcium

antagonists, in vitro effect of, on basophil degranulation (Yeung-Laiwah AC et al), 184 essential messenger in early and late T cell activation (Birx DL et al), 181 ionophore A23 187 induced generation of leukotriene D, (LTD,) from granulocytes of normal, allergic rhinitis (AR) and asthmatic patients measured by radioreceptor assay (RRA) (Kohi F et al), 125 release, intracellular, provoked by certain histamine releasers and its prevention by some antiallergic drugs (Tasaka K), 124 Candida albicans strains, three, comparison of, by immunological methods and relative delayed hypersensitivity potency in guinea pigs (Williamson S et al), 117 Capillary finger stick (FS) and venous (V) serum theophylline (T) concentrations, reliability of micro-method for measuring (Altenburger KM and Massanari M), 128 Cardiopulmonary effects of parenteral albuterol, single dose double-blind placebo-controlled cross over study of (Prenner BM et al), 162 Cardiovascular responses and pulmonary function to exercise in asthmatic children on oral metaproterenol versus theophylline (Oppenheimer P and Schuller D), 113 Casuarina equisetfolia. Australian pine pollen, allergenicity of (Bucholtz G et al), 119 Ceils, antigen-specific suppressor, in patients receiving immunotherapy (Nagaya H), 191 augmenting accessory, bear 1-A and appear MHC-restricted: cellular cooperation in expression of murine delayed-type hypersensitivity (DTH) (Scovem A and Reinprecht C). 152 B, deficiency, permanent intrinsic, due to phenytoin hypersensitivity (Guerra IC et al), 137 B, isolated, from patients with atopic dermatitis, spontaneous IgE formation in vitro by (McNeil D et al), 139 polyclonal, activation and rheumatoid factor production, tetanus toxoid induces (Tar L and Levinson AI), 191 bronchoalveolar lavage, on B-lymphocyte function, effect of (Morgan J et al), 115 clones, human T, characterization of, that regulate IgE production in vitro (Zimmerman B et al), 138 culture supematants, variability in quantitation of IgE protein in (Helm RM et al), 138 function, natural killer, modulation of, by human alveolar macrophages (Weissman DN et al), 152 human nasal metachromatic (NMC) heterogeneity: relation to clinical status and response to beclomethasone dipropionate (BDP) (Otsuka H et al), 153 vascular endothelial, interleukin-1 production, regulation of (Epstein E et al), 191 infiltrate, mononuclear, studies of, in chronic idiopathic urticaria (Elias J and Kaplan AP), 114 intestinal goblet, regulation by T-cells (Levy DA et al), 200 lines, FC,R + human T, production of IgE potentiating factor by (Young MC et al), 109 lymphoid, within murine lung, analytical and functional assessment of (Nuntirooj K et al), 157 mast (MC), cutaneous, in response to defined stimuli of physical allergic class, ultrastructural changes of (Sheffer AL et al), 114 deficient (W/W” and Sl/Sl”) mice, expression of undiminished contact sensitivity and immunological tolerance in (Mekori YA and Galli SJ), 152

Meeting

VOLUME 75 NUMBER 6

Cells-cont’d human,

effect of tryptase from, on fibrinogen and plasminogen (Schwartz LB et al), 183 lung, and basophils, osmotically activated, release histamine but not arachidonic acid metabolites (Eggleston PA et al), 125 in situ degranulation of (Friedman MM et al), 153 mucosal-type, histamine release from (Wardlaw A3 et al), 193 IgE-immunotoxins, selective (Boltansky H et al), 184 intestinal, and lung, monkey, comparison of the effect of antiallergic drugs on (Barrett KE et al), 193 mediator release in vivo, influence of salbutamol and sodium cromoglycate on (Church MK et al), 195 mouse bone marrow-derived, cromolyn inhibition of (Marquardt DL et al), 192 rheumatoid synovial: functional studies (Gruber BL et al), 202 subclasses, murine-derived, quantitative comparison of three arachidonate metabolites from (DuBuske L et al), 126 threshold, altered, in exercise-induced anaphylaxis (Errington GW et al), 193 monoclonal helper T, induce normal B cells to synthesize IgE antibody (Umetsu DT et al), 138 nasal metachromatic (NMC), basophil precursors, and peripheral blood basophils in patients with allergic rhinitis (Denburg J et al), 153 OKT4+, mitogen induced helper and suppressor activity mediated by (Gansbacher B and Levinson AI), 182 PHA stimulated mononuclear, production of histamine release enhancing factor (HREF) by (Younger RE et al), 109 RPM1 8866, reacting with monoclonal antibody (Mab) specific to FC,R, identification of membrane molecules from (Nakajima T et al), 139 soy lectin T, depleted haploidentical bone marrow cells, appearance of multiple paraproteins during early engraftment of, in severe combined immunodeficiency (SCID) (Ghory PK et al), 189 suppressor, generation of, that modulate IgE synthesis in atopic patients during immunotherapy (Tamir R et al), 138 T, from normal and atopic subjects, histamine type 1 (H,) receptor radioligand binding studies in (Cameron W et al), 110 hybridomas, human IgE binding factor producted by (Stadler BM et al), 139 responses, phenotyping in vitro (Suez D and Hayward A), 201 vaccine, rabies human diploid, serum sickness-like reaction associated with skin sensitizing antibody following booster dose of (Deutsch AJ et al), 108 Cellular cooperation in expression of murine delayed-type hypersensitivity (DTH): augmenting accessory cells bear lA and appear MHC-restricted (Scovem H and Reinprecht C), 152 C4d and C4 in hereditary angioedema (HAE) and acquired ClNH deficiency, rocket immunoelectrophoresis for (Curd JG et al), 131 Challenge(s), antigen, endogenous heparin-like material (EHM) elevations following (Lasser EC et al), 176 deliberate insect sting, plasma histamine levels following (Squillace DL et al), 151 food, blind, which provoke migraine, plasma histamine elevation during (Mansfield LE et al), 205 double blind, in prospective allergy prevention program for high risk infants (Mellon M et al), 178 inhalation, neutrophil alveolitis after, in pigeon breeder disease with appearance of seric neutrophil chemotactic activity, neutrophil alveolitis after (Foumier E et al), 132 intranasal histamine, effects of, on eustachian tube function (Doyle W et al), 154 isocapnic cold air (ICAC), within- and between-days reproducibility of (Tessier P et al), 172

abstracts

subject

index

773

Challenge(s)-cont’d methacholine, allergen inhalation, treadmill exercise, and isocapnic hyperventilation mediator release in asthma after (Nagakura T et al), 174 methacholine (MC), in large pediatric population (Hopp R et al), 142 nasal, cytological changes in nasal secretions during (Pelikan Z and Pelikan M), 112 oral (OC), versus skin testing (ST) in food sensitivity (Gandhi MD and Bahna SL), 205 pharmacologic, in guinea pigs, nasal versus bronchial responses to (Wells JH et al), 154 provocative intranasal, with house dust mite, eustachian tube obstruction (ETO) after (Skoner D et al), 111 sulfite, in patients with systemic mastocytosis (SM) or unexplained anaphylaxis (UEA) (Meggs WJ et al), 144 Chemonucleolysis, extended immunologic evaluation of chymopapain sensitization following (Bernstein Di and Bemstein IL), 136 Chemotaxis and supcroxide (0;) generation, leukocyte inhibitory factor (LIF) potentiation of F-met-leu-phe induced (Borish LC et al), 109 Chloroquine (C), dexamethasone (D), or indomethacin (I), effect of, on isoproterenol (ISOP)-induced ventricular fibrillation in heavy rats (Johnson GL et al), 136 Choline, prevention of mediators release by. Anaphylactic reactions to succinylcholine (Vervloet D et al), 150 Cholinergics, anti, and beta-agonists, comparison of bronchodilatation due to, in asthmatic children (Menardo JL et al), 159 urticaria, cold and heat-induced, combined (Famam J et al), 114 Chromatography, high pressure liquid, (HPLC) versus Ames Seralyzer (AS) for serum theophylline determinations (Amdall L et al), 127 Chymopapain,

in vitro, sensitivity testing, an update on (Tsay YG et al), 136 sensitization following chemonucleolysis, extended immunologic evaluation of (Bernstein DI et al), 136 Cl inhibitor, acquired (Cl inh) deficiency (ACID) and hereditary angioedema (HAE), protease-inhibitor complexes in (Zuraw BL and Curd JG), 13 1 and Clq, metabolism of, in acquired Cl inhibitor deficiency (Melamed J et al), 13 I Cladospon’um cladosporioides, isolation of allergens from (Vijay HM et al), 117 ClNH deficiency, acquired, and hereditary angioedema (HAE), rocket immunoclectrophoresis for C4d and C4 in (Curd JG et al), 131 Clq and Cl inhibitor, metabolism of, in acquired Cl inhibitor deficiency (Melamed J et al), 131 Cobalamins (B 12), metabisulfite (MBS)-associated hepatotoxicity and protection by (Flaherty M et al), 198 Cockroach antigen, detection of, in commercial house dust (HD) extracts by ELISA inhibition (Sanders G et al), 146 Coca-monoethinolimide (CME), IgE mediated hypersensitivity reaction to. in fabric softener pad (Herman JJ), 130 Complexes, IgE, IgE-containing circulating immune (IgE-CIC), IgE-rheumatoid factor (RF) skin IgE-deposition in rheumatoid arthritis (RA) patients (pts) (De Clerck LS et al), 202 Complotypes, RA5 immune responses, and HLA antigens responses (Blumenthal M et al), 155 Concanavalin A (CON A) in asthma, enhanced basophil histamine release (HR) to (Gaddy J and Busse W), 124 Conjunctivitis, allergic, role of nasal mucosa in some cases of, and effects of disodium cromoglycate (DSCG) (Pelikan M and Pelikan Z), 186 human giant papillary, development of an animal model for (Cornell-Bell AH et al), 186

774

Meeting

abstracts

subject

index

COPD

and asthma, platelet activating factor in sputum of patients with (Grandel KE et al), 184 Copolymer, soluble, of wasp (Polistes) venom with human serum albumin for immunotherapy (Gewurz A et al), 208 Coprinus micaceus, Fuligo septica, and Alternaria alternara spore allergy in highly ragweed-sensitive subjects (Santilli J et al), 118 Corticosteroids and monocyte activation in bronchial asthma (Gin Wand Kay AB), 157 infusion, low dose continuous, use of, to facilitate insulin pump use in local insulin hypersensitivity (Grant W et al), 107 side effects, incidence of, in chronic steroid dependent asthmatics on TAO (troleandomycin) and methylprednisolone (Harris R and German D), 157 Cow’s milk (M), egg (E) and peanut (PN), IgE RAST positive and RAST negative adverse reactions to, IgG, levels in patients with (Perelmutter L and Gerrard JW), 204 Cromolyn inhibition of mouse bone marrow-derived mast cell mediator release (Marquardt DL et al), 192 sodium nasal solution, 48, placebo controlled trial of, in controlling symptoms of ragweed (RW) induced seasonal allergic rhinitis (Plancey RM and Hein E), 185 therapy versus albuterol in prevention of exercise-induced bronchospam (Marshall SG et al), 173 Crusfacea allergic individuals, immunological evaluation of (Daul CB et al), 206 C3a, anaphylatoxin, enhances mucous glycoprotein release from human airways in vitro (Marom ZM et al), 199 C3D as marker of extraarticular manifestations of rheumatoid arthritis (Peretz A and Duchateau J), 203 Cutaneous allergic reactions, kinin-coagulation pathway activation during late phase of (Atkins P et al), 148 late phase response (LPR) to histamine response in atopic dogs, relationship of (Becker AB et al), 149 manifestations of human serum sickness (Bielory L et al), 130 mast cells (MC) in response to defined stimuli of physical allergic class, ultrastructural changes of (Sheffer AL et al), 114 vascular permeability, measurement of (Keahey TM et al), 129 Cyclooxygenase inhibitor, flurbiprofen, hay fever treatment with (Brooks CD et al), 185 Cyclosporine, effects of, on different interleukin-1 activities (Rosenwasser LJ et al), 182 Cystic fibrosis (CF) and asthma (AS), once a day theophylline (UNIPHYL) for treatment of patients with (BlessingMoore J et al), 106 Cytological changes in nasal secretions during nasal challenge (Pelikan Z and Pehkan M), 112 Cytolysis and eosinophil degranulation, calcium dependent ionophore A23187 induced (Fukuda T et al), 116 Cytotoxicity, enhanced leucocyte, after exercise-induced asthma (Kay AB et al), 194 human T-cell mediated, K channel requirement for (Chandy KG et al), 181 D Dander

extracts, animals, immunotherapy with. Results of bronchial provocation test and total and individual antigenspecific IgG tests in double blind cross-over study (Sundin B et al), 163 Degranulation, in situ, of human lung mast cells (Friedman MM et al), 153 Dermatitis, atopic (AD), persistence of food hypersensitivity (FH) in children with (Sampson HA), 179 increased in vivo skin histamine releasability in (Ting S and Rauls DO), 196 spontaneous IgE formation in vitro by isolated B cells from patients with (McNeil D et al), 139

J. ALLERGY CLIN. IMMUNOL. JUNE 1985

Desensitization,

oral, to trimethoprim-sulfamethoxazole in patient with AIDS (Finegold I), 137 to factor VIII, successful, in patient with classic hemophilia (Maloney MJ et al), 210 peanut (Shenassa MM et al), 177 Dexamethasone (D), indomethacin (I), or chloroquine (C), effect of, on isoproterenol (ISOP)-induced ventricular fibrillation in heavy rats (Johnson GL et al), 136 D. farinae allergens, measurement of, in mite and house dust extracts and in houses of asthmatic patients (Platts-Mills TAE et al), 146 and D. pteronyssinus, major allergens from, defined with monoclonal antibodies, cross-reacting and species spccific epitopes on (Heymann PW et al), 146 Dialysis, anaphylactic reactions to, antibody against ethylene oxidehuman serum albumin in patients with (Patterson BF et al), 150 Diarrhea, chronic, due to cow’s milk (CM) allergy, 4-10 year follow-up (Businco L et al), 206 Diatrizoate (DT), radiocontrast agent, characteristics of basophil histamine release (BHR) after exposure to (Herrod HG et al), 194 Diflunisal, effect of, on pulmonary function in aspirin-sensitive asthma (Szczeklik A and Nizankowska E), 158 Disodium cromoglycate (DSCG), effects of, role of nasal mucosa in some cases of allergic conjunctivitis and (Pelikan M and Pelikan Z), 186 Doxepin, efficacy of, in treatment of chronic idiopathic urticaria (Goldsobel A et al), 130 D. pteronyssinus and D. furinae, major allergens from, defined with monoclonal antibodies, cross-reacting and species specific epitopes on (Heymann PW et al), 146 Drugs, effects of, on exercise-induced dual asthmatic responses (Iikura Y et al), 149 Dust, honeybee whole body, occupational allergy to, in honey processing plant (Ostrom NK et al), 134 house, and mite extracts, and in houses of asthmatic patients, measurement of D. farinae allergens in, and in houses of asthmatic patients (Platts-Mills TAE et al), 146 extracts, commercial, detection of cockroach antigen in, by ELISA inhibition (Sanders G et al), 146 Indian ebony wood, occupational asthma due to (Maestrelli P et al), 134 mite, house, and air conditioning (Carpenter GB et al), 121 eustachian tube obstruction (ETO) after provocative intranasal challenge with (Skoner D et al), 111 in Baltimore area, prevalence of (Norman PS et al), 121 reduction in home: use of acaracide (Mitchell EB et al), 146 Dyes, allergy to (Guerin B et al), 107 E Ear disease

and type II collagen autoimmune arthritis in monkey, induction of (Yoo TJ et al), 202 Egg and Schistosoma mansoni adult worm extracts using immunoblotting techniques, reactivity of specific IgE and IgG of (Schroder H et al), 122 peanut (PN) and cow’s milk (M), IgE mediated, RAST-positive allergy to: relationship to feeding and maternal diet (Gerrard JW and Perelmutter L), 178 and cow’s milk (M), IgE RAST positive apd RAST negative adverse reactions to, IgG, levels’iq patients with (Perelmutter L and Gerrard JW), 204 ELISA assay, detection of IgE and IgG antibodies in: anaphylactic reactions in common variable ‘agammaglobulinemia (CVA) (Burks AW et al), 188 inhibition, detection of cockroach antigeQ in commercial house dust (HD) extracts by (Sanders G et al), 146 Endothelial cell, human vascular, interleukin-1 production, regulation of (Epstein E et al), 191

Meeting

VOLUME 76 NUMBER 6

Enteropathy, immune complex (IC)-induced: character of complexes and effect of blockade of mononuclear phagocyte system (MPS) (Bloch KJ et al), 203 Environmental illness: review of 50 cases (Terr AI), 169 Eosinophii(s)- and neutrophil-mediated complement-dependent killing of schistosomula of S. mansoni, mediators from IgE-dependent reactions that enhance (MacDonald AJ et al), 116 degranulation and cytolysis, calcium dependent ionophore A23187 induced (Fukuda T et al), 116 human, leukotriene C, generation by, after stimulation with IgGcoated particles (Shaw RJ et al), 183 low density, in bronchial asthma (Dunnette SL et al), 116 non-specific bronchial responsiveness, and allergen-induced latephase asthmatic reactions (Durham SR et al), 148 Eosinophilia, hyper, and recurrent angioedema in 2% year old girl (Katzen DR et al), 129 Epicoccum, distinctive antigens of: intra- and interstrain variations (Portnoy J et al), 117 Epidemiologic evaluation: atopy as screening criterion for employment (Evans R et al), 169 Epidemiology and genetics of response to whole rye extract, rye I, and rye II (Freidhoff LR et al), 156 Epinephrine (EPI), albuterol (ALB), and terbutaline (TER), subcutaneous, comparison of, in acute asthma (Kemp JP et al), 162 Epitopes, cross-reacting and species specific, on major allergens from D. pferonyssinus and D. farinae defined with monoclonal antibodies (Heymann PW et al), 146 Ergonovine, potential of, to precipitate bronchial asthmatic attacks via serotonin receptors (Sakamoto Y et al), 141 Esterases, role of, in mechanism of histamine release from human basophils (Meier HL et al), 127 Ethylene oxide-human serum albumin, antibody against, in patients with anaphylactic reactions to dialysis (Patterson BF et al), 1.50 Eustachian tube function, effect of histamine and ragweed nasal provocation on (Gold S et al), 111 intranasal histamine challenge on (Doyle W et al), 154 natural pollen exposure on (Stillwagon P et al), 154 obstruction (ETO) after provocative intranasal challenge with house dust mite (Skoner D et al), 111 Extracts, allergenic, potencies of, an IgE RAST” inhibition method for standardization of (Jones RM et al), 196 simple procedure for total protein determination of (Richman PG and Cissel DS), 120 animal dander, immunotherapy with. Results of bronchial provocation test and total and individual antigen-specific IgG tests in double blind cross-over study (Sundin B et al), 163 aqueous urea-formaldehyde foam insulation (UFFI), failure of, to elicit bronchospasm or bronchial hypersensitivity (Del Carpio J et al), 143 dog allergen, reproduction of skin test potency of, by means of immunochemical standardization procedure (Ingemann L et al), 122 food, placebo responses in intradennal provocation testing with (Jewett DL and Greenberg MR), 205 high-dose glutaraldehyde-modified ragweed (PRW), local nasal immunotherapy (LNIT) with (Dvorin DJ et al), 165 house dust (HD), commercial, detection of cockroach antigen in, by ELISA inhibition (Sanders G et al), 146 imported fire ant whole body (IFA-WBE), specific IgE and IgG responses to immunotherapy (IT) with, in IFA hypersensitivity (H) (Johansson SGO et al), 208 mite and house dust, measurement of D. furinae allergens in, and in houses of asthmatic patients (Platts-Mills TAE et al), 146 obtained from Alternariu (ALT) grown on synthetic versus organic medium, comparison of (Bush R et al), 117

abstracts

subject index

775

Extracts-cont’d pollen, prospective survey of local and systemic reactions to immunotherapy with (Nelson BL et al), 166 polymerized ragweed (PRW), response to local nasal immunotherapy (LNIT) with: comparison of giant and short ragweed-specific antibodies (Tronolone MJ et al), 165 Schistosoma mansoni adult worm and egg, using immunoblotting techniques, reactivity of specific IgE and IgG of (Schroder H et al), 122 standardized mite, early benefits of rush immunotherapy with (Bousquet J et al), 164 wheat flour, analysis of human IgG and IgE binding proteins in (Theobald K et al), 120 whole body, and venom, antigenic analysis of: imported lire ant hypersensitivity (Butcher BT et al), 147 rye, rye I, and rye II, epidemiology and genetics of response to (Friedhoff LR et al), 156 F Factor VIII concentration, hemophiliac patients receiving, longitudinal immunological evaluation of (deShazo RD et al), 191 successfuldesensitization to, in patient with classic hemophilia (Maloney MJ et al), 210 FC,R + human T cell lines, production of IgE potentiating factor by (Young MC et al), 109 R, identification of membrane molecules from RPM1 8866 cells reacting with monoclonal antibody (Mab) specific to (Nakajima T et al), 139 Fibrillation, isoproterenol (ISOP)-induced ventricular, in heavy rats, effect of indomethacin (I), dexamethasone (D), or chloroquine (C) on (Johnson GL et al), 136 Fibrinogen and plasminogen, effect of tryptase from human mast cells on (Schwartz LB et al), 183 Fire ant, imported, hypersensitivity: antigenic analysis of whole body extracts and venom (Butcher BT et al), 147 Solenopsis invictu, allergens of (No&all SL et al), 122 whole body extract (IFA-WBE), specific IgE and IgG responses to immunotherapy (IT) with, in IFA hypersensitivity (H) (Johansson SGG et al), 208 Flavonoids, observations on effects of, on human lymphocyte proliferative responses (Mookerjee BK et al), 201 selected, effect of, on histamine release (HR) and hydrogen peroxide (H,O,) generation by human leukocytes (Ogasawara H and Middleton E Jr), 184 Flurbiprofen, cyclooxygenase inhibitor, hay fever treatment with (Brooks CD et al), 185 F-met-leu-phe induced chemotaxis and superoxide (0;) generation, leukocyte inhibitory factor (LIF) potentiation of (Borish LC et al), 109 Foods, adverse reactions to, during first three years of life (Bock SA), 178 and inhalant allergens, development of antibody response to, in infants and young children (Rowntree S et al), 178 antigen hypersensitivity, altered specific IgG to specific IgE ratio (SGE) in children with (Holsen BB et al), 205 used in skin and RAST testing, variability of (Brummund W et al), 203 challenges, blind, which provoke migraine, plasma histamine elevation during (Mansfield LE et al), 205 double blind, in prospective allergy prevention program for high risk infants (Mellon M et al), 178 effect of, on once daily Theo-Dur in asthmatic subjects (Spector SL et al), 105 extracts, placebo responses in intradermal provocation testing with (Jewett DL and Greenberg MR), 205 hypersensitivity (FH), persistence of, in children with atopic dermatitis (AD) (Sampson HA), 179 IgE antibodies to, comparison between RIA-MAST and RIARAST in detecting (Firestone JE Jr and Bahna SL), 204

776

Meeting

abstracts

subject

index

J. ALLERGY CLIN. IMMUNOL. JUNE 1985

H

Food--cont’d -induced

(allergic) arthritis. I. Rheumatoid arthritis exacerbated by milk (Panush RS et al), 203 reactions, adverse (AFR), in adult populations, epidemiologic survey and validation of (Cohen M et al), 206 sensitivitv. evaluation of RAST in (Bahna SL and Gandhi MD), ’ 204

skin testing (ST) versus oral challenge (OC) in (Gandhi MD and Bahna SL), 205 skin testing in patients with “idiopathic anaphylaxis” (Stricker WE et al), 150 Formaldehyde, anaphylactic shock with (Maurice F et al), 209 48/80, increased, induced local histamine release in patients with chronic utticaria (Bedard PM et al), 126 Fuligo septica, Coprinus micaceus. and Alternaria alternata spore allergy in highly ragweed-sensitive subjects (Santilli J et al), 118 Fusarium solanae antigens/allergens, analysis of (O’Neil CE et al), 174 G Gastroesophageal

reflux (GER) and obstructive airway disease (OAD), relationship between (Wolf S et al), 171 Genetics and epidemiology of response to whole rye extract, rye I and rye II (Freidhoff LR et al), 156 factors controlling overall expression of allergy (Marsh DG et al), 155 markers in aspirin-sensitive asthma (Thomas PS et al), 156 Globulin, native intravenous immune, clinical experience with (Tannenbaum AS et al), 187 Glucan, B-1,3-, induction of macrophage lysosomal hydrolase synthesis and secretion by: possible role of arachidonic acid metabolites (Lew DB et al), 152 Glutaraldehyde-modified ragweed extract (PRW), high-dose, local nasal immunotherapy (LNIT) with (Dvorin DJ et al), 165 Glycoprotein release, mucous, anaphylatoxin C3a enhances, from human airways in vitro (Marom ZM et al), 199 Glycopyrrolate (GA), anticholinergic compound, twelve-hour bronchodilation in asthma with single aerosol dose of (Busse W et al), 160 Gold salts, acute actions of, on canine tracheobronchial smooth muscle (Krzanowski J et al), 123 in vitro and in vivo inhibition of, on leukotriene production (Wang SR et al), 185 Grain workers, allergic respiratory disease among (Blainey AD et al), 135 Granulocyte(s) function, alterations in, when human blood leucocytes are incubated with anti-IgE (reversed-type anaphylaxis (Walsh GM et al), 193 of normal, allergic rhinitis (AR) and asthmatic patients measured by radioreceptor assay (RRA), calcium ionophore A23 187 induced generation of leukotriene D4 (LTD,) from (Kohi F et al), 125 Grass, Kentucky blue, pollen allergen, using murine monoclonal antibody immunosorbent, isolation of (Ekramoddoullah AKM et al), 120 pollen allergen and allergoid, double-blind placebo controlled rush immunotherapy trial with (Jean F et al), 164 antigen B, timothy, characterization of IgG antibody response to (Turner KJ and Malley A), 119 immunotherapy, efficacy of according to allergenic profile of patients (Hejjaoui A et al), 164 -specific IgG antibodies, quantitative immunoenzymatic assay for (Moss R and Hsu Y-P), 175 ragweed, oak, and plantain, mixed allergoid booster immunotherapy (IT) in patients (PTS) allergic to (Creticos PS et al), 164 Grass, tree, and ragweed, polymerized, in patients with multiple inhalant sensitivities, safety and immunogenicity of immunotherapy with (Grammer LC et al), 165

H,-antagonist,

astemizole, in allergic asthma (Howarth PH and Holgate ST), 166 Hay fever patients treated by immunotherapy, auto-anti-idiotypic antibody levels in (Bose R et al), 190 treatment with flurbiprofen, cyclooxygenase inhibitor (Brooks CD et al), 185 Health records, home, impact of, on asthmatic children (Hutchinson V et al), 197 Hemophilia, classic, successful desensitization to factor VIII in patient with (Maloney MJ et al), 210 Hemophiliac patients receiving factor VIII concentrate, longitudinal immunological evaluation of (deShazo RD et al), 191 Heparin-like material, endogenous (EHM), elevations following antigen challenge (Lasser EC et al), 176 Hepatotoxicity, metabisulfite (MBS)-associated, and protection by cobalamins (B12) (Flaherty M et al), 198 HEPP in allergic rhinitis, evaluation of (McDowell LJ et al), 185 Heterogeneity, human nasal metachromatic cell (NMC): relation to clinical status and response to beclomethasone dipropionate (BDP) (Otsuka H et al), 153 Hexahydrophthalic anhydride (HHPA), detection of IgE mediated respiratory sensitization to, by RAST and quantitative radioimmunoassay (QRIA) (Moller DR et al), 170 Histamine and LTD, in patients with exogenous asthma, bronchial hyperreactivity to (Bisgaard H et al), 140 ragweed nasal provocation, effect of, on eustachian tube function (Gold S et al), 111 but not arachidonic acid metabolites, osmotically activated human lung mast cells (MC) and basophils release (Eggleston PA et al), 125 challenge, intranasal, effects of, on eustachian tube function (Doyle W et al), 154 changes in airway responsiveness to preceding fluctuations of bronchomotor tone in occupational asthma (L’Archeveque J et al), 170 elevation, plasma, during blind food challenges which provoke migraine (Mansfield LE et al), 205 hyperreactivity in allergic and idiopathic rhinitis (Druce H et al), 111 in vivo release of. by hyperosmolar stimuli (Silber G et al), 176 leukotriene E4 (LTE,)-induced airway hyperresponsiveness to (Lee TH et al), 140 levels, plasma, following deliberate insect sting challenges (Squillace DL et al), 151 PC-20 measurements, sensitivity and specificity of, in random population (Cockcroft DW et al), 142 plasma, measurement of: modification of single-isotope. enzymatic method (Lund M et al), 124 radioimmunoassay for. Application to histamine release (Morel AM et al), 124 receptor blockade, combined Hl and H2, inhibition of systemic anaphylaxis by, in canine model of ragweed hypersensitivity (Kepron W et al), 169 releasability, vivo skin, increased in, in atopic dermatitis (Ting S and Rauls DO), 196 release (HR), allergic and nonallergic, inhibition of, by azelastine (AZ) and lipoxygenase inhibitors (LI) (Chand Net al), 194 and hydrogen peroxide (H,O,) generation by human leukocytes, effect of selected Ravonoids on (Ogasawara H and Middleton E Jr), 184 basophil (BHR), characteristics of, after exposure to the radiocontrast agent diatrizoate (DT) (Herrod HG et al), 194 effect of sex steroids on (Slater JE and Kaliner MA), 176

VOLUME 75 NUMBER 6

Histamine-cont’d enhanced

basophil, to concanavalin A (CON A) in asthma (Caddy J and Busse W), 124 enhancing factor (HREF), production of, by PHA stimulated mononuclear cells (Younger RE et al), 109 from human basophils, role of esterases in mechanism of (Meier HL et al), 127 mucosal-type human mast cells (Wardlaw AJ et al), 193 in vivo, antigen induced, effects of propanolol on terbutaline suppression of (Rauls DO and Ting S), 123 local, in patients with chronic urticaria, increased 48/80 induced (Bedard PM et al), 126 methacholine-induced, in nasal secretions (Raphael GD et al), 112 specific, from shark leukocytes (Baysa J et al), 125 releasers, certain, intracellular calcium release provoked by, and its prevention by some antiallergic drugs (Tasaka K), 124 releasing (HR) factor from cultured human monocyte-macrophages (M-M) (McGettigan MC et al), 110 response in atopic dogs, relationship of cutaneous late phase response (LPR) to (Becker AB et al), 149 synthesis inhibitor, effect of, on immediate allergic reaction (Pipkom U et al), 154 type 1 (H,) receptor radioligand binding studies in T cells from normal and atopic subjects (Cameron W et al), 110 Histochemistry, immunoperoxidase, localization of guinea pig (GP) lung beta-receptors by (Casale TB et al), 180 HLA-DR2, association of simultaneous sensitivity to Ra5S and Ra5G with (Coulter KM et al), 155 Honey processing plant, occupational allergy to honeybee whole body dust in (Ostrom NK et al), 134 Honeybee and yellow jacket venom-specific IgE, further studies of patients with both (Reisman RE and Laze11 MI), 208 sting allergy, combined active and passive immunotherapy in (Muller U et al), 208 value of risk indices in predicting reactivity to (Day JH), 209 venom (HBV) sensitive patients, treatment of, with fragment of phospholipase A2 (PLA,) (Litwin A et al), 151 whole body dust, occupational allergy to, in honey processing plant (Ostrom NK et al), 134 Hornet (VESPA CRABRO), European, emerging sting problem in Eastern U.S. (Jacobson RS and Hoffman DR), 121 Human airways in vitro, anaphylatoxin C3a enhances mucous glycoprotein release from (Marom ZM et al), 199 allergic skin reactions, patterns of LTC, release in (Talbot SF et al), 183 alveolar macrophages, modulation of natural killer cell function by (Weissman DN et al), 152 basophils, role of esterases in mechanism of histamine release from (Meier HL et al), 127 blood basophils, bulk culture of, from patients with chronic myelogenous leukemia (CML) (Mullarkey MF et al), 127 leucocytes are incubated with anti-IgE (reversed-type anaphylaxis), alterations in granulocyte function when (Walsh GM et al), 193 lymphocytes, NCA release from: effects of salbutamol and sodium cromolyn (SC) on this release (Cundell DR and Davies RJ), 109 bronchus in vitro, anti-IgE induced contraction of (Schellenberg RR et al), 126 diploid cell vaccine, rabies, serum sickness-like reaction associated with skin-sensitizing antibody following booster dose of (Deutsch AJ et al), 108 ne C, geneI, >n by, after stimulation with eosinophils, leukot IgG-coatec particles (ShYw RJ et al), 183 giant papillary conjunctivitis, development of an animal model for (Cornell-Bell AH et al), 186 IgE binding factor produced by T cell hybridomas (Stadler BM et al), 139

Meeting

abstracts

subject

index

777

Human airways-cont’d IgG and IgE binding proteins, analysis of, in wheat flour extracts (Theobald K et al), 120 leukocytes, histamine release (HR) and hydrogen peroxide (H,Oz) generation by, effect of selected flavonoids on (Ogasawara H and Middleton E Jr), 184 lung, bronchial, (HBP) preparations from, thiazinamium chloride (TC) is potent muscle relaxant in (Raffestin B et al), 123 mast cells (MC) and basophils, osmotically activated, release histamine but not arachidonic acid metabolites (Eggleston PA et al), 125 in situ degranulation of (Friedman MM et al), 153 lymphocyte proliferative responses, observations on effects of flavonoids on (Mookerjee BK et al), 201 mast cells, effect of tryptase from, on fibrinogen and plasminogen (Schwartz LB et al), 183 mucosal-type, histamine release from (Wardlaw AJ et al), 193 monocyte-macrophages (M-M), cultured, histamine releasing (HR) factor from (McGettigan MC et al), 110 nasal metachromatic cell (NMC) heterogeneity: relation to clinical status and response to beclomethasone dipropionate (BDP) (Otsuka H et al). 153 neutrophil (PMN) superoxide (0,) production, influenza virus (INF VIR) reduces verapamil (VER) inhibition of (Sharpe G et al), 116 serum albumin, beta propiolactone treated, (BPL-HSA): allergen for humans receiving rabies vaccine (Baer H et al), 137 -oxide, ethylene, antibody against, in patients with anaphylactic reactions to dialysis (Patterson BF et al), 150 soluble copolymer of wasp (Polisres) venom with, for immunotherapy (Gewurz A et al), 208 sickness, cutaneous manifestations of (Bielory L et al), 130 skin test reactivity in, azelastine inhibition of (Merton H et al), 167 subjects, young and old, anti-tetanus toxoid (TT) antibody and auto-anti-idiotype (Id) antibody response of, following boosting with tetanus toxoid (Arreaza EE et al), 190 T cell clones, characterization of, that regulate IgE production in vitro (Zimmerman B et al), 138 lines, production of IgE potentiating factor by FC,R+ (Young MC et al), 109 lymphocytes, lectin stimulated, tyrosine phosphorylation of particulate proteins in (Cart D et al), 181 mitogens and growth factors in, tyrosine phosphorylation of 66KD soluble protein is stimulated by (Bass G et al), 182 vascular endothelial cell interleukin-1 production, regulation of (Epstein E et al), 191 Hybridoma(s) IgE antibody, antigen specific, bronchoalveolar lavage analysis of rat pulmonary late phase reactions mediated by (Lemanske R et al), 148 T cell, human IgE binding factor produced by (Stadler BM et al), 139 Hydrocortisone and airflow impairment in aspirin-induced asthma (Nizankowska E et al), 158 Hydrogen peroxide (H,O,) generation and histamine release (HR) by human leukocytes, effect of selected flavonoids on (Ogasawara H and Middleton E Jr), 184 Hydrolasc synthesis, macrophage lysosomal, and secretion by p1,3-glucan, induction of: possible role of arachidonic acid metabolites (Lew DB et al), 152 Hydroxyzine (H), astemizole (A), and terfenadine (T), comparison of efficacy and adverse effects of (Gendreau-Reid LF et al), 168 Hymenoptera allergy: diagnostic evaluation (Pastorello E et al), 207 Hyperosmolar stimuli, in vivo release of histamine by (Silber G et al). 176

778

Meeting

abstracts

subject

index

Hyperosmolarity

as stimulus to hyperventilation asthma (Smith CM and Anderson SD), 143 Hyperreactivity, airway, and mediator release in clinical models of asthma (Holgate ST et al), 140 bronchial, to LTD, and histamine in patients with exogenous asthma (Bisgaard H et al), 140 histamine, in allergic and idiopathic rhinitis (Dmce H et al), 111 Hyperresponsiveness. airway, leukotriene E4 (LTD,)-induced, to histamine (Lee TH et al), 140 Hypersensitivity, bronchial, or bronchospasm, failure of aqueous urea-formaldehyde foam insulation (UFFI) extract to elicit (Del Carpio J et al), 143 cutaneous delayed (CDH), to tetanus toxoid (IT) in immunized and non-immunized population (Chryssanthopoulos C et al), 200 food antigen, altered specific 1gG to specific IgE ratio (SGE) in children with (Holsen BB et al), 205 persistence of, in children with atopic dermatitis (AD) (Sampson HA), 179 IFA, immunotherapy (IT) with imported fire ant whole body extract (IFA-WBE) in, specific IgE and IgG responses to (Johansson SGO et al), 208 imported fire ant: antigenic analysis of whole body extracts and venom (Butcher BT et al), 147 local insulin, use of low dose continuous corticosteroid infusion to facilitate insulin pump use in (Grant W et al), 107 murine delayed-type (DTH), cellular cooperation in expression of: augmenting accessory cells bear 1-A and appear MHC-restricted (Scovem H and Reinprecht C), 152 phenytoin, permanent intrinsic B cell deficiency due to (Guerra 1C et al), 137 pneumonitis, animal model of (Calvanico NJ and Keller RH), 115 pulmonary macrophage metabolism of M. faeni in model of (Schmitt D and Schuyler M), 115 potency relative delayed, in guinea pigs, comparison of three Candida nlbicum strains by immunological methods and (Williamson S et al), 117 ragweed, inhibition of systemic anaphylaxis by combined Hl and H2 histamine receptor blockade in canine model of (Kepron W et al), 169 Hyperventilation asthma, hyperosmolarity as stimulus to (Smith CM and Anderson SD), 143 isocapnic, methacholine challenge, allergen inhalation, and treadmill exercise, mediator release in asthma after (Nagakura T et al), 174 of cold dry air, bronchoconstriction stimulated by: magnitude and duration of inhibitory effect of three doses of sodium cromoglycate (Juniper EF et al), 173 Hypogammaglobulinemia, severe, associated with very late onset group B streptococcal disease in pretenn infants (Asser S and O’Connor RD), 188 transient, of infancy (THI). New perspective (McGeady SJ and Mansmann HC Jr), 188 Hyposensitization, altered interleukin-2 (IL-2) production and response after (Hsieh KH), 110

“Idiopathic

anaphylaxis”, food skin testing in patients with (Snicker WE et al), 150 and allergic rhinitis, histamine hyperreactivity in (Druce H et al), 111 urticaria, chronic, studies of mononuclear cell infiltrate in (Elias J and Kaplan AP), 114 with astemizole (A), treatment of (Fox RW et al), 167 IgA, anti, antibodies and successful immunoglobulin prophylaxis, antibody deficiency syndromes with (Bjorkander J et al), 137 deficiency/at, selective, patients with, have anti HTLV l-MA antibodies (Tomar RH et al), 190

J. ALLERGY CLIN. IMMUNOL. JUNE 1985

gE and IgG antibodies, detection of, in ELISA assay: anaphylactic reactions in common variable agammaglobulinemia (CVA) (Burks AW et al), 188 specific, antigen suppression of, from peripheral blood lymphocytes (PBL) of Mt. Cedar atopics, study on (Bergeron M et al), 202 human, binding proteins, analysis of, in wheat flour extracts (Theobald K et al), 120 responses, specific, to immunotherapy (IT) with imported fire ant whole body extract (IFA-WBE) in IFA hypersensitivity (H) (Johansson SGO et al), 208 specific, reactivity of, of Schistosoma munsoni adult worm and egg extracts using immunoblotting techniques (Schroder H et al), 122 anti, induced contraction of human bronchus in vitro (Schellenberg RR et al), 126 anti-, (reversed-type anaphylaxis), alterations in granulocyte function when human blood leucocytes are incubated with (Walsh GM et al), 193 antibody, antigen specific hybridoma, bronchoalveolar lavage analysis of rat pulmonary late phase reactions mediated by (Lemanske R et al), 148 monoclonal helper T cells induce normal B cells to synthesize (Umetsu DT et al), 138 murine, responses to trimellitic anhvdride, suopression of (Wei B-Y et al), 198 response, antigen enhancement of, from peripheral blood lymphocytes (PBL) of ragweed atopics (Kazaniwsky N et al), 201 to foods, comparison between RIA-MAST and RIA-RAST in detecting (Firestone JE Jr and Bahna SL), 204 binding factor, human, produced by T cell hybridomas (Stadler BM et al), 139 -dependent reactions that enhance eosinophiland neutrophilmediated complement-dependent killing of schistosomula of S. mnsoni, mediators from (MacDonald AJ et al), 116 formation, spontaneous, in vitro by isolated B cells from patients with atooic dermatitis (McNeil D et al), 139 -containing circulating immune complexes (IgE-CIC), IgErheumatoid factor (RF) and skin IgE-deposition in rheumatoid arthritis (RA) patients (pts) (De Clerck LS et al), 202 -immunotoxins, selective mast cell (Boltansky H et al), 184 involved in quinine adverse reaction (Dor P et al), 108 levels, serum, pulmonary function, and specific 1gE immune responses in monozygotic twins reared apart (Hanson B et al), 155 -mediated disease: anaphylaxis (ANA) to tetanus toxoid (‘IT) (Engler RJM and Zaloga G), 210 hypersensitivity reaction to coca-monoethinolimide (CME) in fabric softener pad (Herman JJ), 130 RAST-positive allergy to peanut (PN), cow’s milk (M) and egg (E): relationship to feeding and maternal diet (Gerrard JW and Perelmutter L), 178 respiratory sensitization, detection of, to hexahydrophthalic anhydride (HHPA) by RAST and quantitative radioimmunoassay (QRlA) (Moller DR et al), 170 potentiating factor, production of, by FC,R + human T cell lines (Young MC et al), 109 production in vitro, characterization of human T cell clones that regulate (Zimmerman B et al), 138 protein in cell culture supematants, variability in quantitation of (Helm RM et al), 138 RAST” inhibition method for standardization of potencies of allergenic extracts (Jones RM et al), 196 positive and RAST negative adverse reactions to peanut (PN), cow’s milk (M) and egg (E), IgG, levels in patients with (Perelmutter L and Gerrard JW), 204 sensitivity to cabbage (Blaiss MS et al), 207

VOLUME 75 NUMBER 6

IgE and IgG antibodies-cont’d sensitization in snow-crab processing workers with occupational asthma (OA) (McCants M et al), 135 specific, ratio (SGE), altered specific ratio to, in children with food antigen hypersensitivity (Holsen BB et al), 205 states, hyper, increased numbers of circulating LEU 2+ LEU 1 1 + , in hyper IgE states (Leung DYM et al), 139 synthesis, generation of suppressor cells that modulate, in atopic patients during immunotherapy (Tamir R et al), 138 venom-specific, as criterion for discontinuing venom immunotherapy (VIT), further evaluation of decline in (Randolph CC and Reisman RE), 151 honeybee and yellow jacket, further studies of patients with both (Reisman RE and Laze11 MI), 208 IgG and IgE antibodies, detection of, in ELISA assay: anaphylactic reactions in common variable agammaglobulinemia (CVA) (Burks AW et al), 188 and IgE antibodies, specific, antigen suppression of, from peripheral blood lymphocytes (PBL) of Mt. Cedar atopits, study on (Bergeron M et al), 202 human, binding proteins, analysis of, in wheat flour extracts (Theobald K et al), 120 responses, specific, to immunotherapy (IT) with imported fire ant whole body extract (IFA-WBE) in IFA hypersensitivity (H) (Johansson SGO et al), 208 specific, reactivity of, of Schistosoma mansoni adult worm and egg extracts using immunoblotting techniques (Schroder H et al), 122 antibodies, grass pollen-specific, quantitative immunoenzymatic assay for (Moss R and Hsu Y-P), 175 response to timothy grass pollen antigen B, characterization of (Turner KJ and Malley A), 119 anti-mouse, familial defect in T cell activation of OKT3 can be overcome by cross-linking of OKT3 with (Ceuppens JL), 182 -coated particles, leukotriene C, generation by human eosinophils after stimulation with (Shaw RJ et al), 183 serum, does not correlate with antibody (ab) 2 concentration, response to pneumococcal polysaccharides (PPS) in immunodeficient children (Smith TF et al), 189 -kappa paraproteinemia, intrauterine, with cellular immune deficiency (Shirley LR et al), 189 4 levels in patients with IgE RAST positive and RAST negative adverse reactions to peanut (PN), cow’s milk (M) and egg (E) (Perelmutter L and Gerrard JW), 204 specific, altered, to specific IgE ratio (SGE), in children with food antigen hypersensitivity (Holsen BB et al), 205 children with, have impaired response to * subclass deficiency, polyribose phosphate (PRP) polysaccharide vaccine (Geha R et al), 188 undiagnosed, pneumonectomy in: tragic teaching case (Gruber RA et al), 189 tests, bronchial provocation test and total and individual antigenspecific, in double blind cross-over study, results of. Immunotherapy with animal dander extracts (Sundin B et al), 163 Immune stimulated regional inflammatory responses mediating lung reactivity in rats (Ahlstedt S et al), 156 Immunoelectrophoresis, rocket, for C4d and C4 in hereditary angioedema (HAE) and acquired (ClNH) deficiency (Curd JG et al), 131 Immunoenzymatic assay, quantitative, for grass pollen-specific IgG antibodies (Moss R and Hsu Y-P), 175 Immunoglobulin prophylaxis, successful, and anti-IgA antibodies, antibody deficiency syndromes (Bjorkander J et al), 137 Immunosorbcnt, murine monoclonal antibody, isolation of Kentucky blue grass pollen allergen using (Ekramoddoullah AKM et al), 120 Immunotherapy, antigen-specific suppressor cells in patients rcceiving (Nagaya H), 191

Meeting

abstracts

subject

index

779

Immunotherapy-cont’d combined active and passive, in honeybee sting allergy (Muller U et al), 208 hay fever patients treated by, auto-anti-idiotypic antibody levels in (Bose R et al), 190 soluble copolymer of wasp (Polistes) venom with human serum albumin for (Gewurz A et al), 208 venom (VIT), is forever? (Golden DBK et al), 208 with imported fire ant whole body extract (IFA-WBE), specific IgE and IgG responses to, in IFA hypersensitivity (H) (Johansson SGO et al), 208 Immunotoxins, selective mast cell IgE- (Boltansky H et al), 184 Indomethacin (I), dexamethasone (D), or chloroquine (C), effect of, on isoprotemnol (ISOP)-induced ventricular fibrillation in heavy rats (Johnson GL et al), 136 Infantile bronchial asthma (BA), diagnostic criteria in the early diagnosis of (Eboriadou M et al), 171 Influenza virus (INF VIR) reduces verapamil (VER) inhibition of human neutrophil (PMN) superoxide (0,) production (Sharpc G et al), 116 Inhalant allergy, comparative evaluation of multiple RAST and discrete RAST for (Verhelst JA et al), 196 immunotherapy, systemic allergic reactions to (Greenberg MA et al), 165 sensitivities, multiple, safety and immunogenicity of immunotherapy with polymerized tree, grass, and ragweed in patients with (Grammer LC et al), 165 Inhibitory factor, leukocyte (LIF), potentiation of F-met-leu-phe induced chemotaxis and superoxide (0;) generation (Borish LC et al), 109 Insect allergy: sting outcome in history-positive, skin-test negative children (Schuberth KC et al), 151 sting challenges, deliberate, plasma histamine levels following (Squillace DL et al), 151 stinging, deaths, analysis of 677 death certificates and 168 autopsies of (Nall TM), 207 Insulin allergy, management of (Fireman P et al), 107 pump use in local insulin hypersensitivity, use of low dose continuous corticosteroid infusion to facilitate (Grant W et al), 107 zinc-containing, generalized chronic urticaria secondary to (Chang KC et al), 131 Interleukin-1 activities, different, effects of cyclosporine on (Rossenwasser LJ et al), 182 production, human vascular endothelial cell, regulation of (Epstein E et al), 191 -2 and thymosin fraction V, effect of, on expression of TAC antigen and lymphocyte transformation in AIDS (Reddy MM et al), 183 production and response, altered, after hyposensitization (Hsieh KH), 110 production by ragweed (RW) sensitive patients (Hawrylko E et al), 110 Intranasal challenge, provocative, with house dust mite, eustachian tube obstruction (ETO) after (Skoner D et al), 111 histamine challenge, effects of, on eustachian tube function (Doyle W et al), 154 Ionophore A23 187, calcium dependent, induced eosinophil degranulation and cytolysis (Fukuda T et al), 116 calcium, induced generation of leukotriene D, (LTD,) from granulocytes of normal, allergic rhinitis (AR) and asthmatic patients measured by radioreceptor assay (RRA) (Kohi F et al), 125 Ions, quatemary ammonium, role of, in mechanisms of anaphylactic reactions to succinylcholine (Sch) (Cador D et al), 150 Ipratropium bromide (Atrovent) nasal spray in vasomotor rhinitis (Dolovich J et al), 160 Isocapnic cold air challenges (ICAC), withinand between-days reproducibility of (Tessier P et al), 172

780

Meeting

abstracts

subject

index

Isoelectric

focussion (IEF), expanded potential of: introduction of brief technique (Anderson MC and Baer H), 174 lsoetharine (I) and terbutaline (T), comparison of, when delivered by closed intermittent flow nebulizer system (Welch MJ et al), 162 Isoproterenol (ISO) and bitolterol mesylate (BMS) solutions by open, continuous flow nebulization in asthma (Ming0 T et al), 163 and bitolterol nebulizer solutions, safety and efficacy study of (Pinnas JL et al), 163 -induced ventricular fibrillation in heavy rats, effect of indomethacin (I), dexamethasone (D), or chloroquine (C) on (Johnson GL et al), 136 Isotope methodology, stable, Theo-24 versus Theo-Dur kinetics using (Walker S et al), 129 K Ketotifen

as prophylactic treatment in asthmatic children aged l-3 years (Volovitz B et al), 199 prevention of decreased BR, inhibition of phospholipid methylation, and cyclic AMP phosphodiesterase stimulation by, in leukocytes from asthmatic subjects (PerrinFayolle M et al), 160 Kinetics of allergen release from Alrernaria (ALT) (Sweeney M et al), 118 Theo-24 versus Theo-Dur, using stable isotope methodology (Walker S et al), 129 Kinin-coagulation pathway activation during late phase of cutaneous allergic reactions (Atkins P et al), 148 Kininogenase activity in bronchoalveolar lavage (BAL) fluids in asthma (Christiansen SC et al), 177 Kininogens in nasal secretions of allergic individuals (Baumgarten CR et al), 112 L Lavage,

bronchoalveolar, analysis of rat pulmonary late phase reactions mediated by antigen specific hybridoma IgE antibody (Lemanske R et al), 148 bronchoalveolar (BAL) fluids in asthma, kininogenase activity in (Christiansen SC et al), 177 in allergic bronchopulmonary aspergillosis (ABPA) (Greenberger PA et al), 133 cells, bronchoalveolar, on B-lymphocyte function, effect of (Morgan J et al), 115 Lectin stimulated human T lymphocytes, tyorisine phosphorylation of particulate proteins in (Cort D et al), 181 LEU 2 + LEU 1 1 + lymphocytes, circulating, increased numbers of, in hyper IgE states (Leung DYM et al), 139 Leukemia, chronic myelogenous (CML), bulk culture of human blood basophils from patients with (Mullarkey MF et al), 127 Leukocytes, circulating, anomalous effects of steroid treatment on (Toogood JH et al), 158 cytotoxicity, enhanced, after exercise-induced asthma (Kay AB et al), 194 from asthmatic subjects, prevention of decreased BR, inhibition of phospholipid methylation, and cyclic AMP phosphodiesterase stimulation by ketotifen in (Perrin-Fayolle M et al), 160 human blood, arc incubated with anti-IgE (reversed-type anaphylaxis), alterations in granulocyte function when (Walsh GM et al), 193 histamine release (HR) and hydrogen peroxide (H,O,) generation by, effect of selected flavonoid on (Ogasawara H and Middleton E Jr), 184 inhibitory factor (LIF) potentiation of F-met-leu-phe induced chemotaxis and superoxide (0;) generation (Borish LC et al), 109 polymorphonuclear (PML) depletion, effect of, on late asthmatic response (LAR) (Murphy KR et al), 148

J. ALLERGY CLIN. IMMUNOL. JUNE 1985

Leukocytes-cont’d and lymphocytes, age-related decline of function of: evaluation of defense function in A-bomb survivors (Suzuki K et al), 200 shark, specific histamine release from (Baysa J et al), 125 Leukotrienes and RMCPl 1, parenteral and enteral release of after systemic anaphylaxis in Nippostrongylus brasiliensisprimed rats (Moqbel R et al), 126 their metabolism in plasma and bronchial fluids (Schonfeld W et al), 126 C, generation of human eosinophils after stimulation with IgGcoated particles (Shaw RJ et al), 183 D, (LTD,) from granulocytes of normal, allergic rhinitis (AR) and asthmatic patients measured by radioreceptor assay (RRA), calcium ionophore A23187 induced generation of (Kohi F et al), 125 receptors in guinea pig (GP) experimental asthma (Takeyama H et al), 140 E, (LTE,)-induced airway hyperresponsiveness to histamine (Lee TH et al), 140 production, in vitro and in vivo inhibition of gold salt on (Wang SR et al), 185 sulphidopeptide, and LTB, in nasal secretions and nasal polyposis (Fitzhaois P et al), 112 Lipoxygenase inhibitors (LI) and azelastine (AZ), allergic and nonallergic histamine release (HR) by, inhibition of (Chand N et al), 194 Locusta migratoria and Schistocerca gregaria, locusts, allergy to (Tee RD et al), 122 Locusts (Schistocerca gregariu and Locusta migratoria), allergy to (Tee RD et al), 122 LTB, and sulphidopeptide leukotrienes in nasal secretions and nasal polyposis (Fitzharris P et al), 112 C, release, patterns of, in human allergic skin reactions (Talbot SF et al), 183 D, and histamine in patients with exogenous asthma, bronchial hyperreactivity to (Bisgaard H et al), 140 Lung and intestinal mast cells, monkey, comparison of the effects of anti-allergic drugs on (Barrett KE et al), 193 beta-receptors, guinea pig (GP), localization of, by immunoperoxidase histochemistry (Casale TB et al), 180 function, response of, to treatment in infants with bronchiolitis (Maayan C et al), 172 human (HBP), bronchial preparations from, thiazinamium chloride (TC) is potent muscle relaxant in (Raffestin B et al), 123 immunologic reactivity, alveolar macrophage activation does not suppress (Schuyler MR), 115 injury, trimellitic anhydride (TMA) induced immunologic. animal model of (Zeiss CR et al), 135 mast cells (MC), human, and basophils, osmotically activated, release histamine but not arachidonic acid metabolites (Eggleston PA et al), 125 in situ degranulation of (Friedman MM et al), 153 murine, analytical and functional assessment of lymphoid cells within (Nuntirooj K et al), 157 reactivity in rats, immune stimulated regional inflammatory responses mediating (Ahlstedt S et al), 156 Lymphocytes and polymorphonuclear leukocytes, age-related decline of function of: evaluation of defense function in A-bomb survivors (Suzuki K et al), 200 B, dysfunction in pediatric AIDS (Pahwa S et al), 192 function, effect of bronchoalveolar lavage cells on (Morgan J et al), 115 blood, peripheral (PBL) of Mt. Cedar atopics, antigen suppression of specific IgE and IgG antibodies from, study on (Bergeron M et al), 202 of ragweed atopics, antigen enhancement of IgE antibody response from (Kazaniwsky N et al), 201 circulating LEU 2 + LEU 11 + , increased numbers of, in hyper IgE states (Leung DYM et al), 139

Meeting

VOLUME 75 NUMBER 6

Lymphocytes and polymorphonuclear leukocytes-cont’d human blood, NCA release from: effects of salbutamol and sodium cromolyn (SC) on this release (Cundell DR and Davies RJ), 109 proliferative responses, observations on effects of flavonoids on (Mookerjee BK et al), 201 T, lectin stimulated, tyrosine phosphorylation of particulate proteins in (Cort D et al), 181 mitogens and growth factors in, tyrosine phosphorylation of 66KD soluble protein is stimulated by (Bass G et al), 182 responses to pollen allergens: effect of polymerized allergen immunotherapy (Buckley RH et al), 120 subpopulations in asthmatics (Tse KS et al), 156 transformation and TAC antigen in AIDS, effect of interleukin2 and thymosin fraction V on expression of (Reddy MM et al), 183 Lysosomal hydrolase synthesis, macrophage, and secretion by p1,3-glucan, induction of: possible role of arachidonic acid metabolites (Lew DB et al), 152 M Macrophage(s),

alveolar, activation does not suppress lung immunologic reactivity (Schuyler MR), 115 human alveolar, modulation of natural killer cell function by (Weissman DN et al), 152 lysosomal hydrolase synthesis and secretion by p-1,3-glucan, induction of: possible role of arachidonic acid metabolites (Lew DB et al), 152 metabolism, pulmonary, of M.fueni in model of hypersensitivity pneumonitis (Schmitt D and Schuyler M), ‘115 monocyte (M-M), cultured human, histamine releasing (HR) factor from (McGettigan MC et al), 110 Marrow cells, bone, soy lectin T cell depleted haploidentical, appearance of multiple paraproteins during early engraftment of, in severe combined immunodeficiency (SCID) (Ghory PK et al), 189 -derived mouse bone, mast cell mediator release, cromolyn inhibition of (Marquardt DL et al), 192 Mast cells (MC), cutaneous, in response to defined stimuli of physical allergic class, ultrastructural changes of (Sheffer AL et al), 114 deficient (W/W” and S 1IS Id) mice, expression of undiminished contact sensitivity and immunological tolerance in (Mekori YA and Galli SJ), 152 degranulation, neutrophil induced (White MV and Kaliner MA), 175 human, effect of tryptase from, on fibrinogen and plasminogen (Schwartz LB et al), 183 lung, and basophils, osmotically activated, release histamine but not arachidonic acid metabolites (Eggleston PA et al), 125 in situ degranulation of (Friedman MM et al), 153 mucosal-type, histamine release from (Wardlaw AJ et al), 193 IgE-immunotoxins, selective (Boltansky H et al), 184 intestinal, and lung, monkey, comparison of the effect of antiallergic drugs on (Barrett KE et al), 193 mediator release in vivo, influence of salbutamol and sodium cromoglycate on (Church MK et al), 195 mouse bone marrow-derived, cromolyn inhibition of (Marquardt DL et al), 192 nasal: characteristics and effect of allergen (Corrado OJ et al), 153 rheumatoid synovial: functional studies (Gruber BL et al), 202 subclasses, murine-derived, quantitative comparison of three arachidonate metabolites from (DuBuske L et al), 126 threshold, altered, in exercise-induced anaphylaxis (Errington GW et al), 193

Mastocytosis,

abstracts

subject

index

781

systemic (SM), or unexplained anaphylaxis (UEA), sulfite challenges in patients with (Meggs WJ et al), 144 Maxillary sinus disease, comparison of A-mode ultrasound and xray for screening of (Berger W and Weiss J), 187 MDM (minor determinant mixtures) of penicillin, relative contribution of constituents of (Gadde J et al), 108 Metabisulfite (MBS)-associated hepatotoxicity and protection of cobalamins (Bl2) (Flaherty M et al), 198 induced asthma (Allen D and Delohery J), 145 sensitive subjects, positive Prausnitz-Kustner reaction in (Yang WH et al), 198 Metabolite(s) antigenicity, drug, generation of, in intestinal mucosa (Wu C et al), 107 arachidonic acid, but not histamine, osmotically activated human lung mast cells (MC) and basophils release (Eggleston PA et al), 125 arachidonic acid, possible role of: induction of macrophage lysosomal hydrolase synthesis and secretion by p-1,3glucan (Lew DB et al), 152 three arachidonate, quantitative comparison of, from murinederived mast cell subclasses (DuBuske L et al), 126 Metaproterenol (M) and albuterol (AL), effect of, administered by metered dose inhaler (MDI) on non-specific airway responsiveness (NR) (Ahrens RC et al), 161 inhaled, inhaled atropine, or combination of both, comparison of, in treatment of acute asthma in children (Guill MF and Maloney MJ), 159 nebulized, dose response study of, for acute asthma in children (Furukawa CT et al), 160 oral, versus theophylline, pulmonary function and cardiovascular responses to exercise in asthmatic children on (Oppenheimer P and Schuller D), 113 Methacholine challenges (MC) in large pediatric population (Hopp R et al), 142 -induced histamine release in nasal secretions (Raphael GD et al), 112 sensitivity (MS) in allergic rhinitis (AR) subjects during ragweed season (Weiss S et al), 149 Methylation, phospholipid, inhibition of, prevention of decreased BR, and cyclic AMP phosphodiesterase stimulation by ketotifen in leukocytes from asthmatic subjects (Perrin-Fayolle M et al), 160 Methylprednisolone and TAO (troleandomycin), incidence of corticosteroid side effects in chronic steroid dependent asthmatics on (Harris R and German D), 157 M.faeni in model of hypersensitivity pneumonitis, pulmonary macrophage metabolism of (Schmitt D and Schuyler M), 115 Mice, mast cell deficient (W/W and Sl/Sld), expression of undiminished contact sensitivity and immunological tolerance in (Mekori YA and Galli SJ), 152 Migraine, blind food challenges which provoke, plasma histamine elevation during (Mansfield LE et al), 205 Milk allergy, cow’s, and betalactoglobulin (IgG), antibody against (Casimir G et al), 206 chronic diarrhea due to. 4-10 year follow-up (Businco L et al), 206 egg (E), and peanut (PN), IgE mediated, RAST-positive allergy to: relationship to feeding and maternal diet (Gerrard JW and Perelmutter L), 178 extreme sensitization to, in infants fed breast milk (BM) or soy milk (SM) (Schwartz RH et al), 177 rheumatoid arthritis exacerbated by. 1. Food-induced (allergic) arthritis (Panush RS et al), 203 Mite(s) and house dust extracts, measurement of L). farina allergens in, and in houses of asthmatic patients (PlattsMills TAE et al), 146 and mould allergen preparation, detection of allergens in. by using protein blotting (Bengtsson A et al), 121

782

Meeting

abstracts

subject

index

Mite(s) and house dust extracts-cont’d exposure and antibody responses of asthmatic children in Atlanta (Kelly L et al), 172 extract, standardized, early benefits of rush immunotherapy with (Bousquet J et al), 164 house dust (HDM) allergic patients, presence of auto-anti-jdiotypic antibodies in (Wu J-P et al), 190 and air conditioning (Carpenter GB et a]), 121 eustachian tube obstruction (ETO) after provocative intranasal challenge with (Skoner D et al), 111 in Baltimore area, prevalence of (Norman PS et al), 121 reduction in home: use of acaracide (Mitchell EB et al), 146 immunotherapy increases non-allergic bronchial reactivity in asthmatic children (Ferguson AC et al), 141 Mitogens and growth factors in human T lymphocytes, tyrosine phosphorylation of 66KD soluble protein is stimulated by (Bass G et al), 182 induced helper and suppressor activity mediated by OKT4 + cells (Gansbacher B and Levinson AI), 182 Metoprolol and bucindolol, two beta antagonists, effect of, on pulmonary function in subjects with asthma (Welsh PW et al), 181 Molecules, membrane, identification of, from RPM1 8866 cells reacting with monoclonal antibody (Mab) specific to FC.R (Nakajima T et al), 139 Monoclonal antibody, murine, immunosorbent, isolation of Kentucky blue grass pollen allergen using (Ekramoddoullah AKM et al), 120 Monocyte and corticosteroids activation in bronchial asthma (Gin W and Kay AB), 157 -macrophages (M-M), cultured human, histamine releasing (HR) factor from (McGetfigan MC et al), 110 Mononuclear cell infiltrate, studies of, in chronic idiopathic urticaria (Elias J and Kaplan AP), 114 PHA stimulated, production of histamine release enhancing factor (HREF) by (Younger RE et al), 109 phagocyte system (MPS), character of complexes and effect of blockade of: immune complex (X)-induced enterapathy (Bloch KJ et al), 203 Monozygotic twins reared apart, pulmonary function, serum IgE levels, and specific IgE immune responses in (Hanson B et al), 155 Mould and mite allergen preparations, detection of allergens in, by using protein blotting (Bengtsson A et al), 121 Mouse bone marrow-derived mast cell mediator release, cromolyn inhibition of (Marquardt DL et al), 192 urinary allergens (MAl), immunologic properties of (LOIUSSOJR et al), 147 Mucosa, intestinal, generation of drug metabolite antigenicity in (Wu C et al), 107 nas& role of, in some casesof allergic conjunctivitis and effects of disodium cromoglycate (SDCG) (Pelikan M and Pelikan Z), 186 Mucosai reactivity in allergic subjects, effect of ragweed nasal provocation on (Georgitis JW), 111 Murine delayed-type hypersensitivity (DTH), cellular cooperation in expression of: augmenting accessory cells bear lA and appear MHC-restricted (Scovem H and Reinprecht C), 152 -derived mast cell subclasses, quantitative comparison of three arachidonate metabolites from (DuBuske L et al), 126 IgE antibody responses to trimellitic anhydride, suppression of (Wei B-Y et al), 198 lung, analytical and functional assessment of lymphoid cells within (Nuntirooj K et al), 157 monoclonal antibody immunosorbent, isolation of Kentucky blue grass pollen allergen using (Ekramoddoullah AKM et al), 120 Muscle relaxant, potent, in bronchial preparations from human lung (HBP), thiazinamium chloride (TC) is (Raffestin B et al), 123

J. ALLEAGY CLIN. IMMUN& JUNE ,985

Muscle relaxant-cont’d smooth, canine tracheobronchial, acute actions of gold salts on (Krzanowski J et al), 123 vascular, and isolated guinea pig airway, relaxant activity of atriopeptins in (O’Donnell M et al), 142 Mycelia and Basidiomyceres spores, antigens in, comparison of (Lopez M et al), 175 N

Nasal Immunotherapy, local (LNIT) with high-dose glutaraldehydemodified ragweed extract (PRW) (Dvorin DJ et al), 165 polymerized ragweed extract (PRW), response to: comparison of giant and short ragweed-specific antibodies (Tronolone MJ et al), 165 mast cells: characteristics and effect of allergen (Corrado OJ et al), 153 metachromatic cells (NMC), basophil precursors, and peripheral blood basophils in patients with allergic rhinitis (Denburg J et al), 153 human heterogeneity: relation to clinical statusandrespome to beclomethasone dipropionate (BDP) (Otsuka H et al), 153 mucosa, role of, in some cases of allergic conjunctivitis and effects of disodium cmmoglycate (DSCG) (Pelikan M and Pelikan Z), 186 provocation, histamine and ragweed, effect of, on eustachian tube function (Gold S et al), 111 ragweed, effect of, on mucosal reactivity in allergic subjects (Georgitis JW), 111 secretions and nasal polyposis, sulphidupeptide leukotrienes and LTB, in ( Fitzharris P et al), 112 during nasal challenge, cytological changes in (Pelikan Z and Pelikan M), 112 methacholine-induced histamine release in (Paphael GD et al), 112 of allergic individuals, kininogens in (Baumgargen CR et al), 112 septal perforation in patients using intranasal beclomethasone dipropionate (BDP) (LaForce C and Davis V), 186 solution, 4% cromolyn sodium, placebo controlled trial of, in controlling symptoms of ragweed (RW) induced seasonal allergic rhinitis (Plancey RM and Hein E), 185 spray, ipratropium bromide (Atrovent), in vasomotor rhinitis (Dolovich J et al), 160 versus bronchial responses to pharmacologic challenges in guinea pigs (Wells JH et al), 154 Naso-bronchial reflex, study of, in allergic rhinitis with asthma (Schumacher MJ et al), 141 NCA release from human blood lymphocytes: effects of salbutamol and sodium cromolyn (SC) on this release (Cundeil DR and Davies RJ), 109 Nedocromil, effect of, on exercise induced asthma (Bleecker ER et al), 173 sodium-new modulator of inflammation for treatment of asthma (Edwards AM et al), 199 Neutrophil alveolitis after inhalation challenge in pigeon breeder disease with appearance of seric neutrophil chemotactic activity (Foumier E et al), 132 and eosinophil-mediated complement-dependent killing of schistosomula of S. munsoni, mediators from IgE-dependent reactions that enhance (MacDonald AJ et al), 116 chemotactic activity in laboratory animal-induced asthma (Newman Taylor AJ et al), 176 sulfite sensitive patients (Altman LC et al), 144 human, (PMN) superoxide (0,) production, influenza virus (INF VIR) reduces verapamil (VER) inhibition of (Sharpe G et al), 116 induced mast cell degranulation (White MV and Kaliner MA). 175

Meeting

VOLUME 75 NUMBER 6

Nipposrrongylus

Nonallergic

brasiliensis-primed rats, parenteral and enteral release of leukotrienes and RMCPl 1 after systemic anaphylaxis in (Moqbel R et al), 125 or allergic asthma, type 1, and rhinitis, patients with, radiographic sinus abnormalities in (Stevens WJ et al), 187 0

Oak,

ragweed,

grass, and plantain, mixed allergoid booster immunotherapy (IT) in patients (PTS) allergic to (Creticos PS et al), 164 OKT3, familial defect in T cell activation by, can be overcome by cross-linking of OKT3 with anti-mouse IgG (Ceuppens JL), 182 4+ cells, mitogen induced helper and suppressor activity mediated by (Gansbacher B and Levinson AI), 182 Ova, Ascaris suum, bronchospastic airway responses to aerosohzed ascaris antigen in normal primates after oral administration of (Stout BK et al), 143 P Paint shop,

prevalence of occupational asthma (OA) in (Cattier A et al), 135 Palladium and platinum, factors affecting diverse reaginic responses to (Biagini RE et al), 136 Papillary conjunctivitis, human giant, development of an animal model for (Cornell-Bell AH et al), 186 Paraproteins, multiple, appearance of, during early engraftment of soy lectin T cell depleted haploidentical bone marrow cells in severe combined immunodeficiency (SCID) (Ghory PK et al), 189 Paraproteinemia, intrauterine &G-kappa, with cellular immune deficiency (Shirley LR et al), 189 Parieraria judaica antigens, immunochemical characterization of (Geraci D et al), 119 Peanut (PN), cow’s milk (M) and egg (E), IgE RAST positive and RAST negative adverse reactions to, IgG, levels in patients with (Perelmutter L and Gerrard JW), 204 desensitization to (Shenassa MM et al), 177 Pemtamethylene diethylene &mine: new cause of occupational asthma (Venables K et al), 170 Penicillin, relative contribution of constituents of minor determinant mixtures (MDM) of (Gadde J et al), 108 T-cell reactivity to (Pichler WJ et al), 108 PHA stimulated mononuclear cells, production of histamine release enhancing factor (HREF) by (Younger RE et al), 109 Phagocyte, mononuclear, system (MPS), character of complexes and effect of blockade of: immune complex (IC)-induced enteropathy (Bloch KJ et al), 203 Pharmacodynamic(s) and pharmacokinetic investigations of terfenadine (Foster TS and Batenhorst RL), 168 of brompheniramine and pseudoephedrine in treatment of perennial rhinitis (Shen DD et ai), 186 Pharmacokinetic and pharmacodynamic investigations of terfenadine (Foster TS and Batenhorst RL), 168 Phenotyping in vitro T cell responses (Suez D and Hayward A), 201 Phenytoin hypersensitivity, permanent intrinsic B cell deficiency due to (Guerra IC et al), 137 Phosphodiesterase stimulation, cyclic AMP, inhibition of phospholipid methylation, and prevention of decreased BR by ketotifen in leukocytes from asthmatic subjects (Perrin-Fayolle M et al), 160 Phospholipase A2 antigenic fragment, immunosuppressive properties of (Michael JG et al), 201 treatment of honeybee venom (HBV) sensitive patients with fragment of (Litwin A et al), 151 Phosphorulation, tyrosine, of particulate proteins in lectin stimulated human T lymphocytes (Cort D et al), 181 of 66KD soluble protein is stimulated by mitogens and growth factors in human T lymphocytes (Bass G et al), 182

Pigeon breeder

abstracts

subject

index

783

disease with appearance of seric neutrophil chemotactic activity, neutrophil alveolitis after inhalation challenge in (Foumier E et al), 132 Placebo controlled rush immunotherapy trial, double-blind, with grass pollen allergen and allergoid (Jean F et al), 164 trial of 4% cromolyn sodium nasal solution in controlling symptoms of ragweed (RW) induced seasonal allergic rhinitis (Plancey RM and Hein E), 185 in treatment of seasonal allergic rhinitis, double-blind randomized evaluation of astemizole in comparison with (Nair N et al), 166 responses in intradermal provocation testing with food extracts (Jewett DL and Greenberg MR), 205 versus procaterol aerosol MDI, multicenter trial of, in patients with asthma (Chervinsky P et al), 161 Plantain, ragweed, grass, oak, mixed allergoid booster immunotherapy (IT) in patients (PTS) allergic to (Creticos PS et al), 164 Plasma and bronchial fluids, leukotrienes and their metabolism in (Schonfeld W et al), 126 /blood, whole, ratio determined by new theophylline test without instrumentation (Hoffman M et al), 128 histamine elevation during blind food challenges which provoke migraine (Mansfield LE et al), 205 levels following deliberate insect sting challenges (Squillace DL et al), 151 measurement of: modification of single-isotope enzymatic method (Lund M et al), 124 Plasminogen and fibrinogen, effect of tryptase from human mast cells on (Schwartz LB et al), 183 Platelet activating factor in sputum of patients with asthma and COPD (Grandel KE et al), 184 activation, specific abnormal, in aspirin sensitive asthma: basis for in vitro diagnostic test (Ameisen JC et al), 123 Platinum and palladium, factors affecting diverse reaginic responses to (Biagini RE et al), 136 Pneumococcal polysaccharides (PPS), antibody (ab) response to, in immunodeficient children, serum IgG, concentration does not correlate with (Smith TF et al). 189 Pneumonectomy in undiagnosed IgG subclass deficiency: tragic teaching case (Gruber RA et al), 189 Pneumonitis, hypersensitivity, animal model of (Calvanico NJ and Keller RH), 115 pulmonary macrophage metabolism of M. faeni in model of (Schmitt D and Schuyler M), 115 Pollen allergen, grass, and allergoid, double-blind placebo controlled rush immunotherapy trial with (Jean F et al), 164 Kentucky blue grass, isolation of, using murine monoclonal antibody immunosorbent (Ekramoddoullah AKM et al), 120 lymphocyte responses to: effect of polymerized allergen immunotherapy (Buckley RH et al), 120 antigen B, timothy grass, characterization of IgG antibody response to (Turner KJ and Malley A), 119 exposure, natural, effect of, on eustachian tube function (Stillwagon P et al), 154 extracts, prospective survey of local and systemic reactions to immunotherapy with (Nelson BL et al). 166 grass, immunotherapy, efficacy of, according to allergenic profile of patients (Hejjaoui A et al), 164 peach, occupational allergy to (Ohta K et al), 134 proteins, extractable oak, analysis of (Zenger VE and Wedner HJ), 175 -specific, grass, IgG antibodies, quantitative immunoenzymatic assay for (Moss R and Hsu Y-P), 175 Polymotphonuclear leukocytes and lymphocytes, age-related decline of function of: evaluation of defense function in A-bomb survivors (Suzuki K et al), 200 depletion, effect of, on late asthmatic response (LAR) (Murphy KR et al), 148

784

Meeting

abstracts

subject

index

J. ALLERGY CLIN. IMMUNOL. JUNE 1985

Polyposis,

nasal, and nasal secretions, sulphidopeptide leukotrienes and LTB, in (Fitzharris P et al), 112 Polysaccharides, pneumoccal (PPS), antibody (ab) response to, in immunodeficient children, serum IgG, concentration does not correlate with (Smith TF et al), 189 Prausnitz-Kustner reaction, positive, in metabisulfite sensitive subjects (Yang WH et al), 198 Procaterol in asthmatic patients, albuterol-controlled multicenter study of (Repsher L), 180 Propanolol, effects of, on terbutaline suppression of antigen induced histamine release in vivo (Rauls DO and Ting S), 123 Propiolactone, beta, treated human serum albumin (BPL-HSA): allergen for humans receiving rabies vaccine (Baer H et al), 137 Protease-inhibitor complexes in hereditary angioedema (HAE) and acquired Cl inhibitor (Cl inh) deficiency (ACID) (Zuraw BL and Curd JG), 13 1 Protein(s) blotting, detection of allergens in mould and mite allergen by using (Bengtsson A et al), 121 determination, total, of allergenic extracts, simple procedure for (Richman PG and Cissel DS), 120 extractable oak pollen, analysis of (Zenger VE and Wedner HJ), 175 IgE, in cell culture supematants, variability in quantitation of (Helm RM et al), 138 particulate, tyrosine phosphorylation of, in lectin stimulated human T lymphocytes (Cart D et al), 181 66KD soluble, tyrosine phosphorylation of, is stimulated by mitogens and growth factors in human T lymphocytes (Bass G et al), 182 Pseudoephedrine and brompheniramine, phannacodynamics of, in treatment of perennial rhinitis (Shen DD et al), 186 Psyllium seed, inhaled, anaphylaxis in nurses caused by (Schoenwetter WE), 209 Pulmonary effects of SO? versus SO,-saline aerosol (Koenig JQ et al), 145 function and cardiovascular responses to exercise in asthmatic children on oral metaprotercnol versus theophylline (Oppenheimer P and Schuller D), 113 effect of diflunisal on, in aspirin-sensitive asthma (Szczeklik A and Nizankowska E), 158 in subjects with asthma, effect of two beta antagonists, bucindolol and metoprolol, on (Welsh PW et al), 181 serum IgE levels, and specific IgE immune responses in monozygotic twins reared apart (Hanson B et al), 155 late phase reactions, rat, mediated by antigen specific hybridoma IgE antibody, bronchoalveolar lavage analysis of (Lemanske R et al), 148 macrophage metabolism of M.fueni in model of hypersensitivity pneumonitis (Schmitt D and Schuyler M), 115

Q Quinine

adverse

reaction,

IgE involved

in (Dar

P et al),

108

R Rabies

human

diploid cell vaccine, serum sickness-like reaction associated with skin-sensitizing antibody following booster dose of (Deutsch AJ et al), 108 vaccine, allergen for humans receiving: beta propiolactone treated human serum albumin (BPL-HSA) (Baer H et al), 137 Radiocontrast agent diatrizoate (DT), characteristics of basophil histamine release (BHR) after exposure to (Herrod HG et al), 194 Radiography versus ultrasound for diagnosis of sinusitis (Shapiro G et al), 187 Radioimmunoassay for histamine. Application to histamine release (Morel AM et al), 124 quantitative (QRIA), and RAST, detection of IgE mediated respiratory sensitization to hexahydrophthalic anhydride (HHPA) by (Moller DR et al), 170

Radioimmunoelectrophoresis (CRIE-inh.), crossed, analysis of cross-reacting and partially identical allergens by inhibition of (Maasch HJ et al), 119 Radioligand binding studies, histamine type 1 (H,) receptor, in T cells from normal and atopic subjects (Cameron W et al), 110 Radioreceptor assay (RRA), calcium ionophore A23 187 induced generation of leukotriene D, (LTD,) from granulocytes of normal, allergic rhinitis (AR) and asthmatic patients measured by (Kohi F et al), 125 Ra5S and Ra5G with HLA-DR2, association of simultaneous sensitivity to (Coulter KM et al), 155 RA5 immune responses, HLA antigens, and complotypes (Blumenthal M et al), 155 Ragweed and histamine nasal provocation, effect of, on eustachian tube function (Gold S et al), 111 extract (PRW), high-dose glutaraldehyde-modified, local nasal immunotherapy (LNIT) with (Dvorin DJ et al), 165 polymerized (PRW), response to local nasal immunotherapy (LNIT) with: comparison of giant and short ragweedspecific antibodies (Tronolone MJ et al). 165 grass, and hee, polymerized, in patients with miltiple inhalant sensitivities, safety and immunogenicity of immunotherapy with (Grammer LC et al), 165 oak, and plantain, mixed allergoid booster immunotherapy (IT) in patients (PTS) allergic to (Creticos PS et al), 164 hypersensitivity, inhibition of systemic anaphylaxis by combined Hl and H2 histamine receptor blockade in canine model of (Kepron W et al), 169 induced seasonal allergic rhinitis, placebo controlled trial of 4% cromolyn sodium nasal-solution in controlling symptoms of (Plancev RM and Hein E). 185 nasal provocation, effect of, on mucosal reactivity in allergic subjects (Georgitis JW), 111 season, methacholine sensitivity (MS) in allergic rhinitis (AR) subiects during (Weiss S et al), 149 sensitive patients, interleikin-2 (IL-2) production by (Hawryiko E et al), 110 RAST and quantitative radioimmunoassay (QRIA), detection of IgE mediated respiratory sensitization to hexahydrophthalic anhydride (HHPA) by (Moller DR et al). 170 skin testing, variability of food antigens used in (Brummund W et al), 203 evaluation of, in food sensitivity (Bahna SL and Gandhi MD), 204 inhibition method, IgE, for standardization of potencies of allergenic extracts (Jones RM et al), 196 multiple, and the discrete RAST, comparative evaluation of, for inhalant allergy (Verhelst JA et al), 196 positive and RAST negative, IgE, adverse reactions to peanut (PN), cow’s milk (M) and egg (E). IeG, levels in patients with (Perelmutter L and de&r; Jw), 204 IgE mediated allergy to peanut (PN), cow’s milk (M) and egg (E): relationship to feeding and maternal diet (Gerrard JW and Perelmutter L), 178 Reaction, quinine adverse, IgE involved in (Dor P et al), 108 serum sickness-like, associated with skin-sensitizing antibody following booster dose of rabies human diploid cell vaccine (Deutsch AJ et al), 108 Reactivity, T-cell, to penicillin (Pichler WJ et al), 108 Reaginic responses, diverse, to platinum and palladium, factors affecting (Biagini RE et al), 136 Receptors, beta adrenergic, non-antibody serum factor in asthmatic patients inhibits binding to (Lad P et al), 180 blockade, combined Hl and H2 histamine. inhibition of svstemic , anaphylaxis by, in canine model of ragweed hypersensitivity (Kepron W et al), 169 Hl and H2, in treatment of local heart urticaria (LHU): confirmation (Buchbinder EM et al), 132

Meeting

VOLUME 75 NUMBER 6

Receptors-cont’d leukotriene

D,, in guinea pig (GP) experimental asthma (Takeyama H et al), 140 radioligand binding studies, histamine type 1 (H,), in T cells from normal and atopic subjects (Cameron W et al), 110 serotonin, potential of ergonovine to precipitate bronchial asthmatic attacks via (Sakamoto Y et al), 141 Respiratory disease, allergic, among grain workers (Blainey AD et al), 135 chronic (C.R.D.), immunologic and allergologic parameters in children with (Van Bever H and Stevens W), 197 responses to formaldehyde, formaldehyde free UFFI off-gas and particles in UFFI related asthma (Lees REM et al), 169 sensitization, IgE mediated, to hexahydrophtahalic anhydride (HHPA), detection of, by RAST-and quantitative radioimmunoassav - (ORIA) (Moller DR et al). 170 ._ Rheumatoid arthritis, C3D as marker of extraarticular ‘manifestations of (Peretz A and Duchateau I), 203 exacerbated by milk. I. Food-induced (allergic) arthritis (Panush RS et al), 203 factor, IgE- (RF), skin IgE-deposition, IgE, and IgE-containing circulating immune complexes (IgE-CIC) in rheumatoid arthritis (RA) patients (pts) (De Clerck LS et al), 202 production and polyclonal B cell activation, tetanus toxoid induces (Tar L and Levinson AI), 191 Rhinitis, allergic and idiopathic, histamine hyperreactivity in (Druce H et al), 111 basophil precursors, peripheral blood basophils, and nasal metachromatic cells (NMC) in patients with (Denburg J et al), 153 evaluation of HEPP in (McDowell LJ et al), 185 -major study of habits and attitudes of consumers (Hess A and Lyon D), 200 seasonal, ragweed (RW) induced, placebo controlled trial of 4% cromolyn sodium nasal solution in controlling symptoms of (Plancey RM and Hein E), 185 subjects during ragweed season, methacholine sensitivity (MS) in (Weiss S et al), 149 with asthma, study of naso-bronchial reflex in (Schumacher MJ et al), 141 normal and asthmatic patients measured by radioreceptor assay (RRA), calcium ionophore A23187 induced generation of leukotriene D, (LTD,) from granulocytes of (Kohi F et al), 125 patients with type 1 allergic or non-allergic asthma and, radiographic sinus abnormalities in (Stevens WJ et al), 187 perennial, pharmacodynamics of brompheniramine and pseudoephedrine in treatment of (Shen DD et al), 186 seasonal allergic, double-blind randomized evaluation of asterizole in comparison with placebo in treatment of (Nair N et al), 166 vasomotor, ipratropium bromide (Atrovent) nasal spray in (Dolovich J et al), 160 RIA-MAST and RIA-RAST, comparison between, in detecting IgE antibodies to foods (Firestone JE Jr and Bahna SL), 204 RIA-RAST and RIA-MAST, comparison between, in detecting IgE antibodies to foods (Firestone JE Jr and Bahna SL), 204 RMCPl 1 and leukotrienes, parenteral and enteral release of, after systemic anaphylaxis in Nipposfrongylus brusiliensisprimed rats (Moqbel R et al), 125 S Salbutamol

(SAL), (THEO)

aerosol, and single in asthma treatment

daily dose theophylline (Smith A et al), 113

abstracts

subject

index

785

Salbutamol (SAL)-cont’d and sodium cromoglycate, influence of, on mast ceil mediator release in vivo (Church MK et al), 195 cromolyn (SC) on this release, effects of: NCA release from human blood lymphocytes (Cundell DR and Davies RJ), 109 Salts, gold, acute actions of, on canine tracheobronchial smooth muscle (Krzanowski J et al), 123 in vitro and in vivo inhibition of. on leukotriene production (Wang SR et al), 185 Schistocerca gregaria and Locusfu migraroria, locusts. allergy to (Tee RD et al), 122 Schisrosoma mansoni adult worm and egg extracts using immunoblotting techniques, reactivity of specific IgE and IgG of (Schroder H et al), 122 mediators from IgE-dependent reactions that enhance eosinophiland neutrophil-mediated complement-dependent killing of schistosomula of (MacDonald AJ et al), I16 Schistosomula of S. mansoni, mediator from IgE-dependent reactions that enhance eosinophiiand neutrophil-mediated complement-dependent killing of (MacDonald AJ et al). 116 @CID), severe combined immunodeficiency, appearance of multiple paraproteins during early engraftment of soy lectin T cell depleted haploidentical bone marrow cells in (Ghory PK et al), 189 Sensitivity(ies), food, evaluation of RAST in (Bahna SL and Gandhi MD), 204 skin testing (ST) versus oral challenge (OC) in (Gandhi MD and Bahna SL), 205 IgE, to cabbage (Blaiss MS et al), 207 multiple inhalant, safety and immunogenicity of immunotherapy with polymerized tree, grass. and ragweed in patients with (Grammer LC et al), 165 skin, patient. importance of, in evaluating dose-dependent adverse reactions during imunotherapy (Turkeltaub PC and Baer H), 163 Sensitization. extreme, to cow’s milk (CM) in infants fed breast milk (BM) or soy milk (SM) (Schwartz RH et al). 177 Septal perforation, nasal, in patients using intranasal beclomethasone dipropionate (BDP) (LaForce C and David V), 186 Seralyzer system, use of, for theophylline level determination in office setting (Lotner GZ and Tinkelman DG), 127 Serotonin receptors, potential of ergonovine to precipitate bronchial asthmatic attacks via (Sakamoto Y et al), 141 Serum albumin. ethylene oxide-human, antibody against, in patients with anaphylactic reactions to dialysis (Patterson BF et al), 150 human, beta propiolactone treated (PBL-HSA): allergen for humans receiving rabies vaccine (Baer H et al), 137 soluble copolymer of wasp (Polisres) venom with, for immunotherapy (Gewurz A et al), 208 factor, non-antibody, in asthmatic patients inhibits binding to beta adrenergic receptors (Lad P et al), 180 IgE levels. pulmonary function, and specihc IgE immune responses in monozygotic twins reared apart (Hanson B et al), 155 sickness, human, cutaneous manifestations of (Bielory L et al), 130 -like reaction associated with skin-sensitizing antibody following booster dose of rabies human diploid cell vaccine (Deutsch AJ et al), 108 theophylline determination, high pressure liquid chromatography (HPLC) versus Ames Seralyzer (AS) for (Amdall L et al), 127 Silicosis, immunologic changes reflecting disease activity in (Stankus RP and Salvaggio JE), 1.57 Sinus abnormalities, radiographic, in patients with type I allergic or non-allergic asthma and rhinitis (Stevens WJ et al), 187

786

Meeting

abstracts subject index

Sinus abnormalities-cont’d disease, maxillary, comparison of A-mode ultrasound and x-ray for the screening of (Berger W and Weiss J), 187 Sinusitis, ultrasound versus radiography for diagnosis of (Shapiro G et al), 187 SK&F 93944, double-blind controlled safety and efficacy trial of (McCall MK et al), 168 Skin and RAST testing, variability of food antigens used in (Brummund W et al), 203 IgE-deposition, IgE, IgE-containing circulating immune complexes (IgE-CIC), and IgE-rheumatoid factor (RF) in rheumatoid arthritis (RA) patients (pts) (De Clerck LS et al), 202 reactions, human allergic, patterns of LTC, release in (Talbot SF et al), 183 sensitivity, patient, importance of, in evaluating dose-dependent adverse reactions during immunotherapy (Turkeltaub PC and Baer H), 163 -sensitizing antibody following booster dose of rabies human diploid cell vaccine, serum sickness-like reaction associated with (Deutsch AJ et al), 108 -test negative children, history-positive, sting outcome in: insect allergy (Schuberth KC et al), 151 potency, reproduction of, of dog allergen extracts by means of immunochemical standardization procedure (Ingemann L et al), 122 reactivity in humans, axelastine inhibition of (Merton H et al), 167 syringes, intradermal (I.D.), viral contamination of: comparison of two needle changing techniques (Koepke JW et al), 195 variation of, according to age of patients (Skassa-Brociek W et al), 195 Skin testing (ST) and immunotherapy (IT), fatalities (F) from (Lackey R et al), 166 food, in patients with “idiopathic anaphylaxis” (Stricker WE et al), 150 use of common syringes in (Shulan DJ et al), 195 versus oral challenges (OC) in food sensitivity (Gandhi MD and Bahna SL), 205 Smoke, cigarette, from mothers increases bronchial reactivity and asthma severity in their children (Murray AB and Morrison BJ), 171 Smooth muscle, canine tracheobronchial, acute actions of gold salts on (Krzanowski J et al), 123 vascular, and isolated guinea pig airway, relaxant activity of atriopeptins in (O’Donnell M et al), 142 Snow-crab processing workers with occupational asthma (OA), IgE sensitization in (McCants M et al), 135 Sodium cromoglycate and salbutamol, influence of, on mast cell mediator release in vivo (Church MK et al), 195 magnitude and duration of inhibitory effect of three doses of: bronchoconstriction stimulated by hyperventilation of cold dry air (Juniper EF et al), 173 Sodium cromolyn (SC) and salbutamol on this release, effects of: NCA release from human blood lymphocytes (Cundell DR and Davies RI), 109 Solenopsis invicta, imported fire ant (IFA), allergens of (Nordvall SL et al), 122 Spore(s) allergy in highly ragweed-sensitive subjects, Coprinus micaceus, Fuligo septica, and Akemaria alternata (Santilli J et al), I18 Basidiomycetes. and mycelia, antigens in, comparison of (Lopez M et al), 175 Sputum of patients with asthma and COPD, platelet activating factor in (Grandel KE et al), 184 Steroid(s) dependent asthmatics, theophylline in (Brenner M et al), 128 sex, effect of, on basophil histamine release (Slater JE and Kaliner MA), 176

J. ALLERGY CLIN. IMMUNOL. JUNE 1995

Steroid(s) dependent asthmatics-cont’d treatment on circulating leukocytes, anomalous effects of (Toogood JH et al), 158 Streptococcal disease, very late onset group B, in preterm infants, severe hypogammaglobulinemia associated with (Asser S and O’Connor RD), 188 Sting challenges, deliberate insect, plasma histamine levels following (Squillace DL et al), 151 honeybee, allergy, combined active and passive immunotherapy in (Muller U et al), 208 value of risk indices in predicting reactivity to (Day JH), 209 outcome in history-positive, skin-test negative children: insect allergy (Schuberth KC et al), 151 problem, emerging, in Eastern U.S., European hornet (VESPA CRABRO) (Jacobson RS and Hoffman DR), 121 Succinylcholine, anaphylactic reactions to. Prevention of mediators release by choline (Vervolet D et al), 150 role of quatemary ammonium ions in mechanisms of (Cador D et al), 150 Sugar “allergy” and children’s behavior (Mahan LK et al), 177 Sulfite(s) and sulfur dioxide (SO,) sensitivity, simultaneous (Sprenger JD et al), 144 challenges in patients with systemic mastocytosis (SM) or unexplained anaphylaxis (UEA) (Meggs WJ et al), 144 ingested, prevalence and degree of sensitivity to (Buckley CE et al), 144 residues, detection of, in restaurant salads (Taylor SL et al), 198 sensitive asthmatics (SSA), reactivity to inhaled Bronkosol in (Simon RA), 145 patients, neutrophil chemotactic activity in (Altman LC et al), 144 Sulfite sensitivity: restaurant-provoked asthma (Howland WC and Simon RA), 145 Sulfur dioxide (SO,) and sulfite sensitivity, simultaneous (Sprenger JD et al), 144 versus SO,-saline aerosol, pulmonary effects of (Koenig JQ et al), 145 Sulphidopeptide leukotrienes and LTB, in nasal secretions and nasal polyposis (Fitzharris P et al), 112 Supematants, ceil culture, variability in quantitation of IgE protein in (Helm RM et al), 138 Supemxide (0;) generation, leukocyte inhibitory factor (LIF) potentiation of F-met-leu-phe induced chemotaxis and (Borish LC et al), 109 human neutrophil (PMN), production, influenza virus (INF VlR) reduces verapamil (VER) inhibition of (Sharp: G et al), 116 Sweat bee allergy, evaluation of, with sweat bee venom (Pence H et al), 209 Syndromes, antibody deficiency, with anti-IgA antibodies and successful immunoglobulin prophylaxis (Bjorkander J et al), 137 Synthesis, IgE, in atopic patients during immunotherapy, generation of suppressor cells that modulate (Tamir R et al), 138 Systemic reactions, cold-induced, detection and management of cold urticaria patients at high risk for (Wanderer A et al), 114 T Tachyphylaxis, beta-adrenergic, attempt of predicting (Clause1 AM et al), 180 T cell activation by OKT3, familial defect in, can be overcome by cross-linking of OKT3 with anti-mouse IgG (Ceuppens JL), 182 early and late, essential messenger in: calcium (Birx DL et al), 181 clones, human, characterization of, that regulate IgE pmduction in vitro (Zimmerman B et al), 138 from normal and atopic subjects, histamine type 1 (H,) receptor radioligand binding studies in (Cameron W et al), 110

Meeting

VOLUME 75 NUMBER 6

T cell activation by OKT3-cont’d hybridomas, human IgE binding factor produced by (Stadler BM et al), 139 intestinal goblet cell regulation by (Levy DA et al), 200 lines, FC,R+ human, production of IgE potentiating factor by (Young MC et al), 109 mediated cytotoxicity, human, K channel requirement for (Chandy KG et al), 181 monoclonal helper, induce normal B cells to synthesize IgE antibody (Umetsu DT et al), 138 reactivity to penicillin (Pichler WJ et al), 108 responses, phenotyping in vitro (Suez D and Hayward A), 201 Terbutaline (TER), albuterol (ALB), and epinephrine (EPI), subcutaneous, comparison of, in acute asthma (Kemp JP et al), 162 and albuterol (ALB), subcutaneous: a single-dose crossover comparison in acute asthma (Hoernke JA et al), 179 isoetharine (I), comparison of, when delivered by closed intermittent flow nebulizer system (Welch MJ et al), 162 long-term oral, double-blind study of: efficacy and side effects (Kray KT et al), 179 suppression of antigen induced histamine release in vivo, effects of propanolol on (Rauls DO and Ting S), 123 sustained-release (SR), vs. SR theophylline, comparison of, in young patients with asthma (Roberts JR et al), 113 Terfenadine (T), astemizole (A), and hydroxyzine (H), comparison of efficacy and adverse effects of (Gendreau-Reid LF et al), 168 effect of, on methacholine-induced bronchoconstriction in asthma (Pate1 KR et al), 168 pharmacokinetic and pharmacodynamic investigations of (Foster TS and Batenhorst RL), 168 Tetanus toxoid (‘IT), anaphylaxis (ANA) to: IgE-mediated disease (Engler RJM and Zaloga G), 210 anti-tetanus toxoid (‘IT) antibody and auto-anti-idiotype (Id) antibody responses of young and old human subjects following boosting with (Arreaza EE et al), 190 cutaneous delayed hypersensitivity (CDH) to, in immunized and non-immunized population (Chryssanthopoulos C et al), 200 induces polyclonal B cell activation and rheumatoid factor production (Tar L and Levinson AI), 191 Theo-Dur in asthmatic subjects, effect of food on once daily (Spector SL et al). 105 versus Theo-24 kinetics using stable isotope methodology (Walker S et al), 129 Theo-24 versus Theo-Dur kinetics using stable isotope methodology (Walker S et al), 129 Theophylline (T) and inhaled albuterol (A) used separately and in combination (C), physiological and psychological variables during maintenance therapy with (Joad J et al). 113 concentrations, venous (V) and capillary finger stick (FS) serum, reliability of micro-method for measuring (Altenburger KM and Massanari M), 128 determinations. serum, high pressure liquid chromatography (HPLC) versus Ames Seralyzer (AS) for (Amdall L et al), 127 in steroid dependent asthmatics (Brenner M et al), 128 levels, comparison of, in asthmatics sequentially receiving four different sustained release (SR) preparations (Gonzalez S et al), 106 determination in office setting, use of Seralyzer system for (Lotner GZ and Tinkelman DG), 127 once and twice daily sustained release, in asthma, comparison of (Thomas R et al), 106 preparations, sustained-release, determination of in vivo mean absorption and dissolution times of (Saccar CL et al), 105 two sustained release (SR), in asthmatic children, short term comparison of (Rachelefsky G et al), 105

abstracts

subject

index

787

Theophylline (T) and inhaled albuterol (A)--cont’d slow-release, inhibits late asthmatic reaction to toluendiisocyanate in sensitized subjects (Crescioli S et al). 129 single daily dose. and aerosol salbutamol (SAL) in asthma treatment (Smith A et al), 113 SR vs. sustained-release (SR) terbutaline, comparison of, in young patients with asthma (Roberts JR et al), 113 sustained release (SRT): absorption in young children (Haltom JR and Szefler SJ), 105 test, new, without instrumentation, whole blood/plasma ratio determined by (Hoffman M et al), 128 whole blood, evaluation of, requiring no instrument (Comboy C et al), 128 24-hour: variability in trough to peak (TIP) ratios (Jaber M et al), 106 (UNIPHYL), once a day, for treatment of patients with asthma (AS) and cystic fibrosis (CF) (Blessing-Moore J et al), 106 versus oral metaproterenol, pulmonary function and cardiovascular responses to exercise in asthmatic children on (Oppenheimer P and Schuller D), 113 Thiazinamium chloride (TC) is potent muscle relaxant in bronchial preparations from human lung (HBP) (Raffestin B et al), 123 Thymosin fraction V and interleukin-2, effect of, on expression of TAC antigen and lymphocyte transformation in AIDS (Reddy MM et al), 183 Thymus, pathology of, in pediatric acquired immune deficiency syndrome (AIDS) (Joshi VV et al), 192 Toluendiisocyanate in sensitized subjects, slow-release theophylline inhibits late asthmatic reaction to (Crescioli S et al), 129 Tracheitis, bacterial-broader clinical spectrum (Stempel DA), 199 Tracheobronchial smooth muscle, canine, acute actions of gold salts on (Krzanowski J et al), 123 Tree, grass, and ragweed, polymerized, in patients with multiple inhalant sensitivities, safety and immunogenicity of immunotherapy with (Grammer LC et al), 165 Triatoma protracra, species specific allergens from, identification and characterization of (Chapman MD et al), 147 Trimellitic anhydride (TMA) induced immunologic lung injury, animal model of (Zeiss CR et al), 135 suppression of murine IgE antibody responses to (Wei B-Y et al). 198 Trimethoprim-sulfamethoxazole in patient with AIDS, oral desensitization to (Finegold I), 137 Troleandomycin (TAO) and methylprednisolone, incidence of corticosteroid side effects in chronic steroid dependent asthmatics on (Harris R and German D), 157 Trypsin, anaphylactic reactivity to (Tonne1 AB et al). 210 Tryptase from human mast cells, effect of, on fibrinogen and plasminogen (Schwartz LB et al). 183 U UFFI

off-gas,

formaldehyde free, formaldehyde, and particles in UFFI related asthma, respiratory responses to (Lees REM et al), 169 Ultrasound, A-mode, and x-ray, comparison of, for screening of maxillary sinus disease (Berger W and Weiss J). 187 versus radiography for diagnosis of sinusitis (Shapiro G et al), 187 UNIPHYL, once a day theophylline, for treatment of patients with asthma (AS) and cystic fibrosis (CF) (Blessing-Moore J et al), 106 Urea-formaldehyde foam insulation (UFFI) extract, aqueous, failure of, to elicit bronchospasm or bronchial hypersensitivity (Del Carpio J et al), 143

788

Meeting

abstracts

subject

index

Urticaria,

chronic idiopathic (CIU), efficacy of astemizole (AST) for treatment of (Bernstein IL and Bernstein DI), 130 doxepin in treatment of (Goldsobel A et al), 130 studies of mononuclear cell infiltrate in (Elias J and Kaplan AP). 114 with astemizole (A), treatment of (Fox RW et al), 167 increased 48180 induced local histamine release in patients with (Bedard PM et al), 126 cold and heat-induced. combined (Famam J et al), 114 patients at high risk for cold-induced systemic reactions, detection and management of (Wanderer A et al), 114 delayed pressure (DPU). morphologic characteristics of (Dobozin BS et al), 132 generalized chronic, secondary to zinc-containing insulin (Chang KC et al). 131 local heat (LHU). HI and H2 receptor blockade in treatment of: confirmation (Buchbinder EM et al), 132 V

Vaccine,

polyribose phosphate (PRP) polysaccharide, children with IgG, subclass deficiency have an impaired response to (Geha R et al), 188 rabies, allergen for humans receiving: beta propiolactone treated human serum albumin (BPL-HSA) (Baer H et al), 137 human diploid cell, serum sickness-like reaction associated with skin-sensitizing antibody following booster dose of (Deutsch AJ et al), 108 Vascular endothelial cell interleukin-I production, human, regulation of (Epstein E et al), 191 permeability, cutaneous, measurement of (Keahey TM et al), 129 smooth muscle and isolated guinea pig airway, relaxant activity of atriopeptins in (O’Donnell M et al), 142 Venom and whole body extracts, antigenic analysis of: imported tire ant hypersensitivity (Butcher BT et al), 147 honeybee, (HBV) sensitive patients, treatment of, with fragment of phospholipase A, (PLA,) (Litwin A et al), 151 immunotherapy (VIT), is forever? (Golden DBK et al), 208 -specitic IgE as criterion for discontinuing venom immunotherapy (VIT), further evaluation of decline in (Randolph CC and Reisman RE), 15 I honeybee and yellow jacket, further studies of patients with both (Reisman RE and Lazell MI), 208

J. ALLERGY CLIN. IMMUNOL JUNE lSR5

Venom and whole body extracts-cont’d sweat bee, evaluation of sweat bee allergy with (Pence H et al), 209 wasp (Polistes). soluble copolymer of, with human serum albumin for immunotherapy (Gewurz A et al), 208 Venous 0’) and capillary finger stick (FS) serum theophylline (T) concentrations, reliability of micro-method for measuring (Altenburger KM and Massanari M), 128 Ventricular fibrillation in heavy rats, effect of indomethacin (I), dexamethasone (D), or chloroquine (C) on isoproterenol (ISOP)-induced (Johnson GL et al), 136 Verapamil, inhaled (V), blocking of exercise-induced bronchoconstriction (EIB) by (Hendeles L et al), 173 inhibition of human neutrophil (PMN) superoxide (0,) production, influenza virus (INF VIR) reduces (Sharpe G et al), 116 VESPA CRABRO, European hornet, emerging sting problem in Eastern U.S. (Jacobson RS and Hoffman DR), 121 Viral contamination of intradermal (I.D.) skin test (S.T.) syringes: comparison of two needle changing techniques (Koepke JW et al), 195 Virus, influenza (INF VIR) reduces verapamil (VER) inhibition of human neutrophil (PMN) superoxide (0,) production (Sharpe G et al), 116 W Wasp (Polisresi Worm,

venom, soluble copolymer of, with human serum albumin for immunotherapy (Gewurz A et al), 208 Schistosoma mansoni adult, and egg extracts using immunoblotting techniques, reactivity of specific IgE and IgG of (Schroder H et al). 122

x X-ray

and A-mode ultrasound, comparison maxillary sinus disease (Berger

of, for screening of W and Weiss J), 187

Y Yellow

jacket

venom-specific of patients with 208

IgE, and honeybee, further studies both (Reisman RE and Lazell MI),